{
  "usdmVersion": "4.0",
  "generatedAt": "2026-01-30T11:02:39.151940",
  "generator": "Protocol2USDM v7.2.0",
  "study": {
    "id": "e2bc7f82-100c-4e80-9fc6-24327d431065",
    "instanceType": "Study",
    "versions": [
      {
        "id": "96740ad9-9ac5-4e02-8247-0a23f3a5c002",
        "instanceType": "StudyVersion",
        "versionIdentifier": "1.0",
        "studyDesigns": [
          {
            "id": "a46bc8b6-a55f-4978-a75b-7f81d48fa08a",
            "name": "Study Design",
            "rationale": "Protocol-defined study design for investigating efficacy and safety",
            "instanceType": "InterventionalStudyDesign",
            "eligibilityCriteria": [
              {
                "id": "56a7d9cf-3a81-4d3c-94ff-b6e73bc805ba",
                "identifier": "1",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "754f4cd7-ef7b-4394-b343-7014325886c6",
                "instanceType": "EligibilityCriterion",
                "name": "Age requirement",
                "nextId": "5c943a1b-a7ba-478b-9660-e02961d12755"
              },
              {
                "id": "5c943a1b-a7ba-478b-9660-e02961d12755",
                "identifier": "2",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "f9af4d7f-2b70-476f-af7e-ef6a97774940",
                "instanceType": "EligibilityCriterion",
                "name": "Diagnosis of WD",
                "previousId": "56a7d9cf-3a81-4d3c-94ff-b6e73bc805ba",
                "nextId": "eb17ce59-df42-4496-9276-335070fd23c6"
              },
              {
                "id": "eb17ce59-df42-4496-9276-335070fd23c6",
                "identifier": "3",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "340a523a-2f47-4cc8-8d89-afc7d64590a2",
                "instanceType": "EligibilityCriterion",
                "name": "Benefit from decoppering therapy",
                "previousId": "5c943a1b-a7ba-478b-9660-e02961d12755",
                "nextId": "c6ccc877-f746-4bf6-bbe8-d8ac971444e9"
              },
              {
                "id": "c6ccc877-f746-4bf6-bbe8-d8ac971444e9",
                "identifier": "4",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "bd423c24-eabd-4a3a-b3ef-f9682ae428fc",
                "instanceType": "EligibilityCriterion",
                "name": "Compliance with procedures",
                "previousId": "eb17ce59-df42-4496-9276-335070fd23c6",
                "nextId": "c2a8746a-f986-4341-a096-f3815126f0d9"
              },
              {
                "id": "c2a8746a-f986-4341-a096-f3815126f0d9",
                "identifier": "5",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "4ed1cf23-2f6d-4f59-8b22-9071c7f7f9e8",
                "instanceType": "EligibilityCriterion",
                "name": "Reside in CRU",
                "previousId": "c6ccc877-f746-4bf6-bbe8-d8ac971444e9",
                "nextId": "93348403-fa8d-49f7-8c0a-3c3524121908"
              },
              {
                "id": "93348403-fa8d-49f7-8c0a-3c3524121908",
                "identifier": "6",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "99025a75-49df-4abf-b8c7-c9c1f1be74f9",
                "instanceType": "EligibilityCriterion",
                "name": "Discontinue chelator therapy",
                "previousId": "c2a8746a-f986-4341-a096-f3815126f0d9",
                "nextId": "1421b8a2-2152-4a51-addd-58e9c82e6c5a"
              },
              {
                "id": "1421b8a2-2152-4a51-addd-58e9c82e6c5a",
                "identifier": "7",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "67f49933-0fa9-4eac-a460-b80e56e660c6",
                "instanceType": "EligibilityCriterion",
                "name": "Venous access",
                "previousId": "93348403-fa8d-49f7-8c0a-3c3524121908",
                "nextId": "438ab99b-d44c-486f-8037-f2653c1175ad"
              },
              {
                "id": "438ab99b-d44c-486f-8037-f2653c1175ad",
                "identifier": "8",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "30aad786-7cd2-4ceb-b375-9f83623f8f0a",
                "instanceType": "EligibilityCriterion",
                "name": "Swallow intact tablets",
                "previousId": "1421b8a2-2152-4a51-addd-58e9c82e6c5a",
                "nextId": "7a18990a-5ed4-48c0-b123-b4548f4ced4e"
              },
              {
                "id": "7a18990a-5ed4-48c0-b123-b4548f4ced4e",
                "identifier": "9",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5847b9c0-94b6-4444-859a-a5a3d03a61df",
                "instanceType": "EligibilityCriterion",
                "name": "Avoid mineral use",
                "previousId": "438ab99b-d44c-486f-8037-f2653c1175ad",
                "nextId": "396d3614-e13a-4dfe-b5fc-cfa4bfe67971"
              },
              {
                "id": "396d3614-e13a-4dfe-b5fc-cfa4bfe67971",
                "identifier": "10",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "13920a7c-9bfe-445f-a680-e7a895f4411f",
                "instanceType": "EligibilityCriterion",
                "name": "Dietary adherence",
                "previousId": "7a18990a-5ed4-48c0-b123-b4548f4ced4e",
                "nextId": "29dcf37e-14e9-4336-aad6-34285b1e4c20"
              },
              {
                "id": "29dcf37e-14e9-4336-aad6-34285b1e4c20",
                "identifier": "11",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "9175a8c3-f3ac-47a2-ba33-b88d8b2c2276",
                "instanceType": "EligibilityCriterion",
                "name": "Contraceptive use",
                "previousId": "396d3614-e13a-4dfe-b5fc-cfa4bfe67971",
                "nextId": "da991917-90de-493d-9d9d-b2a0ba0a57f5"
              },
              {
                "id": "da991917-90de-493d-9d9d-b2a0ba0a57f5",
                "identifier": "12",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "3158767c-86ca-4aaf-be95-48fda4f3cc8a",
                "instanceType": "EligibilityCriterion",
                "name": "Informed Consent",
                "previousId": "29dcf37e-14e9-4336-aad6-34285b1e4c20"
              },
              {
                "id": "0e6c54f5-c1e7-4fe9-a487-3852662e6b49",
                "identifier": "E1",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "9ee9ffa0-41ee-4aef-a1ba-690e315157b3",
                "instanceType": "EligibilityCriterion",
                "name": "Decompensated cirrhosis",
                "nextId": "281318ee-9de5-4516-abc3-29836fc74fbd"
              },
              {
                "id": "281318ee-9de5-4516-abc3-29836fc74fbd",
                "identifier": "E2",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "e8cd5e45-3284-4bbf-9967-571d14db6472",
                "instanceType": "EligibilityCriterion",
                "name": "Modified Nazer score",
                "previousId": "0e6c54f5-c1e7-4fe9-a487-3852662e6b49",
                "nextId": "fb152bbd-7b2a-4ff9-b1ff-f0ce3abe021f"
              },
              {
                "id": "fb152bbd-7b2a-4ff9-b1ff-f0ce3abe021f",
                "identifier": "E3",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "d4ace5d1-735b-417a-bcf6-23bcf6ca80f3",
                "instanceType": "EligibilityCriterion",
                "name": "Gastrointestinal bleed",
                "previousId": "281318ee-9de5-4516-abc3-29836fc74fbd",
                "nextId": "c1360b05-711e-48db-b0b6-3d9d37333901"
              },
              {
                "id": "c1360b05-711e-48db-b0b6-3d9d37333901",
                "identifier": "E4",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "1b01300f-411a-4bde-99f7-12a9e23afdde",
                "instanceType": "EligibilityCriterion",
                "name": "ALT elevation",
                "previousId": "fb152bbd-7b2a-4ff9-b1ff-f0ce3abe021f",
                "nextId": "bb0d5209-c65b-4959-b1a1-8fafce1a8426"
              },
              {
                "id": "bb0d5209-c65b-4959-b1a1-8fafce1a8426",
                "identifier": "E5",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "6905cf66-bf51-404f-a58b-484a4a0cebf9",
                "instanceType": "EligibilityCriterion",
                "name": "Neurological disease",
                "previousId": "c1360b05-711e-48db-b0b6-3d9d37333901",
                "nextId": "933e7291-1b9e-40f8-9039-874c98062611"
              },
              {
                "id": "933e7291-1b9e-40f8-9039-874c98062611",
                "identifier": "E6",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5c4d5ce3-67d4-417b-a329-6463ce38a46b",
                "instanceType": "EligibilityCriterion",
                "name": "Hemoglobin level",
                "previousId": "bb0d5209-c65b-4959-b1a1-8fafce1a8426",
                "nextId": "fe58d30d-f1ae-47ae-b6b1-cc256f29a491"
              },
              {
                "id": "fe58d30d-f1ae-47ae-b6b1-cc256f29a491",
                "identifier": "E7",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "39b4e4e2-104a-4e86-8baf-c17528c482bb",
                "instanceType": "EligibilityCriterion",
                "name": "Active infection",
                "previousId": "933e7291-1b9e-40f8-9039-874c98062611",
                "nextId": "de809841-c523-462e-b5da-908119995eaa"
              },
              {
                "id": "de809841-c523-462e-b5da-908119995eaa",
                "identifier": "E8",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "14fb12a6-899d-4da9-9784-8205d3719225",
                "instanceType": "EligibilityCriterion",
                "name": "Other medical disorders",
                "previousId": "fe58d30d-f1ae-47ae-b6b1-cc256f29a491",
                "nextId": "17e3fd3b-9b93-4ef1-9e21-28284baa7d3a"
              },
              {
                "id": "17e3fd3b-9b93-4ef1-9e21-28284baa7d3a",
                "identifier": "E9",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "f2b18c8d-fd46-4dda-bbde-86a363e62e5c",
                "instanceType": "EligibilityCriterion",
                "name": "Previous ALXN1840 treatment",
                "previousId": "de809841-c523-462e-b5da-908119995eaa",
                "nextId": "18a71437-0e47-4a6d-bee0-d1aba28c6689"
              },
              {
                "id": "18a71437-0e47-4a6d-bee0-d1aba28c6689",
                "identifier": "E10",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "c2fd7780-2e7b-4791-a895-7913429445f8",
                "instanceType": "EligibilityCriterion",
                "name": "Previous zinc treatment",
                "previousId": "17e3fd3b-9b93-4ef1-9e21-28284baa7d3a",
                "nextId": "aa64271b-f912-47e2-a69e-2274446185c0"
              },
              {
                "id": "aa64271b-f912-47e2-a69e-2274446185c0",
                "identifier": "E11",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "63a3211e-ceb1-42a9-9094-39a07f17b9a8",
                "instanceType": "EligibilityCriterion",
                "name": "Experimental therapy",
                "previousId": "18a71437-0e47-4a6d-bee0-d1aba28c6689",
                "nextId": "7181e465-f32c-4954-8dd2-33002bb7e633"
              },
              {
                "id": "7181e465-f32c-4954-8dd2-33002bb7e633",
                "identifier": "E12",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "60dc34bb-2946-4fa5-9f41-32eb8580695d",
                "instanceType": "EligibilityCriterion",
                "name": "Renal failure",
                "previousId": "aa64271b-f912-47e2-a69e-2274446185c0",
                "nextId": "bda58c87-7211-498e-80c7-efea510382f1"
              },
              {
                "id": "bda58c87-7211-498e-80c7-efea510382f1",
                "identifier": "E13",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "70fa056f-042b-49ea-86bd-ff9c30ab1121",
                "instanceType": "EligibilityCriterion",
                "name": "Pregnancy or breastfeeding",
                "previousId": "7181e465-f32c-4954-8dd2-33002bb7e633",
                "nextId": "5ff5a274-c17d-4bce-905b-16b9207fbc29"
              },
              {
                "id": "5ff5a274-c17d-4bce-905b-16b9207fbc29",
                "identifier": "E14",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5af035f7-95e8-4fed-ab4f-6b4167026dd5",
                "instanceType": "EligibilityCriterion",
                "name": "Known sensitivity",
                "previousId": "bda58c87-7211-498e-80c7-efea510382f1",
                "nextId": "e48aa2aa-1f83-4289-afe8-371521245f80"
              },
              {
                "id": "e48aa2aa-1f83-4289-afe8-371521245f80",
                "identifier": "E15",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "0bd6a392-8561-495e-b1ee-4ebb1705ef17",
                "instanceType": "EligibilityCriterion",
                "name": "Non-compliance",
                "previousId": "5ff5a274-c17d-4bce-905b-16b9207fbc29",
                "nextId": "424b1297-ffeb-4c34-9882-2d60d72953c5"
              },
              {
                "id": "424b1297-ffeb-4c34-9882-2d60d72953c5",
                "identifier": "E16",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "dd8fc848-52e4-4e07-9606-bb04c49dd316",
                "instanceType": "EligibilityCriterion",
                "name": "Substance abuse",
                "previousId": "e48aa2aa-1f83-4289-afe8-371521245f80",
                "nextId": "25984ee6-0c6c-4f42-b4be-9ba01fb7760f"
              },
              {
                "id": "25984ee6-0c6c-4f42-b4be-9ba01fb7760f",
                "identifier": "E17",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "39412cf7-4b1a-4c3b-93de-603c514534ec",
                "instanceType": "EligibilityCriterion",
                "name": "Positive drug screen",
                "previousId": "424b1297-ffeb-4c34-9882-2d60d72953c5",
                "nextId": "1a037463-d316-43cf-b28d-80010fb976d8"
              },
              {
                "id": "1a037463-d316-43cf-b28d-80010fb976d8",
                "identifier": "E18",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "536d6b83-8cbb-4f1d-90fc-46cf59095c49",
                "instanceType": "EligibilityCriterion",
                "name": "Alcohol consumption",
                "previousId": "25984ee6-0c6c-4f42-b4be-9ba01fb7760f",
                "nextId": "fbad0ea5-7b7a-4952-852a-c3af0ba57968"
              },
              {
                "id": "fbad0ea5-7b7a-4952-852a-c3af0ba57968",
                "identifier": "E19",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "55a2526a-5434-4c4a-bfc9-90e53132fe36",
                "instanceType": "EligibilityCriterion",
                "name": "Meal completion",
                "previousId": "1a037463-d316-43cf-b28d-80010fb976d8"
              }
            ],
            "population": {
              "id": "68991d95-5cb2-48a6-82c6-e65c17ae8757",
              "name": "Study Population",
              "includesHealthySubjects": false,
              "criterionIds": [
                "56a7d9cf-3a81-4d3c-94ff-b6e73bc805ba",
                "5c943a1b-a7ba-478b-9660-e02961d12755",
                "eb17ce59-df42-4496-9276-335070fd23c6",
                "c6ccc877-f746-4bf6-bbe8-d8ac971444e9",
                "c2a8746a-f986-4341-a096-f3815126f0d9",
                "93348403-fa8d-49f7-8c0a-3c3524121908",
                "1421b8a2-2152-4a51-addd-58e9c82e6c5a",
                "438ab99b-d44c-486f-8037-f2653c1175ad",
                "7a18990a-5ed4-48c0-b123-b4548f4ced4e",
                "396d3614-e13a-4dfe-b5fc-cfa4bfe67971",
                "29dcf37e-14e9-4336-aad6-34285b1e4c20",
                "da991917-90de-493d-9d9d-b2a0ba0a57f5",
                "0e6c54f5-c1e7-4fe9-a487-3852662e6b49",
                "281318ee-9de5-4516-abc3-29836fc74fbd",
                "fb152bbd-7b2a-4ff9-b1ff-f0ce3abe021f",
                "c1360b05-711e-48db-b0b6-3d9d37333901",
                "bb0d5209-c65b-4959-b1a1-8fafce1a8426",
                "933e7291-1b9e-40f8-9039-874c98062611",
                "fe58d30d-f1ae-47ae-b6b1-cc256f29a491",
                "de809841-c523-462e-b5da-908119995eaa",
                "17e3fd3b-9b93-4ef1-9e21-28284baa7d3a",
                "18a71437-0e47-4a6d-bee0-d1aba28c6689",
                "aa64271b-f912-47e2-a69e-2274446185c0",
                "7181e465-f32c-4954-8dd2-33002bb7e633",
                "bda58c87-7211-498e-80c7-efea510382f1",
                "5ff5a274-c17d-4bce-905b-16b9207fbc29",
                "e48aa2aa-1f83-4289-afe8-371521245f80",
                "424b1297-ffeb-4c34-9882-2d60d72953c5",
                "25984ee6-0c6c-4f42-b4be-9ba01fb7760f",
                "1a037463-d316-43cf-b28d-80010fb976d8",
                "fbad0ea5-7b7a-4952-852a-c3af0ba57968"
              ],
              "instanceType": "StudyDesignPopulation",
              "description": "Target population defined by eligibility criteria"
            },
            "objectives": [
              {
                "id": "96d15560-f0f2-432a-b80b-4929a9dae8f3",
                "name": "Primary Objective",
                "text": "Assess net copper balance with daily repeat-dose ALXN1840 treatment (15 mg and 30 mg) in participants with Wilson disease (WD)",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "86538238-4f49-4eb3-b09d-82a4ef9384d7"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "4954e3b9-8eb5-4f7b-a1d1-c8984fdd80b8",
                "name": "Secondary Objective 1",
                "text": "Assess change in copper balance in response to ALXN1840 15 mg/day and 30 mg/day during ALXN1840 accumulation and at steady state periods versus the pretreatment baseline in participants with WD",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "229fcebe-3985-4b5e-8c4f-ed3aba1abadc"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "00061edf-54d2-44fd-aa85-5443486cceff",
                "name": "Secondary Objective 2",
                "text": "Investigate the effect of ALXN1840 (15 mg/day and 30 mg/day) on the disposition of copper in participants with WD",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "83fec0f5-7399-41db-96b5-73db792c4391"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "851ff5b4-c3be-44f9-97c5-9545129571f4",
                "name": "Secondary Objective 3",
                "text": "Investigate the effect of ALXN1840 on the disposition of molybdenum at steady state at 15 mg/day and 30 mg/day in participants with WD",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "4f329e21-7b26-4c2a-a0cf-a79c13f8b210"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "0e735ab7-2ff8-4060-9ef4-2f31c94a4780",
                "name": "Secondary Objective 4",
                "text": "Assess steady-state total molybdenum balance as a measure of ALXN1840 15 mg/day and 30 mg/day in participants with WD",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "0014966d-496a-4f0c-8e96-5c6a4e855f46"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "396a2f63-a33c-4cb1-af9b-0f8426eeea70",
                "name": "Secondary Objective 5",
                "text": "Assess accumulation of molybdenum with ALXN1840 treatment at 15 mg/day and 30 mg/day in participants with WD",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "1a796116-93db-4e3e-9860-9c99758723f4"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "045bcf5e-0e45-4da7-9cf2-f92be776d3d5",
                "name": "Secondary Objective 6",
                "text": "Determine the steady-state plasma pharmacokinetic (PK) of total molybdenum and plasma ultrafiltrate (PUF) molybdenum (as surrogate measures of ALXN1840, 15 mg and 30 mg) in participants with WD",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "c28c4ed9-3808-47f5-a69a-3be6643bb72b"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "bc040793-be85-4e69-b733-55b8e12eab72",
                "name": "Safety Objective",
                "text": "Evaluate the safety and tolerability of repeated-dose administration of ALXN1840 15 mg/day and 30 mg/day in participants with WD",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "0bafaa71-8125-44ce-90f9-4a41f5a0b33b"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "2e538dfb-3750-4667-894d-021a8166b4ec",
                "name": "Exploratory Objective 1",
                "text": "Determine dose response of ALXN1840 15 mg/day and 30 mg/day for copper balance in participants with WD",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "d5f277e8-db26-4189-8aca-1c88d7bba37b"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "56aa7bea-7e53-4f96-b36d-98d0a16b3348",
                "name": "Exploratory Objective 2",
                "text": "Determine the effect of treatment duration on copper balance in participants with WD",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "f589b7b5-df78-46fe-8f0f-ce55aadcfc3e"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "d1467d67-820c-492a-a136-542689d3ea26",
                "name": "Exploratory Objective 3",
                "text": "Assess the effects of ALXN1840 on ceruloplasmin, ceruloplasmin-bound copper LBC profiles in plasma in participants with WD",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "5f0c35c3-780f-4be2-921a-c5d2529f1c41"
                ],
                "instanceType": "Objective"
              }
            ],
            "endpoints": [
              {
                "id": "86538238-4f49-4eb3-b09d-82a4ef9384d7",
                "name": "Primary Endpoint",
                "text": "Mean daily copper balance where copper balance is measured by the calculated difference between copper intake (in food and drink) and copper output (in feces and urine) during ALXN1840 accumulation and steady-state periods for each dose",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "229fcebe-3985-4b5e-8c4f-ed3aba1abadc",
                "name": "Secondary Endpoint 1",
                "text": "Change in mean daily copper balance as measured by the calculated difference between copper intake (in food and drink) and copper output (in feces and urine) from pretreatment baseline (Days -4 through -1) and ALXN1840 accumulation and steady-state periods for each dose",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "83fec0f5-7399-41db-96b5-73db792c4391",
                "name": "Secondary Endpoint 2",
                "text": "Copper quantified in food, drink, feces, and urine, including plasma total and labile bound copper (LBC) during ALXN1840 accumulation and steady-state periods for each dose",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacodynamic"
              },
              {
                "id": "4f329e21-7b26-4c2a-a0cf-a79c13f8b210",
                "name": "Secondary Endpoint 3",
                "text": "Molybdenum quantified in food, drink, feces, and urine, plasma total molybdenum at ALXN1840 steady state",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "0014966d-496a-4f0c-8e96-5c6a4e855f46",
                "name": "Secondary Endpoint 4",
                "text": "Mean daily molybdenum balance as demonstrated through measurement of molybdenum intake (in food, drink and ALXN1840), and molybdenum output (feces and urine) representing ALXN1840 steady state",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "1a796116-93db-4e3e-9860-9c99758723f4",
                "name": "Secondary Endpoint 5",
                "text": "Accumulation of molybdenum as determined by molybdenum balance",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "c28c4ed9-3808-47f5-a69a-3be6643bb72b",
                "name": "Secondary Endpoint 6",
                "text": "PK parameters for plasma total and PUF-molybdenum",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "0bafaa71-8125-44ce-90f9-4a41f5a0b33b",
                "name": "Safety Endpoint",
                "text": "Safety parameters: Treatment emergent adverse events (TEAEs)/serious adverse events (SAEs); Clinical laboratory assessments (serum chemistry, hematology, coagulation, and urinalysis); Physical examinations; Heart rate, intervals (PR, QRS, QT and QTc), and clinically significant electrocardiogram (ECG) findings as determined by triplicate 12-lead ECG; Vital sign assessments (blood pressure and heart rate)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "d5f277e8-db26-4189-8aca-1c88d7bba37b",
                "name": "Exploratory Endpoint 1",
                "text": "Assess dose response of ALXN1840 on copper balance focusing on copper balance",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "f589b7b5-df78-46fe-8f0f-ce55aadcfc3e",
                "name": "Exploratory Endpoint 2",
                "text": "Determine the effect of time following initiation of ALXN1840 treatment on copper balance",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "5f0c35c3-780f-4be2-921a-c5d2529f1c41",
                "name": "Exploratory Endpoint 3",
                "text": "Ceruloplasmin, ceruloplasmin-bound copper, and LBC: Change in ceruloplasmin at Days 1, 8, 25, 29, 36, and Day 39 compared with predose",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Biomarker"
              }
            ],
            "estimands": [
              {
                "id": "4bc43fef-6840-408e-a892-a62687499628",
                "name": "Primary Efficacy Estimand",
                "populationSummary": "Participants with Wilson Disease (WD) meeting eligibility criteria Summary measure: Mean daily balance for each dose level.",
                "analysisPopulationId": "c4ead87a-a204-4696-bd37-36c37624bf49",
                "variableOfInterestId": "86538238-4f49-4eb3-b09d-82a4ef9384d7",
                "interventionIds": [
                  "23dbb3fc-5105-4296-bf56-c4332f7a3790"
                ],
                "intercurrentEvents": [
                  {
                    "id": "5f680fdf-8332-41da-8d5d-ab5305f0e1a4",
                    "name": "Treatment discontinuation",
                    "text": "Participant discontinues ALXN1840 before completion of the steady-state collection period",
                    "strategy": "While on Treatment",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "1656baf5-f841-4340-b7d1-fbb782319cc9",
                    "name": "Dose modification/interruption",
                    "text": "Dose is decreased or interrupted due to safety concerns or meeting Dose Modification criteria",
                    "strategy": "Hypothetical",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "ALXN1840 (15 mg and 30 mg daily)",
                "analysisPopulation": "Participants with Wilson Disease (WD) meeting eligibility criteria",
                "variableOfInterest": "Mean daily copper balance (calculated difference between copper intake and output) during accumulation and steady-state periods",
                "summaryMeasure": "Mean daily balance for each dose level"
              },
              {
                "id": "eaf36e7c-a16e-46c7-9425-501b96cb9cc2",
                "name": "Secondary Efficacy Estimand - Change from Baseline",
                "populationSummary": "Participants with Wilson Disease (WD) meeting eligibility criteria Summary measure: Mean change from baseline.",
                "analysisPopulationId": "ee16b3f1-f9af-4a6b-9295-a7d046fc02ee",
                "variableOfInterestId": "229fcebe-3985-4b5e-8c4f-ed3aba1abadc",
                "interventionIds": [
                  "a411894c-c68f-4896-9867-8d2342fff49c"
                ],
                "intercurrentEvents": [
                  {
                    "id": "5f680fdf-8332-41da-8d5d-ab5305f0e1a4",
                    "name": "Treatment discontinuation",
                    "text": "Participant discontinues ALXN1840 before completion of the steady-state collection period",
                    "strategy": "While on Treatment",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "1444953f-4642-44bc-bc74-fad4971bc159",
                    "name": "Use of prohibited medication",
                    "text": "Use of zinc therapy or other chelators during the study period",
                    "strategy": "Hypothetical",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "ALXN1840 (15 mg and 30 mg daily) vs. Pretreatment Baseline",
                "analysisPopulation": "Participants with Wilson Disease (WD) meeting eligibility criteria",
                "variableOfInterest": "Change in mean daily copper balance from pretreatment baseline (Days -4 through -1) to accumulation and steady-state periods",
                "summaryMeasure": "Mean change from baseline"
              },
              {
                "id": "d3012392-167e-4f61-ba47-bdaeb4eb36ca",
                "name": "Secondary Molybdenum Balance Estimand",
                "populationSummary": "Participants with Wilson Disease (WD) meeting eligibility criteria Summary measure: Mean daily balance.",
                "analysisPopulationId": "f1cb8a4a-ae5e-4e4f-957f-502567397e8c",
                "variableOfInterestId": "0014966d-496a-4f0c-8e96-5c6a4e855f46",
                "interventionIds": [
                  "861d9038-97b8-4a5d-bcac-f24360c87401"
                ],
                "intercurrentEvents": [
                  {
                    "id": "5f680fdf-8332-41da-8d5d-ab5305f0e1a4",
                    "name": "Treatment discontinuation",
                    "text": "Participant discontinues ALXN1840 before steady-state molybdenum assessment",
                    "strategy": "While on Treatment",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "ALXN1840 (15 mg and 30 mg daily)",
                "analysisPopulation": "Participants with Wilson Disease (WD) meeting eligibility criteria",
                "variableOfInterest": "Mean daily molybdenum balance (intake vs output) at steady state",
                "summaryMeasure": "Mean daily balance"
              },
              {
                "id": "a2877d27-79cd-48d0-b3e3-73c8d44e2d1d",
                "name": "Primary: Net Negative Copper Balance",
                "instanceType": "Estimand",
                "populationSummary": "Net Copper Balance < 0 (Net Negative)",
                "variableOfInterestId": "",
                "analysisPopulationId": "",
                "intercurrentEvents": [],
                "interventionIds": [],
                "extensionAttributes": [
                  {
                    "id": "ee0e0c21-feec-4c74-8c0a-b2f3759a2ee7",
                    "url": "https://protocol2usdm.io/extensions/x-algorithm",
                    "valueString": "Net Copper Balance = (Copper Intake) - (Copper Output in Feces + Copper Output in Urine)",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              }
            ],
            "blindingSchema": {
              "id": "818ad6a8-aa37-403a-891d-885cef0f1107",
              "standardCode": {
                "id": "b4b38392-b616-4499-9827-db22f1cc68c0",
                "code": "Open Label",
                "codeSystem": "http://www.cdisc.org",
                "codeSystemVersion": "2024-09-27",
                "decode": "Open Label",
                "instanceType": "Code"
              },
              "instanceType": "AliasCode"
            },
            "randomizationType": {
              "code": "Non-Randomized"
            },
            "arms": [
              {
                "id": "996ebc3e-3f8c-4f9d-af0f-9ab440c6aad4",
                "name": "ALXN1840 Treatment",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Single-arm treatment where participants receive 15 mg/day for approximately 28 days, followed by titration to 30 mg/day starting on Day 29.",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "26.01d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "5b63a7c5-ee9c-45b4-9e31-eec6c36974c5",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              }
            ],
            "studyCohorts": [
              {
                "id": "0a3f1c2c-a541-4533-9756-0c8b3f50c4db",
                "name": "Cohort 1 (Treatment experienced)",
                "instanceType": "StudyCohort",
                "characteristic": "Patients who have received WD therapy for > 28 days"
              },
              {
                "id": "a26a7d81-bb00-451f-9960-bfcd84f00193",
                "name": "Cohort 2 (Treatment nave)",
                "instanceType": "StudyCohort",
                "characteristic": "Patients who have received WD therapy for  28 days"
              }
            ],
            "studyCells": [
              {
                "id": "4c3b9d10-e9ab-4479-8928-a87a424b8bfb",
                "armId": "996ebc3e-3f8c-4f9d-af0f-9ab440c6aad4",
                "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4",
                "elementIds": [
                  "54da0f3d-dd96-4789-8faf-8fadd4900f26"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "4912d0b8-beb6-48f3-aa90-c14f72b23057",
                "armId": "996ebc3e-3f8c-4f9d-af0f-9ab440c6aad4",
                "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769",
                "elementIds": [
                  "7c65fa37-3a45-488c-a198-e3712fb694f3"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "fee70ef9-90cc-48fb-8cb4-9e865551ffbf",
                "armId": "996ebc3e-3f8c-4f9d-af0f-9ab440c6aad4",
                "epochId": "b329d201-0097-428f-a975-638b81cdd1ab",
                "elementIds": [
                  "42f9ef55-399e-4a7e-9c16-d36a3ddd1ff5"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "b3b8167b-d3a7-46c6-b7a0-c6ce7f9bcef6",
                "armId": "996ebc3e-3f8c-4f9d-af0f-9ab440c6aad4",
                "epochId": "e1c84807-638c-4fe2-9296-6c57a7fc1979",
                "elementIds": [
                  "d7c0836b-88ca-4f11-b68a-37037db1efce"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "911ab2a4-b5f5-4c96-aafd-d059a3ec2ee9",
                "armId": "996ebc3e-3f8c-4f9d-af0f-9ab440c6aad4",
                "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc",
                "elementIds": [
                  "94033821-fd9c-49ef-8d86-3a6dfcf38834"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "ff585920-03df-4a25-aa9f-b9121fa99733",
                "armId": "996ebc3e-3f8c-4f9d-af0f-9ab440c6aad4",
                "epochId": "778933b2-8764-4d4d-a845-ad7210b5a7b1",
                "elementIds": [
                  "2df9ed35-79f2-478b-ab59-fd3da0cd4623"
                ],
                "instanceType": "StudyCell"
              }
            ],
            "studyElements": [
              {
                "id": "54da0f3d-dd96-4789-8faf-8fadd4900f26",
                "name": "ALXN1840 Treatment - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for ALXN1840 Treatment during Screening"
              },
              {
                "id": "7c65fa37-3a45-488c-a198-e3712fb694f3",
                "name": "ALXN1840 Treatment - Run-in Period",
                "instanceType": "StudyElement",
                "description": "Treatment period for ALXN1840 Treatment during Run-in Period"
              },
              {
                "id": "42f9ef55-399e-4a7e-9c16-d36a3ddd1ff5",
                "name": "ALXN1840 Treatment - Inpatient Period 1",
                "instanceType": "StudyElement",
                "description": "Treatment period for ALXN1840 Treatment during Inpatient Period 1"
              },
              {
                "id": "d7c0836b-88ca-4f11-b68a-37037db1efce",
                "name": "ALXN1840 Treatment - Outpatient Period",
                "instanceType": "StudyElement",
                "description": "Treatment period for ALXN1840 Treatment during Outpatient Period"
              },
              {
                "id": "94033821-fd9c-49ef-8d86-3a6dfcf38834",
                "name": "ALXN1840 Treatment - Inpatient Period 2",
                "instanceType": "StudyElement",
                "description": "Treatment period for ALXN1840 Treatment during Inpatient Period 2"
              },
              {
                "id": "2df9ed35-79f2-478b-ab59-fd3da0cd4623",
                "name": "ALXN1840 Treatment - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for ALXN1840 Treatment during Follow-up"
              }
            ],
            "maskingRoles": [
              {
                "id": "22a06840-d920-4317-9a26-b35dc0f24d7f",
                "text": "This is an Open Label study with no masking",
                "isMasked": false,
                "instanceType": "Masking"
              }
            ],
            "procedures": [
              {
                "id": "24decd27-23c1-43b9-8b7c-900057276b21",
                "name": "Blood sampling for PK/PD",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "abfcad9d-76b7-4f41-b151-071047435fa0",
                  "code": "36415",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Collection of venous blood by venipuncture",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Pharmacokinetic and Pharmacodynamic Blood Draw",
                "description": "Collection of blood for plasma total Mo, PUF-Mo, plasma total and PUF-Cu, LBC, ceruloplasmin, and ceruloplasmin-bound Cu"
              },
              {
                "id": "e165d841-2182-4332-b365-aad1e15e8852",
                "name": "12-lead ECG",
                "procedureType": "Diagnostic Procedure",
                "code": {
                  "id": "b5e4bc36-701c-4565-b803-eab8314e159c",
                  "code": "93000",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Electrocardiogram, routine ECG with at least 12 leads",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Electrocardiogram",
                "description": "Triplicate 12-lead electrocardiogram to monitor heart rate and intervals (PR, QRS, QT, QTc)"
              },
              {
                "id": "855b90ee-fcb6-4844-ad61-4a43127caa56",
                "name": "Vital sign measurements",
                "procedureType": "Monitoring",
                "code": {
                  "id": "a4df63ff-6f8b-41ef-adf5-00efbe0b7b70",
                  "code": "C25548",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Monitoring",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Vital Signs",
                "description": "Assessment of body temperature, heart rate, respiratory rate, and systolic/diastolic blood pressure"
              },
              {
                "id": "1be43fec-3d98-4e0f-9d34-a58ed1ac1c74",
                "name": "Physical examination",
                "procedureType": "Assessment",
                "code": {
                  "id": "107a668d-b610-4aeb-97fd-30756af8275a",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Physical Exam",
                "description": "Assessments of cardiovascular, respiratory, gastrointestinal, and neurological systems"
              },
              {
                "id": "f241c07a-7a26-440f-9c73-9cf52f3e3d3d",
                "name": "24-hour urine collection",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "473fc0b3-f6ef-4093-a3ea-0db2dc7429b9",
                  "code": "C70793",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Biospecimen Collection",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Urine Collection",
                "description": "Collection of urine for measurement of copper and molybdenum content"
              },
              {
                "id": "849704ea-0b1e-457d-bbd3-1f13815a70af",
                "name": "Fecal collection",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "1a42328a-322e-4878-920e-dff1e455c4bd",
                  "code": "C70793",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Biospecimen Collection",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Stool Collection",
                "description": "Individual collection of fecal samples for copper and molybdenum content analysis"
              },
              {
                "id": "a8deb9b9-b7b0-41d0-80ab-4af6909d3a43",
                "name": "Inductively coupled plasma mass spectrometry",
                "procedureType": "Diagnostic Procedure",
                "code": {
                  "id": "97c2b117-7a4b-4276-8e9a-32bec4743903",
                  "code": "C25391",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Diagnostic Procedure",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "ICP-MS",
                "description": "Laboratory analysis to determine copper and molybdenum concentrations in samples"
              },
              {
                "id": "5fd9167b-7b61-4d18-a173-c31b06444479",
                "name": "Pregnancy testing",
                "procedureType": "Diagnostic Procedure",
                "code": {
                  "id": "29c9954f-7f7b-4d5f-b01a-29b1c0784bf0",
                  "code": "C25391",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Diagnostic Procedure",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Pregnancy Test",
                "description": "Urine or serum pregnancy tests for females of childbearing potential"
              }
            ],
            "medicalDevices": [
              {
                "id": "3a4cc166-c3e0-4476-9f1c-c0b4c3b77851",
                "name": "Cannula",
                "instanceType": "MedicalDevice",
                "label": "Venous Cannula",
                "description": "Placed to minimize needle sticks for repeated blood draws; not to be left in place longer than 72 hours",
                "deviceType": {
                  "id": "017786b7-750d-47b7-9c34-efc9b0286cd2",
                  "code": "Drug Delivery Device",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Drug Delivery Device",
                  "instanceType": "Code"
                }
              },
              {
                "id": "fa0af43a-84f6-422c-913e-d0b9645b4314",
                "name": "Catheter",
                "instanceType": "MedicalDevice",
                "label": "IV Catheter",
                "description": "Used for venous access; requires flushing every 8 hours",
                "deviceType": {
                  "id": "f4013503-96fd-483d-a132-bedf6029cc4f",
                  "code": "Drug Delivery Device",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Drug Delivery Device",
                  "instanceType": "Code"
                }
              },
              {
                "id": "74e9b72e-5894-4d08-85bf-332f76819581",
                "name": "12-lead ECG device",
                "instanceType": "MedicalDevice",
                "label": "ECG Machine",
                "description": "Equipment used to perform triplicate 12-lead electrocardiograms",
                "deviceType": {
                  "id": "f77aa509-7c8f-40ca-a847-fa48f0623c1a",
                  "code": "Diagnostic Device",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Diagnostic Device",
                  "instanceType": "Code"
                }
              },
              {
                "id": "c29e9796-363f-45b5-bd9c-093d4f245fe6",
                "name": "Automated blood pressure device",
                "instanceType": "MedicalDevice",
                "label": "Automated BP Monitor",
                "description": "Device used for assessing blood pressure and heart rate",
                "deviceType": {
                  "id": "fd01fb1b-0cd1-45b6-8cc9-3e9be087dbb3",
                  "code": "Monitoring Device",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Monitoring Device",
                  "instanceType": "Code"
                }
              },
              {
                "id": "cdccbeae-a9d7-4389-bc4c-87663620fbe4",
                "name": "SMS text messaging",
                "instanceType": "MedicalDevice",
                "label": "SMS Compliance Tool",
                "description": "Used by participants to confirm study intervention administration during outpatient periods",
                "deviceType": {
                  "id": "ad82d779-6b3e-4deb-bdbd-afb455a4fc67",
                  "code": "Monitoring Device",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Monitoring Device",
                  "instanceType": "Code"
                }
              }
            ],
            "epochs": [
              {
                "id": "57136ab0-8f90-44b4-8f55-9d2f130018f4",
                "name": "Screening",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "a76ac699-4fec-4f4b-807f-22fde930b2f7",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "532831c0-7a68-470d-851a-b2dd89054f4b",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "6566ac55-2311-4525-81de-aa36df224420",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "e19b9e1d-44cc-4c07-ada3-204c9f36f267",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "1"
                  }
                ]
              },
              {
                "id": "173bebeb-5135-479e-b0e3-f5d97463f769",
                "name": "C-I",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "62ff7290-a201-4d8c-a836-af27874f404a",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "9e080dbe-d6fe-4cc4-b0a4-44082feeca23",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "f5adfa26-fc6b-478c-a964-2211a4a4d4c7",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "b4e073d3-7f9d-4a39-bd17-083fe084b5c6",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "2"
                  }
                ]
              },
              {
                "id": "b329d201-0097-428f-a975-638b81cdd1ab",
                "name": "Inpatient Period 1",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "ccea2d75-b5ef-42e7-b856-25c8126c736f",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "32c0a0ae-7585-4609-9a5c-7f2a12cc52b7",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "46cc5676-df55-4e01-975c-ee02839eddf0",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "d3cd960b-7962-41a7-8590-e0cdf1057c72",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "3"
                  }
                ]
              },
              {
                "id": "e1c84807-638c-4fe2-9296-6c57a7fc1979",
                "name": "OP",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "621963a2-c55e-422c-a9a7-3e9f1c2fddfc",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "67d14be9-ebf4-4c0c-bd65-39e9b6cdcd4a",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "ce52d46c-2236-43d6-b2b2-538427cdf2fd",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "40a3580b-1cb0-4f56-8620-2817a476325c",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "4"
                  }
                ]
              },
              {
                "id": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc",
                "name": "Inpatient Period 2",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "50962258-a6e8-4a59-bea6-cb43305de54c",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "2a855f85-1a1d-454f-8752-70102d969c75",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "81437a5b-5aee-4d5a-ad64-ab7acb967240",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "340e9f18-b570-42f9-84f7-c482ef233319",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "5"
                  }
                ]
              },
              {
                "id": "778933b2-8764-4d4d-a845-ad7210b5a7b1",
                "name": "UNS",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "760f7af9-7570-4b35-8d92-6fa4002ffbdc",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "4b841f30-f527-45b7-a84f-e1253f2536df",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "12a89855-53b7-4627-a850-39ef00a77ec1",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "766aa1f1-1a57-41e0-b080-a086cf45cb0b",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "6"
                  }
                ]
              },
              {
                "id": "4e0fe673-f9be-4e80-8aa0-88cfc78319fa",
                "name": "EOS or ET",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "ee646525-b77a-4549-b24d-adca4fcbcc3c",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "4af1353b-6c73-46f9-8426-6beb22a12eb5",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "2af513b4-00f6-4d04-9fe6-4cd78af88df2",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "4f1ea47d-af2e-4ea1-b645-2fc879c9b26a",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "7"
                  }
                ]
              }
            ],
            "model": {
              "id": "57f7eeb4-9eb2-4161-adbc-1bf1bd6ad6c2",
              "code": "C82638",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Single Group Study",
              "instanceType": "Code"
            },
            "scheduleTimelines": [
              {
                "id": "bdccf9bd-75d7-4398-94d6-2b149cf308e2",
                "name": "Main Schedule Timeline",
                "mainTimeline": true,
                "instanceType": "ScheduleTimeline",
                "entryCondition": "Subject enrolled in study",
                "entryId": "6a03ad61-dbd6-4f75-861c-f246ceed662b",
                "instances": [
                  {
                    "id": "6a03ad61-dbd6-4f75-861c-f246ceed662b",
                    "activityIds": [
                      "5305c784-10dd-4d7a-9c79-6f5c340e32e5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "47d95a45-6315-4250-abaa-3798f33a1265",
                    "activityIds": [
                      "153847fb-d939-4a3e-aca4-34c3fdb5d735"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_3",
                    "encounterId": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                    "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769"
                  },
                  {
                    "id": "8cbef6ab-b4b8-4b4a-8c36-b06a67d8dee1",
                    "activityIds": [
                      "153847fb-d939-4a3e-aca4-34c3fdb5d735"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "2d12536b-fd14-4dff-b43f-8b8c98183489",
                    "activityIds": [
                      "6610c275-e6f3-4043-93ff-60831ad5ea5d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_11",
                    "encounterId": "443a5337-c8fb-4990-acd2-e54beb41b824",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "72d8e2ea-b779-4620-b915-73d72bfbc5ad",
                    "activityIds": [
                      "6610c275-e6f3-4043-93ff-60831ad5ea5d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_22",
                    "encounterId": "f74ddc2e-7d88-458e-802f-dfb0b065c8b4",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "45245504-ab06-4e74-9e87-cac061267063",
                    "activityIds": [
                      "1708b8e7-b182-4172-8f2c-9bd62015af1a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_12",
                    "encounterId": "8d49c51d-fda5-400e-bb15-d3d28ad266e4",
                    "epochId": "e1c84807-638c-4fe2-9296-6c57a7fc1979"
                  },
                  {
                    "id": "dc49434e-393c-4c3b-a4b4-e6100374bbde",
                    "activityIds": [
                      "6a843cd3-19dc-4619-9fb3-8d904686bbc8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "1357a4a7-a4c2-449f-ba37-ffbd8e0dfe11",
                    "activityIds": [
                      "6a843cd3-19dc-4619-9fb3-8d904686bbc8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_3",
                    "encounterId": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                    "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769"
                  },
                  {
                    "id": "7353fd42-eadd-4dc3-a30e-d14c433b4d6e",
                    "activityIds": [
                      "6a843cd3-19dc-4619-9fb3-8d904686bbc8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "008dfd2e-8907-4634-8556-d13e6d793ff7",
                    "activityIds": [
                      "f1a61cfd-0d72-475e-89de-e1ba29c0d15d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "96d2c5ed-0be4-476f-9f8f-769e233f88ba",
                    "activityIds": [
                      "f1a61cfd-0d72-475e-89de-e1ba29c0d15d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_3",
                    "encounterId": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                    "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769"
                  },
                  {
                    "id": "3a50f115-90e7-4a2e-9c9d-4c48eddc00c0",
                    "activityIds": [
                      "f1a61cfd-0d72-475e-89de-e1ba29c0d15d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_11",
                    "encounterId": "443a5337-c8fb-4990-acd2-e54beb41b824",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "45306655-eb1d-46fb-a491-aa86ff314431",
                    "activityIds": [
                      "f1a61cfd-0d72-475e-89de-e1ba29c0d15d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_24",
                    "encounterId": "7c21b6db-6a2e-4316-963d-b9c0d809be67",
                    "epochId": "4e0fe673-f9be-4e80-8aa0-88cfc78319fa"
                  },
                  {
                    "id": "9746efac-313d-4b38-a20f-c3dd1a46774b",
                    "activityIds": [
                      "5faad3f6-2b83-46c8-816d-4ace6abc5381"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "43811330-efa2-4c79-a90e-7435bd758bcb",
                    "activityIds": [
                      "ef37d001-a448-41b4-bc4d-ed31e8ecb092"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "e9735e61-01f3-4d5a-9278-eb4c2e013bce",
                    "activityIds": [
                      "ef37d001-a448-41b4-bc4d-ed31e8ecb092"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_3",
                    "encounterId": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                    "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769"
                  },
                  {
                    "id": "1a15958f-0c16-42fc-8e18-24919334439b",
                    "activityIds": [
                      "a08930fc-ae5c-40fc-b468-a8d8d5e1b31b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "a934841a-0a55-45b1-b772-d2c040954f4d",
                    "activityIds": [
                      "a08930fc-ae5c-40fc-b468-a8d8d5e1b31b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_3",
                    "encounterId": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                    "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769"
                  },
                  {
                    "id": "44c6bf70-974a-4028-9e7f-0ff53637b44f",
                    "activityIds": [
                      "c5f7f4af-321b-487d-8367-e7f64930c782"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "7f3f29a4-08da-4bc3-b8cb-f810514b052d",
                    "activityIds": [
                      "13dc7b44-1063-4555-bd7a-c190da52131e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "083a5db6-81b4-4bf5-bb97-5a556edfe249",
                    "activityIds": [
                      "ee790981-6f50-4074-a528-d18d2002d1d6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "e30cf067-0ed6-4a2b-831b-1877cfe4723b",
                    "activityIds": [
                      "44625ba9-8e87-4aaf-a000-fe1cfd0cee3f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "cc367736-1a3d-4be9-a7a7-b8e3613ab436",
                    "activityIds": [
                      "44625ba9-8e87-4aaf-a000-fe1cfd0cee3f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "98818000-efe9-4134-b203-ed6f42e7e13e",
                    "activityIds": [
                      "0f414ebf-d42c-40ad-8b57-0ba36b1a7e23"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "50f76ce9-62e8-491e-b366-053a483198f9",
                    "activityIds": [
                      "0f414ebf-d42c-40ad-8b57-0ba36b1a7e23"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_3",
                    "encounterId": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                    "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769"
                  },
                  {
                    "id": "d4c36542-f9d7-4d24-8560-21a8adbb4e48",
                    "activityIds": [
                      "0f414ebf-d42c-40ad-8b57-0ba36b1a7e23"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "70bf9c73-a7d1-4b7e-93b6-16f1634646c3",
                    "activityIds": [
                      "0f414ebf-d42c-40ad-8b57-0ba36b1a7e23"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_24",
                    "encounterId": "7c21b6db-6a2e-4316-963d-b9c0d809be67",
                    "epochId": "4e0fe673-f9be-4e80-8aa0-88cfc78319fa"
                  },
                  {
                    "id": "d56fef9a-d47a-49c8-9f67-cb384e399035",
                    "activityIds": [
                      "73d6e759-c678-49c2-aada-c053c3b851b2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "c9026e98-6a5e-429d-bf86-07a1a1733af7",
                    "activityIds": [
                      "73d6e759-c678-49c2-aada-c053c3b851b2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_3",
                    "encounterId": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                    "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769"
                  },
                  {
                    "id": "1e52de2e-9aa2-4aaf-81b2-dd4716ba4de6",
                    "activityIds": [
                      "73d6e759-c678-49c2-aada-c053c3b851b2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "bdfc3f8a-90c8-4357-8808-609001e86efd",
                    "activityIds": [
                      "73d6e759-c678-49c2-aada-c053c3b851b2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_22",
                    "encounterId": "f74ddc2e-7d88-458e-802f-dfb0b065c8b4",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "971760d7-72f5-4de7-ada2-c3245c68dd2f",
                    "activityIds": [
                      "8b54e2ab-2acc-4536-b0f3-d331d2574e43"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_16@enc_4",
                    "encounterId": "c96db2ab-ad9e-4d0e-b88b-a92f11765aaf",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "bcd7faf6-910a-4186-9ec5-1af0050c5d2a",
                    "activityIds": [
                      "98509a6d-7634-4bdd-af34-60334b12b32c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_6",
                    "encounterId": "8c40da25-cece-48ad-940c-040d7ee8242e",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "a821e3b5-a5b4-484c-9669-1efa962db67e",
                    "activityIds": [
                      "fcd57369-1ef5-4d3f-b63f-d90264281374"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_18@enc_2",
                    "encounterId": "3281c593-af16-41b6-ae63-33e05a0acb2d",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "05d29fcf-b2a0-42a3-8c9a-7cf07c38107f",
                    "activityIds": [
                      "ea994424-deba-4e26-a84a-4557d942a173"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "522c5347-b27f-40fa-ab3f-732413e9705e",
                    "activityIds": [
                      "ea994424-deba-4e26-a84a-4557d942a173"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_8",
                    "encounterId": "fae139a7-c907-49fb-9f60-244cccace73f",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "2eb56199-473f-4232-9d64-42424b01b50f",
                    "activityIds": [
                      "ea994424-deba-4e26-a84a-4557d942a173"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_9",
                    "encounterId": "6bd0c3a4-2308-4654-9907-90e12db4721d",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "ebcfa633-dfc2-42db-ab3c-661f3ac98fd1",
                    "activityIds": [
                      "ea994424-deba-4e26-a84a-4557d942a173"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_10",
                    "encounterId": "a620e15f-365d-4654-9cd3-adaa5bcda509",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "b3840262-9a5d-43ae-9e79-c417678c2859",
                    "activityIds": [
                      "ea994424-deba-4e26-a84a-4557d942a173"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_11",
                    "encounterId": "443a5337-c8fb-4990-acd2-e54beb41b824",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "6996f6e7-0e5a-4c2a-af17-82af81a0b095",
                    "activityIds": [
                      "ea994424-deba-4e26-a84a-4557d942a173"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_12",
                    "encounterId": "8d49c51d-fda5-400e-bb15-d3d28ad266e4",
                    "epochId": "e1c84807-638c-4fe2-9296-6c57a7fc1979"
                  },
                  {
                    "id": "038ce10e-17ac-4d8c-986a-9cf6adb1cebc",
                    "activityIds": [
                      "ea994424-deba-4e26-a84a-4557d942a173"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "b6f7568b-f525-4d38-a5a9-983579119474",
                    "activityIds": [
                      "ea994424-deba-4e26-a84a-4557d942a173"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_14",
                    "encounterId": "9069fbec-10a0-4cab-8000-2757531c4359",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "8e6886f9-a7f6-4cfc-9fc4-82647bb1830b",
                    "activityIds": [
                      "ea994424-deba-4e26-a84a-4557d942a173"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_15",
                    "encounterId": "497f7786-8f6e-4d53-b370-9a88152b27c1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "3ddb4a42-bfa3-4766-aa58-30f226acd496",
                    "activityIds": [
                      "ea994424-deba-4e26-a84a-4557d942a173"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_16",
                    "encounterId": "23543897-7ea8-407e-964d-9d64950ff747",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "21268037-571d-4f65-b9d6-988c99d214bb",
                    "activityIds": [
                      "8f77a8c3-1ebd-4c43-b776-f7769ed32c55"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_17",
                    "encounterId": "10fefe8a-3a1a-4317-893e-77b2263b4ea1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "438d0499-2923-4efa-9c29-cf130664e120",
                    "activityIds": [
                      "8f77a8c3-1ebd-4c43-b776-f7769ed32c55"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_18",
                    "encounterId": "3d7d40d1-628b-4ff5-ad2b-f1612252cf1a",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "c4a6add9-644f-48c4-8719-1a6368750383",
                    "activityIds": [
                      "8f77a8c3-1ebd-4c43-b776-f7769ed32c55"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_19",
                    "encounterId": "977e1d9b-33ad-4706-893c-7f7b8a0e750b",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "70154db1-9339-41a7-a2d1-c39cd0950eb4",
                    "activityIds": [
                      "8f77a8c3-1ebd-4c43-b776-f7769ed32c55"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_20",
                    "encounterId": "3d37ddc0-dd83-44ac-bc92-382b247512db",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "7643dce8-5d38-435d-9e1f-f7a626af22c0",
                    "activityIds": [
                      "8f77a8c3-1ebd-4c43-b776-f7769ed32c55"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_21",
                    "encounterId": "fa569f3d-48b7-4c3f-8449-7fdebebe6343",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "a3de1f8e-ed35-4064-88bf-cc4047760af4",
                    "activityIds": [
                      "10e2d3bc-40c0-4b49-9c91-084cd735996b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_12",
                    "encounterId": "8d49c51d-fda5-400e-bb15-d3d28ad266e4",
                    "epochId": "e1c84807-638c-4fe2-9296-6c57a7fc1979"
                  },
                  {
                    "id": "cb5227f5-9c25-4c20-a3c5-34c76c76c83a",
                    "activityIds": [
                      "10e2d3bc-40c0-4b49-9c91-084cd735996b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "24827d9b-b0e1-401f-a311-faa32189f54b",
                    "activityIds": [
                      "e6a2afad-c0ca-4f46-9769-921725016179"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "e9361dbf-ba5d-4a94-b4b5-b5edd75e5447",
                    "activityIds": [
                      "e6a2afad-c0ca-4f46-9769-921725016179"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_9",
                    "encounterId": "6bd0c3a4-2308-4654-9907-90e12db4721d",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "8a54f776-3134-45b7-b5b9-dcb4505b3eae",
                    "activityIds": [
                      "e6a2afad-c0ca-4f46-9769-921725016179"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_15",
                    "encounterId": "497f7786-8f6e-4d53-b370-9a88152b27c1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "8df0af24-624d-422f-ac45-467714fe220b",
                    "activityIds": [
                      "e6a2afad-c0ca-4f46-9769-921725016179"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_16",
                    "encounterId": "23543897-7ea8-407e-964d-9d64950ff747",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "a9ad95b5-2e48-4db4-924e-e3d34ce804f3",
                    "activityIds": [
                      "e6a2afad-c0ca-4f46-9769-921725016179"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_17",
                    "encounterId": "10fefe8a-3a1a-4317-893e-77b2263b4ea1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "dab0339a-96d6-42ce-b109-b219be39e8a0",
                    "activityIds": [
                      "e6a2afad-c0ca-4f46-9769-921725016179"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_18",
                    "encounterId": "3d7d40d1-628b-4ff5-ad2b-f1612252cf1a",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "bc1fc1a7-4f1f-400f-9990-8d4469761ca0",
                    "activityIds": [
                      "e6a2afad-c0ca-4f46-9769-921725016179"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_19",
                    "encounterId": "977e1d9b-33ad-4706-893c-7f7b8a0e750b",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "08855209-b0bf-4ac5-9c44-23169e6b6c11",
                    "activityIds": [
                      "e6a2afad-c0ca-4f46-9769-921725016179"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_20",
                    "encounterId": "3d37ddc0-dd83-44ac-bc92-382b247512db",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "af887c36-fc35-4273-880f-dd2fd1087773",
                    "activityIds": [
                      "e6a2afad-c0ca-4f46-9769-921725016179"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_21",
                    "encounterId": "fa569f3d-48b7-4c3f-8449-7fdebebe6343",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "cc226a44-aafd-434b-82a6-9f17563f4889",
                    "activityIds": [
                      "e6a2afad-c0ca-4f46-9769-921725016179"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_22",
                    "encounterId": "f74ddc2e-7d88-458e-802f-dfb0b065c8b4",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "56539d23-d0f9-49e1-a728-51ebec9e4b74",
                    "activityIds": [
                      "bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "7f3fc3de-80e3-4efd-a406-cc7f49c24742",
                    "activityIds": [
                      "bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_3",
                    "encounterId": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                    "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769"
                  },
                  {
                    "id": "cde23de8-414d-41be-b5c3-011c7b4bf27d",
                    "activityIds": [
                      "bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_6",
                    "encounterId": "8c40da25-cece-48ad-940c-040d7ee8242e",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "918a1e66-9820-47c5-8040-1887db49d573",
                    "activityIds": [
                      "bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_10",
                    "encounterId": "a620e15f-365d-4654-9cd3-adaa5bcda509",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "91d1deaf-e70e-41c3-88bc-4471d43cf796",
                    "activityIds": [
                      "bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_12",
                    "encounterId": "8d49c51d-fda5-400e-bb15-d3d28ad266e4",
                    "epochId": "e1c84807-638c-4fe2-9296-6c57a7fc1979"
                  },
                  {
                    "id": "c0d19d78-a82b-42d4-a8e8-1d6c74cf552f",
                    "activityIds": [
                      "bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "70b63505-dd4b-42e7-b84f-047a5e7ec687",
                    "activityIds": [
                      "bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_16",
                    "encounterId": "23543897-7ea8-407e-964d-9d64950ff747",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "14c08abc-b1cc-4087-a19e-1dba642eb3d1",
                    "activityIds": [
                      "bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_18",
                    "encounterId": "3d7d40d1-628b-4ff5-ad2b-f1612252cf1a",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "1e8feeb0-0f9d-4646-8f64-918cacccce07",
                    "activityIds": [
                      "bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_22",
                    "encounterId": "f74ddc2e-7d88-458e-802f-dfb0b065c8b4",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "d3369d73-eba8-4d0e-8272-b10a5de24564",
                    "activityIds": [
                      "bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_24",
                    "encounterId": "7c21b6db-6a2e-4316-963d-b9c0d809be67",
                    "epochId": "4e0fe673-f9be-4e80-8aa0-88cfc78319fa"
                  },
                  {
                    "id": "82edbc28-b404-420d-8fe0-62ff76b40220",
                    "activityIds": [
                      "6197c352-60bf-4f51-876e-373344f5ca28"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "531ea166-7bc5-4bb6-828d-ddf7921f5e5a",
                    "activityIds": [
                      "6197c352-60bf-4f51-876e-373344f5ca28"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_3",
                    "encounterId": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                    "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769"
                  },
                  {
                    "id": "e4fd6e75-74eb-4f9a-aa80-2b0cf7d7dfa1",
                    "activityIds": [
                      "6197c352-60bf-4f51-876e-373344f5ca28"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_10",
                    "encounterId": "a620e15f-365d-4654-9cd3-adaa5bcda509",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "ac693ec3-278c-4cd3-826a-2a3ce36c6408",
                    "activityIds": [
                      "6197c352-60bf-4f51-876e-373344f5ca28"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_12",
                    "encounterId": "8d49c51d-fda5-400e-bb15-d3d28ad266e4",
                    "epochId": "e1c84807-638c-4fe2-9296-6c57a7fc1979"
                  },
                  {
                    "id": "973543be-2e47-4d4b-93dc-ca1b93f8a015",
                    "activityIds": [
                      "6197c352-60bf-4f51-876e-373344f5ca28"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "62cae557-377a-46cf-9f2d-273fe9121d3f",
                    "activityIds": [
                      "6197c352-60bf-4f51-876e-373344f5ca28"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_16",
                    "encounterId": "23543897-7ea8-407e-964d-9d64950ff747",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "d7f802a6-906f-4701-a4ef-7ff746eec12f",
                    "activityIds": [
                      "6197c352-60bf-4f51-876e-373344f5ca28"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_22",
                    "encounterId": "f74ddc2e-7d88-458e-802f-dfb0b065c8b4",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "ad5aaa39-0c00-46ea-996a-dd7e2fd37421",
                    "activityIds": [
                      "6197c352-60bf-4f51-876e-373344f5ca28"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_24",
                    "encounterId": "7c21b6db-6a2e-4316-963d-b9c0d809be67",
                    "epochId": "4e0fe673-f9be-4e80-8aa0-88cfc78319fa"
                  },
                  {
                    "id": "286c5813-907a-4b1d-b193-9d9c705bc5b2",
                    "activityIds": [
                      "82ae0e2d-6367-40c3-933d-23becc413381"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "4b59db4f-312b-46a8-b47b-364872ff9ab0",
                    "activityIds": [
                      "82ae0e2d-6367-40c3-933d-23becc413381"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_3",
                    "encounterId": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                    "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769"
                  },
                  {
                    "id": "bca6e4a7-d561-4b3e-93b4-83739d6bf63c",
                    "activityIds": [
                      "82ae0e2d-6367-40c3-933d-23becc413381"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "59a0344b-3d9e-43c5-873c-d2194279c404",
                    "activityIds": [
                      "82ae0e2d-6367-40c3-933d-23becc413381"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_24",
                    "encounterId": "7c21b6db-6a2e-4316-963d-b9c0d809be67",
                    "epochId": "4e0fe673-f9be-4e80-8aa0-88cfc78319fa"
                  },
                  {
                    "id": "0b0e4845-d31b-4819-84c4-f4a60dc09b03",
                    "activityIds": [
                      "041d2c05-695c-45ab-98c7-77f18949e879"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_27@enc_4",
                    "encounterId": "c96db2ab-ad9e-4d0e-b88b-a92f11765aaf",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "250fc337-d98d-4d67-835b-1f5e70d9e3fb",
                    "activityIds": [
                      "eed510fb-92ae-4758-87ce-38f6c63e1511"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "a91959a0-fe8c-4e86-89db-4a82e734068a",
                    "activityIds": [
                      "eed510fb-92ae-4758-87ce-38f6c63e1511"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_4",
                    "encounterId": "c96db2ab-ad9e-4d0e-b88b-a92f11765aaf",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "08188ae3-cd9f-4fa3-9cb5-b9eddc2535bf",
                    "activityIds": [
                      "eed510fb-92ae-4758-87ce-38f6c63e1511"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "82c2e5ff-51aa-476c-a557-86268beaeecf",
                    "activityIds": [
                      "eed510fb-92ae-4758-87ce-38f6c63e1511"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_11",
                    "encounterId": "443a5337-c8fb-4990-acd2-e54beb41b824",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "ba7a7a36-f953-41ef-903b-1ee30c5bc7a3",
                    "activityIds": [
                      "eed510fb-92ae-4758-87ce-38f6c63e1511"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "21ab7b71-8875-4d3d-9ca3-56d95da56f3c",
                    "activityIds": [
                      "eed510fb-92ae-4758-87ce-38f6c63e1511"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_22",
                    "encounterId": "f74ddc2e-7d88-458e-802f-dfb0b065c8b4",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "2e625cbf-1e0c-47f8-ab04-04a891eb7d6d",
                    "activityIds": [
                      "eed510fb-92ae-4758-87ce-38f6c63e1511"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_24",
                    "encounterId": "7c21b6db-6a2e-4316-963d-b9c0d809be67",
                    "epochId": "4e0fe673-f9be-4e80-8aa0-88cfc78319fa"
                  },
                  {
                    "id": "d2696f47-2e87-4bd5-955f-a194cbdf78bd",
                    "activityIds": [
                      "6f840b08-1ea8-4290-9c04-2c9c4719d6c1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "9600e694-6bd8-4e53-81b7-3b638530487b",
                    "activityIds": [
                      "6f840b08-1ea8-4290-9c04-2c9c4719d6c1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_4",
                    "encounterId": "c96db2ab-ad9e-4d0e-b88b-a92f11765aaf",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "693579c1-026c-40e0-91e5-d43ce154d8b9",
                    "activityIds": [
                      "6f840b08-1ea8-4290-9c04-2c9c4719d6c1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "1efb1d19-7886-4245-a3a6-d94f31aec650",
                    "activityIds": [
                      "6f840b08-1ea8-4290-9c04-2c9c4719d6c1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_11",
                    "encounterId": "443a5337-c8fb-4990-acd2-e54beb41b824",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "971c09b0-243a-43ea-a98c-fbd7270ba66c",
                    "activityIds": [
                      "6f840b08-1ea8-4290-9c04-2c9c4719d6c1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "b02aeeb1-20ee-4732-87b0-08e9009d58d2",
                    "activityIds": [
                      "6f840b08-1ea8-4290-9c04-2c9c4719d6c1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_21",
                    "encounterId": "fa569f3d-48b7-4c3f-8449-7fdebebe6343",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "8c72d875-87d1-4b17-ad34-581ff2d72258",
                    "activityIds": [
                      "6f840b08-1ea8-4290-9c04-2c9c4719d6c1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_24",
                    "encounterId": "7c21b6db-6a2e-4316-963d-b9c0d809be67",
                    "epochId": "4e0fe673-f9be-4e80-8aa0-88cfc78319fa"
                  },
                  {
                    "id": "ae43e7fb-4725-4a40-8a3e-a2ff0bd0e3c3",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "806eb137-1c6b-4ed6-a81b-d18cb655082e",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_3",
                    "encounterId": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                    "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769"
                  },
                  {
                    "id": "4afb53bb-c903-44bc-b8d0-f1824d507653",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_4",
                    "encounterId": "c96db2ab-ad9e-4d0e-b88b-a92f11765aaf",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "56cef6a1-e5bd-4c5e-9b83-996b83f6d28b",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_5",
                    "encounterId": "4c6ce239-8bac-4969-bec1-a3c5bc26b7d2",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "cb27a956-1b39-4a2c-9daf-5841098b6b5d",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_6",
                    "encounterId": "8c40da25-cece-48ad-940c-040d7ee8242e",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "8c311263-6e0d-4ee6-af32-a78b40b27055",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "feb321a2-349a-4c61-a3c2-4c285f97dc9a",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_8",
                    "encounterId": "fae139a7-c907-49fb-9f60-244cccace73f",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "72ff9765-1462-4c81-8c0f-4893b54a0a5e",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_9",
                    "encounterId": "6bd0c3a4-2308-4654-9907-90e12db4721d",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "1447aac2-8f83-4c97-bd65-d584f4b01c4b",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_10",
                    "encounterId": "a620e15f-365d-4654-9cd3-adaa5bcda509",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "48c18d2d-6c3e-4044-a4d2-460c919c1150",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_11",
                    "encounterId": "443a5337-c8fb-4990-acd2-e54beb41b824",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "26b4d3cc-c424-43e0-8cdf-b5537b872812",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_12",
                    "encounterId": "8d49c51d-fda5-400e-bb15-d3d28ad266e4",
                    "epochId": "e1c84807-638c-4fe2-9296-6c57a7fc1979"
                  },
                  {
                    "id": "80c59087-e6fd-46b5-81c6-7557a2906e33",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "39640b57-3977-4bab-8d8f-fc88314560ae",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_14",
                    "encounterId": "9069fbec-10a0-4cab-8000-2757531c4359",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "a24eef92-ff4e-4d40-a3f3-5159b27e99ae",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_15",
                    "encounterId": "497f7786-8f6e-4d53-b370-9a88152b27c1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "65e0f6fd-1249-45c7-8860-a7b641ce40cc",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_16",
                    "encounterId": "23543897-7ea8-407e-964d-9d64950ff747",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "cd30f1e5-42db-4a10-83a5-cd39474f3e29",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_17",
                    "encounterId": "10fefe8a-3a1a-4317-893e-77b2263b4ea1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "69a776d1-bccd-48f4-9ad6-017ca6e2d15e",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_18",
                    "encounterId": "3d7d40d1-628b-4ff5-ad2b-f1612252cf1a",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "54bfc9fe-e213-4a96-a544-ec5e7b945cb3",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_19",
                    "encounterId": "977e1d9b-33ad-4706-893c-7f7b8a0e750b",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "f9431391-6f86-4044-8d22-04771e3937c4",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_20",
                    "encounterId": "3d37ddc0-dd83-44ac-bc92-382b247512db",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "37190811-7b3d-4ac9-8735-f7611f547be9",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_21",
                    "encounterId": "fa569f3d-48b7-4c3f-8449-7fdebebe6343",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "e02000f6-132d-4834-9a72-c6fa533eb9ff",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_22",
                    "encounterId": "f74ddc2e-7d88-458e-802f-dfb0b065c8b4",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "c83396de-48bd-4d99-af69-d45bdecbb69c",
                    "activityIds": [
                      "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_24",
                    "encounterId": "7c21b6db-6a2e-4316-963d-b9c0d809be67",
                    "epochId": "4e0fe673-f9be-4e80-8aa0-88cfc78319fa"
                  },
                  {
                    "id": "0e945386-2d0d-45c8-9041-287f89b546b5",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_4",
                    "encounterId": "c96db2ab-ad9e-4d0e-b88b-a92f11765aaf",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "aa1504a2-66eb-4de2-9d37-ef135ebbee0a",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_5",
                    "encounterId": "4c6ce239-8bac-4969-bec1-a3c5bc26b7d2",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "eb14a89c-cc88-4004-902b-ff8425b0fd79",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_6",
                    "encounterId": "8c40da25-cece-48ad-940c-040d7ee8242e",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "32a3aa31-d991-4402-85c6-407ce4dbd373",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "4a89f605-a1e8-4b61-b598-f07334f4db0e",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_8",
                    "encounterId": "fae139a7-c907-49fb-9f60-244cccace73f",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "37979049-035f-4b15-b2e6-2a2e4c261592",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_9",
                    "encounterId": "6bd0c3a4-2308-4654-9907-90e12db4721d",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "6fb91806-9ff3-4a40-be97-25412c77deca",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_10",
                    "encounterId": "a620e15f-365d-4654-9cd3-adaa5bcda509",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "c18faa47-2068-48ca-861e-f72a363de50c",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "e9393121-52e2-41d3-9f25-51863f15f87a",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_14",
                    "encounterId": "9069fbec-10a0-4cab-8000-2757531c4359",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "a1a9c0d7-ecb5-4c2c-ac39-4171b157bb04",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_15",
                    "encounterId": "497f7786-8f6e-4d53-b370-9a88152b27c1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "5dbbca58-8db2-4d6e-ba3e-82f40d8ed24b",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_16",
                    "encounterId": "23543897-7ea8-407e-964d-9d64950ff747",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "c062138a-5021-4d6f-a404-8b0db1c86dbb",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_17",
                    "encounterId": "10fefe8a-3a1a-4317-893e-77b2263b4ea1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "821e6e60-f02f-428e-b880-1e7b84595623",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_18",
                    "encounterId": "3d7d40d1-628b-4ff5-ad2b-f1612252cf1a",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "20407c65-2bf1-4d91-99fe-5d43a4dc0942",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_19",
                    "encounterId": "977e1d9b-33ad-4706-893c-7f7b8a0e750b",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "41f982bc-3aa3-4f5e-a898-aae59f0f14ec",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_20",
                    "encounterId": "3d37ddc0-dd83-44ac-bc92-382b247512db",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "79b72dda-fc4d-45ae-b1f5-9072dac8175b",
                    "activityIds": [
                      "3e676ade-fb1a-49be-ad73-415ed117f94e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_21",
                    "encounterId": "fa569f3d-48b7-4c3f-8449-7fdebebe6343",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "bbf6568e-d119-4b51-8ccc-a70f15787b68",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_4",
                    "encounterId": "c96db2ab-ad9e-4d0e-b88b-a92f11765aaf",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "617961ed-df23-4c14-a724-2a68cfcc243a",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_5",
                    "encounterId": "4c6ce239-8bac-4969-bec1-a3c5bc26b7d2",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "ad43adbc-7349-4958-90a3-be42fab81f31",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_6",
                    "encounterId": "8c40da25-cece-48ad-940c-040d7ee8242e",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "88f7913b-d0b4-4203-8dc2-f2cfebf97559",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "419a4f2c-bb1a-449b-8f6d-aa8a2976c759",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_8",
                    "encounterId": "fae139a7-c907-49fb-9f60-244cccace73f",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "6b386b9e-4e18-4f1e-ba29-13abf2d537bc",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_9",
                    "encounterId": "6bd0c3a4-2308-4654-9907-90e12db4721d",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "05f3686c-2be7-47b4-9c4c-082c09e90fec",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_10",
                    "encounterId": "a620e15f-365d-4654-9cd3-adaa5bcda509",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "c853edaf-469b-4271-a046-746ddeeefc1a",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_11",
                    "encounterId": "443a5337-c8fb-4990-acd2-e54beb41b824",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "b4dfbe4d-2a8c-47d7-82fb-800e8cf9b818",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "3cf64d37-511a-4c0a-821c-3196c388f714",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_14",
                    "encounterId": "9069fbec-10a0-4cab-8000-2757531c4359",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "85dd8c0a-d059-4d02-b73c-8459ce539842",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_15",
                    "encounterId": "497f7786-8f6e-4d53-b370-9a88152b27c1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "a67c8ca1-d39f-40f2-b720-1e7fffb45c6a",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_16",
                    "encounterId": "23543897-7ea8-407e-964d-9d64950ff747",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "37e0c009-b127-494d-a99b-92831aed34f4",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_17",
                    "encounterId": "10fefe8a-3a1a-4317-893e-77b2263b4ea1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "24ca1e94-9f31-4fd8-8418-f57e9af4ef18",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_18",
                    "encounterId": "3d7d40d1-628b-4ff5-ad2b-f1612252cf1a",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "1db6178b-af1a-43f7-aa9b-61aec377447d",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_19",
                    "encounterId": "977e1d9b-33ad-4706-893c-7f7b8a0e750b",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "2c0f9cfe-fa99-46a0-a4a8-81ccce7dd0eb",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_20",
                    "encounterId": "3d37ddc0-dd83-44ac-bc92-382b247512db",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "e079ed9a-c37f-4e9b-b07c-30bf7784ff5a",
                    "activityIds": [
                      "beb465a9-633b-4ba6-861f-8ebbdb4da1b8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_21",
                    "encounterId": "fa569f3d-48b7-4c3f-8449-7fdebebe6343",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "c0da5e95-f911-4f22-a31f-74cb62cdb131",
                    "activityIds": [
                      "468b2bb3-7af5-421d-a550-5c54d876fba6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_6",
                    "encounterId": "8c40da25-cece-48ad-940c-040d7ee8242e",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "d8371cef-e5ea-4ef0-a094-e0002696137e",
                    "activityIds": [
                      "468b2bb3-7af5-421d-a550-5c54d876fba6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "e3614487-eff3-43c1-9904-576feacf3a46",
                    "activityIds": [
                      "468b2bb3-7af5-421d-a550-5c54d876fba6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_8",
                    "encounterId": "fae139a7-c907-49fb-9f60-244cccace73f",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "8bffb088-b75c-4be1-8d15-8fe21d0b9e03",
                    "activityIds": [
                      "468b2bb3-7af5-421d-a550-5c54d876fba6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_9",
                    "encounterId": "6bd0c3a4-2308-4654-9907-90e12db4721d",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "0dfac10c-f4c6-4ffb-8ea1-f23dbea8296a",
                    "activityIds": [
                      "468b2bb3-7af5-421d-a550-5c54d876fba6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_10",
                    "encounterId": "a620e15f-365d-4654-9cd3-adaa5bcda509",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "552ea748-e270-49c8-928e-902138b62319",
                    "activityIds": [
                      "468b2bb3-7af5-421d-a550-5c54d876fba6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_15",
                    "encounterId": "497f7786-8f6e-4d53-b370-9a88152b27c1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "482e12c0-4087-42be-be91-0743c7f72c10",
                    "activityIds": [
                      "468b2bb3-7af5-421d-a550-5c54d876fba6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_16",
                    "encounterId": "23543897-7ea8-407e-964d-9d64950ff747",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "dee6a543-e3dc-4bb6-90b9-154e1d0de2fe",
                    "activityIds": [
                      "468b2bb3-7af5-421d-a550-5c54d876fba6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_17",
                    "encounterId": "10fefe8a-3a1a-4317-893e-77b2263b4ea1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "7750e84d-d15e-403c-a36f-5983dddc5321",
                    "activityIds": [
                      "468b2bb3-7af5-421d-a550-5c54d876fba6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_18",
                    "encounterId": "3d7d40d1-628b-4ff5-ad2b-f1612252cf1a",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "4eefd1ba-972a-4e30-be9b-8b4200a15c96",
                    "activityIds": [
                      "468b2bb3-7af5-421d-a550-5c54d876fba6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_19",
                    "encounterId": "977e1d9b-33ad-4706-893c-7f7b8a0e750b",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "ca16ff42-6e01-495f-be6d-7f45cd9c286c",
                    "activityIds": [
                      "468b2bb3-7af5-421d-a550-5c54d876fba6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_20",
                    "encounterId": "3d37ddc0-dd83-44ac-bc92-382b247512db",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "dd923932-cb6a-4e93-9242-26d800143559",
                    "activityIds": [
                      "468b2bb3-7af5-421d-a550-5c54d876fba6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_21",
                    "encounterId": "fa569f3d-48b7-4c3f-8449-7fdebebe6343",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "58430a12-bba5-4ae6-86c7-15e2610b5efd",
                    "activityIds": [
                      "36e59d41-e065-44e8-b91a-5f16699cfa1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_6",
                    "encounterId": "8c40da25-cece-48ad-940c-040d7ee8242e",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "560284f5-0e94-4118-8407-586d5707d6be",
                    "activityIds": [
                      "36e59d41-e065-44e8-b91a-5f16699cfa1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "6b1cfc35-9e9c-464f-a1a2-a33fe4186146",
                    "activityIds": [
                      "36e59d41-e065-44e8-b91a-5f16699cfa1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_8",
                    "encounterId": "fae139a7-c907-49fb-9f60-244cccace73f",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "5ece5665-c01a-44d9-969c-da5cf15755ed",
                    "activityIds": [
                      "36e59d41-e065-44e8-b91a-5f16699cfa1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_9",
                    "encounterId": "6bd0c3a4-2308-4654-9907-90e12db4721d",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "ac70f7b5-fc21-4b11-ac85-8ef0fb6c17d1",
                    "activityIds": [
                      "36e59d41-e065-44e8-b91a-5f16699cfa1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_10",
                    "encounterId": "a620e15f-365d-4654-9cd3-adaa5bcda509",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "0b5b08a7-c433-467a-9e3d-720cf63eb75d",
                    "activityIds": [
                      "36e59d41-e065-44e8-b91a-5f16699cfa1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_15",
                    "encounterId": "497f7786-8f6e-4d53-b370-9a88152b27c1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "af6530e3-2ed6-4916-b6b2-48a58a2e3b64",
                    "activityIds": [
                      "36e59d41-e065-44e8-b91a-5f16699cfa1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_16",
                    "encounterId": "23543897-7ea8-407e-964d-9d64950ff747",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "730bb4f1-a431-442d-bb03-0edf696db942",
                    "activityIds": [
                      "36e59d41-e065-44e8-b91a-5f16699cfa1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_17",
                    "encounterId": "10fefe8a-3a1a-4317-893e-77b2263b4ea1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "b1712682-f07d-48cd-a483-d11a8a79f838",
                    "activityIds": [
                      "36e59d41-e065-44e8-b91a-5f16699cfa1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_18",
                    "encounterId": "3d7d40d1-628b-4ff5-ad2b-f1612252cf1a",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "312a2aed-8bb7-4f37-9207-ec995d135f32",
                    "activityIds": [
                      "36e59d41-e065-44e8-b91a-5f16699cfa1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_19",
                    "encounterId": "977e1d9b-33ad-4706-893c-7f7b8a0e750b",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "517373a2-cff5-465e-afe7-86226dceef77",
                    "activityIds": [
                      "36e59d41-e065-44e8-b91a-5f16699cfa1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_20",
                    "encounterId": "3d37ddc0-dd83-44ac-bc92-382b247512db",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "8bbde58d-ce15-4219-8573-c6a66df0a148",
                    "activityIds": [
                      "36e59d41-e065-44e8-b91a-5f16699cfa1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_21",
                    "encounterId": "fa569f3d-48b7-4c3f-8449-7fdebebe6343",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "44ec10f8-8802-43bc-b32c-35f76b84c0c5",
                    "activityIds": [
                      "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_35@enc_6",
                    "encounterId": "8c40da25-cece-48ad-940c-040d7ee8242e",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "71b991dc-80dd-44ab-9950-05e41e1a533c",
                    "activityIds": [
                      "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_35@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "1065c43a-b8d8-4670-a09e-8f62082c6d7a",
                    "activityIds": [
                      "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_35@enc_8",
                    "encounterId": "fae139a7-c907-49fb-9f60-244cccace73f",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "b7ac2e3b-81ed-4d3f-abd4-119af81adaf7",
                    "activityIds": [
                      "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_35@enc_9",
                    "encounterId": "6bd0c3a4-2308-4654-9907-90e12db4721d",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "3532e924-fb75-4404-8214-c486507d56fa",
                    "activityIds": [
                      "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_35@enc_10",
                    "encounterId": "a620e15f-365d-4654-9cd3-adaa5bcda509",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "38d1f98d-d09e-44d4-86bf-2c558e449ee2",
                    "activityIds": [
                      "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_35@enc_15",
                    "encounterId": "497f7786-8f6e-4d53-b370-9a88152b27c1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "d4c97cda-5c97-4978-ac9b-70c4bfe759e1",
                    "activityIds": [
                      "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_35@enc_16",
                    "encounterId": "23543897-7ea8-407e-964d-9d64950ff747",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "2f674a34-fa7e-4e72-9922-fa71a25566d6",
                    "activityIds": [
                      "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_35@enc_17",
                    "encounterId": "10fefe8a-3a1a-4317-893e-77b2263b4ea1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "f4af1120-c174-4b03-b10f-d10e4e78a892",
                    "activityIds": [
                      "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_35@enc_18",
                    "encounterId": "3d7d40d1-628b-4ff5-ad2b-f1612252cf1a",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "bd678698-1161-4ef3-afaf-856e0cee0979",
                    "activityIds": [
                      "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_35@enc_19",
                    "encounterId": "977e1d9b-33ad-4706-893c-7f7b8a0e750b",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "b5025ef4-d060-4f13-b92d-979d2d25b5e6",
                    "activityIds": [
                      "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_35@enc_20",
                    "encounterId": "3d37ddc0-dd83-44ac-bc92-382b247512db",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "4a8b2de7-1d94-4edd-a496-d244bb33040a",
                    "activityIds": [
                      "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_35@enc_21",
                    "encounterId": "fa569f3d-48b7-4c3f-8449-7fdebebe6343",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "7f62687d-e0d4-407c-a448-0be490e77b78",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_1",
                    "encounterId": "64dac216-5a49-4ef7-b37c-03586f19113b",
                    "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4"
                  },
                  {
                    "id": "42cdf9a4-fa32-4fb7-9a19-aa9b2a53d013",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_3",
                    "encounterId": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                    "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769"
                  },
                  {
                    "id": "4a76d5d0-023b-45c8-913b-8881e2321e58",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_4",
                    "encounterId": "c96db2ab-ad9e-4d0e-b88b-a92f11765aaf",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "04da5710-3d8e-4887-ae1a-f27dba85de95",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_5",
                    "encounterId": "4c6ce239-8bac-4969-bec1-a3c5bc26b7d2",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "ff778438-a255-4cbf-bb1d-e3d6252ac6aa",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_6",
                    "encounterId": "8c40da25-cece-48ad-940c-040d7ee8242e",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "2bd5d98c-ac17-46a8-a530-f7aad02d7bcc",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_7",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "91e3b8f2-35e5-4797-a856-3d74dd54bfb9",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_8",
                    "encounterId": "fae139a7-c907-49fb-9f60-244cccace73f",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "c5bd666b-1b15-47ed-ab42-f2fdbec525fc",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_9",
                    "encounterId": "6bd0c3a4-2308-4654-9907-90e12db4721d",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "01555c0a-062f-4af6-8752-300804b5d998",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_10",
                    "encounterId": "a620e15f-365d-4654-9cd3-adaa5bcda509",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "18ee1e54-d30e-4805-a564-bea699cfb8df",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_11",
                    "encounterId": "443a5337-c8fb-4990-acd2-e54beb41b824",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab"
                  },
                  {
                    "id": "0eee3361-152a-42d3-84f5-dcb1b453bd24",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_12",
                    "encounterId": "8d49c51d-fda5-400e-bb15-d3d28ad266e4",
                    "epochId": "e1c84807-638c-4fe2-9296-6c57a7fc1979"
                  },
                  {
                    "id": "064a301d-8aa7-4a53-b470-e41704a7f76b",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_13",
                    "encounterId": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "e265505d-7e7c-4c90-9cc9-8602d27d18b9",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_14",
                    "encounterId": "9069fbec-10a0-4cab-8000-2757531c4359",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "c9e5f8d3-06ad-4817-9ad4-a6090561ad17",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_15",
                    "encounterId": "497f7786-8f6e-4d53-b370-9a88152b27c1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "9126179b-d9ae-4759-a4b9-91d2d29643db",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_16",
                    "encounterId": "23543897-7ea8-407e-964d-9d64950ff747",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "a0a4bbd9-a0a7-47b1-aac9-1e147742e9df",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_17",
                    "encounterId": "10fefe8a-3a1a-4317-893e-77b2263b4ea1",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "390c7e58-7550-4dba-b337-d63551ed3616",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_18",
                    "encounterId": "3d7d40d1-628b-4ff5-ad2b-f1612252cf1a",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "4a55b0cb-135b-4419-8756-592aa36ed1c2",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_19",
                    "encounterId": "977e1d9b-33ad-4706-893c-7f7b8a0e750b",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "5430dd57-a7be-45da-8053-11ff9c7de024",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_20",
                    "encounterId": "3d37ddc0-dd83-44ac-bc92-382b247512db",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "d5afaf93-d152-4629-86a7-ddb15c413624",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_21",
                    "encounterId": "fa569f3d-48b7-4c3f-8449-7fdebebe6343",
                    "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc"
                  },
                  {
                    "id": "b7cd1d69-8f16-4b7f-8064-9214fa351058",
                    "activityIds": [
                      "553bb4c2-c383-43b1-9e58-533287a502a7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_36@enc_24",
                    "encounterId": "7c21b6db-6a2e-4316-963d-b9c0d809be67",
                    "epochId": "4e0fe673-f9be-4e80-8aa0-88cfc78319fa"
                  },
                  {
                    "id": "e45d62eb-dd03-4103-9410-520959121109",
                    "name": "InformedConsent",
                    "description": "Event anchor: InformedConsent",
                    "activityIds": [
                      "5305c784-10dd-4d7a-9c79-6f5c340e32e5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "15cd238b-b8ad-497d-b691-ca65810371f8",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "314849e6-b9fa-48b1-94f6-599d312066d2",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 10
                      }
                    ],
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab",
                    "scheduledDay": 1
                  },
                  {
                    "id": "5c4ba03f-4057-4b34-b588-1996326b41fc",
                    "name": "Baseline",
                    "description": "Visit anchor: Baseline",
                    "encounterId": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "15cd238b-b8ad-497d-b691-ca65810371f8",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      },
                      {
                        "id": "314849e6-b9fa-48b1-94f6-599d312066d2",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 50
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "7ee7c94f-38ab-4892-a4c7-57b76b707bbb",
                    "name": "FirstDose",
                    "description": "Event anchor: FirstDose",
                    "activityIds": [
                      "79de9a46-95ba-4cd1-b1b9-e344a7167dc3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "15cd238b-b8ad-497d-b691-ca65810371f8",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "314849e6-b9fa-48b1-94f6-599d312066d2",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 60
                      }
                    ],
                    "epochId": "b329d201-0097-428f-a975-638b81cdd1ab",
                    "scheduledDay": 1
                  }
                ]
              }
            ],
            "encounters": [
              {
                "id": "64dac216-5a49-4ef7-b37c-03586f19113b",
                "name": "Screening (Day -42 to -9)",
                "instanceType": "Encounter",
                "type": {
                  "id": "7825655c-db11-4af6-b0e1-8e3c17aa3b38",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Visit",
                  "instanceType": "Code"
                },
                "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4",
                "extensionAttributes": [
                  {
                    "id": "6b841ede-ff56-4168-ae86-6f59b9dd08be",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6bde0fbd-3604-4b6c-866d-e171df3d3e31",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "d003a7ab-4671-426b-bb9b-11ec636c4de1",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -42
                  }
                ]
              },
              {
                "id": "3281c593-af16-41b6-ae63-33e05a0acb2d",
                "name": "Screening (Day -21)",
                "instanceType": "Encounter",
                "type": {
                  "id": "e1fe6625-538d-4d91-acff-d56b8ed1f1f8",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Visit",
                  "instanceType": "Code"
                },
                "epochId": "57136ab0-8f90-44b4-8f55-9d2f130018f4",
                "extensionAttributes": [
                  {
                    "id": "a731e171-5bc1-4e26-a940-673731a65d14",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "e89da98e-eae1-4006-a29d-17c24f056158",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "8d46561f-c0f2-45a5-a1b7-2910d638a1d2",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -21
                  }
                ]
              },
              {
                "id": "9b7718d5-2779-48a1-92b3-1269dc7330b7",
                "name": "C-I (Day -8)",
                "instanceType": "Encounter",
                "type": {
                  "id": "9fe560b3-f67d-41b5-b182-0841aa529026",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "173bebeb-5135-479e-b0e3-f5d97463f769",
                "extensionAttributes": [
                  {
                    "id": "d800ee63-c7a0-4c2c-a34a-6ba5cc23a691",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4a8339a4-1bec-454a-8563-99337a890964",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "db6f97b8-1793-4878-afb4-80eb426b4ca3",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -8
                  }
                ]
              },
              {
                "id": "c96db2ab-ad9e-4d0e-b88b-a92f11765aaf",
                "name": "Inpatient Period 1 (Day -7)",
                "instanceType": "Encounter",
                "type": {
                  "id": "46de4a81-d01b-4def-8f7b-b7b5a7345508",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "b329d201-0097-428f-a975-638b81cdd1ab",
                "extensionAttributes": [
                  {
                    "id": "b7c10e78-ca91-4ef9-92cb-42e1e82a9e09",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d2a68835-3093-40be-9e5b-4f1f584fea46",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "9985331b-4a17-4d1b-a5d7-95a1660e1959",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -7
                  }
                ]
              },
              {
                "id": "4c6ce239-8bac-4969-bec1-a3c5bc26b7d2",
                "name": "Inpatient Period 1 (Day -6 through -5)",
                "instanceType": "Encounter",
                "type": {
                  "id": "734b4cd3-ddb3-45db-a015-28a335b06878",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "b329d201-0097-428f-a975-638b81cdd1ab",
                "extensionAttributes": [
                  {
                    "id": "3d434b75-9a94-4a5f-9a09-921ee7b40a04",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "bbf43102-3bff-4b68-8190-165a2198f4a8",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "93fb5e31-8864-4bbd-b263-50e46da750b4",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -6
                  }
                ]
              },
              {
                "id": "8c40da25-cece-48ad-940c-040d7ee8242e",
                "name": "Inpatient Period 1 (Day -4 through -1)",
                "instanceType": "Encounter",
                "type": {
                  "id": "347d96fc-b330-4dcd-b4ae-524dc7ec1226",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "b329d201-0097-428f-a975-638b81cdd1ab",
                "extensionAttributes": [
                  {
                    "id": "06adda80-a301-41aa-9d19-a878eb58e51d",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6d36b35b-11b7-474a-a4eb-1afeec62de5b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "ef9efed9-594d-4be6-a35c-fad0f42304ee",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -4
                  }
                ]
              },
              {
                "id": "09997838-65b4-415d-8f67-7a38e5f11cd3",
                "name": "Inpatient Period 1 (Day 1)",
                "instanceType": "Encounter",
                "type": {
                  "id": "0020f6a0-e1a5-41f9-b36c-7d8fc9ee62a9",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "b329d201-0097-428f-a975-638b81cdd1ab",
                "extensionAttributes": [
                  {
                    "id": "67cb3e56-a33c-4348-b5da-a4473dfdc1ea",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b0446c8c-b015-4329-99d2-efe1a8a8e3ba",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "adb5d41c-7b41-4095-932a-fce7084d418f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 1
                  }
                ]
              },
              {
                "id": "fae139a7-c907-49fb-9f60-244cccace73f",
                "name": "Inpatient Period 1 (Day 2-3)",
                "instanceType": "Encounter",
                "type": {
                  "id": "0a177b62-778d-463e-803c-8608241f3b68",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "b329d201-0097-428f-a975-638b81cdd1ab",
                "extensionAttributes": [
                  {
                    "id": "92f1a2dc-69da-41d0-bf0c-bef932c9f93b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "7aac5cf4-2893-4614-8402-4f82c22d0b64",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "2b130c85-426d-4605-8733-1e7e5587b310",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 2
                  }
                ]
              },
              {
                "id": "6bd0c3a4-2308-4654-9907-90e12db4721d",
                "name": "Inpatient Period 1 (Day 4-7)",
                "instanceType": "Encounter",
                "type": {
                  "id": "a7657f97-3485-49ca-8f90-518824cf4583",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "b329d201-0097-428f-a975-638b81cdd1ab",
                "extensionAttributes": [
                  {
                    "id": "c2812680-593c-4d64-95eb-ffb4b2fdc6dc",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "595dd236-8394-48f5-9a17-d6ed7cb731c6",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "e1860daa-108e-4e10-b833-dbca58a2cad6",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 4
                  }
                ]
              },
              {
                "id": "a620e15f-365d-4654-9cd3-adaa5bcda509",
                "name": "Inpatient Period 1 (Day 8)",
                "instanceType": "Encounter",
                "type": {
                  "id": "29c3fb80-dfa4-41dc-9552-6b6b24bcc51d",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "b329d201-0097-428f-a975-638b81cdd1ab",
                "extensionAttributes": [
                  {
                    "id": "295bb980-4b73-43c4-87c4-caff880c11fa",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "404cc5c4-7a0e-48f4-b012-af0e76d4f83d",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "8d657a8a-2877-4d9f-9adf-c9e2d0afdfcb",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 8
                  }
                ]
              },
              {
                "id": "443a5337-c8fb-4990-acd2-e54beb41b824",
                "name": "Inpatient Period 1 (Day 9)",
                "instanceType": "Encounter",
                "type": {
                  "id": "f84268b1-113d-4ddf-9237-0ef21810eba0",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "b329d201-0097-428f-a975-638b81cdd1ab",
                "extensionAttributes": [
                  {
                    "id": "74d166d2-0936-4924-8695-f09f29103841",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "20aa58f0-f7c0-48f4-9fcf-cc6a2586a5e7",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "de7040b1-fc6f-4a43-9383-60d62a405011",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 9
                  }
                ]
              },
              {
                "id": "8d49c51d-fda5-400e-bb15-d3d28ad266e4",
                "name": "OP (Day 10-22)",
                "instanceType": "Encounter",
                "type": {
                  "id": "768e8c52-4646-49de-81d3-31461d311e66",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e1c84807-638c-4fe2-9296-6c57a7fc1979",
                "extensionAttributes": [
                  {
                    "id": "cdd1f460-5d5f-4212-a13f-967c7d0cf0ef",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ad59c7a6-0df0-4ec3-a1f0-e3d1f21c7615",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "2502a831-7b51-42c2-ad7f-fc2e96f0b65c",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 10
                  }
                ]
              },
              {
                "id": "4cf5ed67-3949-43a1-8ea1-b9f74950088e",
                "name": "Inpatient Period 2 (Day 23)",
                "instanceType": "Encounter",
                "type": {
                  "id": "40bb4573-d658-4324-b616-42676e6ea9ea",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc",
                "extensionAttributes": [
                  {
                    "id": "b144f878-59bf-4d43-bd73-958d50170bc7",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "76310948-9f57-4ba2-8ee9-a1bbd83e42ff",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "c4fcc001-2841-4bb7-9163-3eed3f2a8920",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 23
                  }
                ]
              },
              {
                "id": "9069fbec-10a0-4cab-8000-2757531c4359",
                "name": "Inpatient Period 2 (Day 24)",
                "instanceType": "Encounter",
                "type": {
                  "id": "b22a35a8-5538-43f5-936e-44316633de8c",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc",
                "extensionAttributes": [
                  {
                    "id": "621a4dd5-93c4-41dd-a924-3bdd69b24989",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ea61e902-be8e-44a4-9fd5-3bbad950de67",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "c9278f25-072a-44a1-9644-fe3c478c9e8f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 24
                  }
                ]
              },
              {
                "id": "497f7786-8f6e-4d53-b370-9a88152b27c1",
                "name": "Inpatient Period 2 (Day 25)",
                "instanceType": "Encounter",
                "type": {
                  "id": "0f1bdec9-6606-47b6-8591-4faf712d03be",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc",
                "extensionAttributes": [
                  {
                    "id": "1a98fd78-bdde-4032-b1fb-b48266d07455",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "1e90b4dc-3b77-4ee3-a853-1c52b314937e",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "2b751052-c564-4176-9068-9fc0c744dd74",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 25
                  }
                ]
              },
              {
                "id": "23543897-7ea8-407e-964d-9d64950ff747",
                "name": "Inpatient Period 2 (Day 26-28)",
                "instanceType": "Encounter",
                "type": {
                  "id": "2297d325-8798-4cb2-b7b4-0735e2142de2",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc",
                "extensionAttributes": [
                  {
                    "id": "3b62c59f-7325-433b-abff-269f793f7958",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d8bc3296-a61a-4246-8844-91cb16942f45",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "725d624b-971b-45ee-97cf-7ad608a97b8e",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 26
                  }
                ]
              },
              {
                "id": "10fefe8a-3a1a-4317-893e-77b2263b4ea1",
                "name": "Inpatient Period 2 (Day 29)",
                "instanceType": "Encounter",
                "type": {
                  "id": "16e30147-6562-4103-8b31-5eb58466d9e6",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc",
                "extensionAttributes": [
                  {
                    "id": "7368b2c9-2c61-4214-83a2-74abbc221210",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "cbf1cd22-98cb-44c5-96aa-7373f663c785",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "b8024226-7c8e-4155-b2e9-57ecd6e720a0",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 29
                  }
                ]
              },
              {
                "id": "3d7d40d1-628b-4ff5-ad2b-f1612252cf1a",
                "name": "Inpatient Period 2 (Day 30-35)",
                "instanceType": "Encounter",
                "type": {
                  "id": "8f2a2441-1312-4ed9-b28d-226476031c62",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc",
                "extensionAttributes": [
                  {
                    "id": "30a920df-0f28-4983-aa01-106a97883df1",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d2791847-2088-4494-8d47-cf0fed20fa3e",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "8dc4525f-99c7-481a-932f-27543b97a719",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 30
                  }
                ]
              },
              {
                "id": "977e1d9b-33ad-4706-893c-7f7b8a0e750b",
                "name": "Inpatient Period 2 (Day 36)",
                "instanceType": "Encounter",
                "type": {
                  "id": "6fcb3305-4097-4d06-9ed0-95a067a25098",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc",
                "extensionAttributes": [
                  {
                    "id": "6456b843-0a62-40ba-ba11-7cc28041b48f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "a15bdc41-cd30-4d13-8ef9-a2d189d97ec7",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "20c5e780-756f-4e55-8c62-e90a3fa5138e",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 36
                  }
                ]
              },
              {
                "id": "3d37ddc0-dd83-44ac-bc92-382b247512db",
                "name": "Inpatient Period 2 (Day 37-38)",
                "instanceType": "Encounter",
                "type": {
                  "id": "b58a9f1c-d917-4ed2-9ce5-9f62197c05ec",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc",
                "extensionAttributes": [
                  {
                    "id": "e3ce43c6-115c-450f-a8b7-ca6567f60a65",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ec7c6fd7-b3b6-4715-b11f-cdfc2828cf44",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "37152a61-4b4b-48f6-9614-dc6ac25c02cd",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 37
                  }
                ]
              },
              {
                "id": "fa569f3d-48b7-4c3f-8449-7fdebebe6343",
                "name": "Inpatient Period 2 (Day 39)",
                "instanceType": "Encounter",
                "type": {
                  "id": "92005154-c9a6-4209-adc6-961bd918e9e0",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc",
                "extensionAttributes": [
                  {
                    "id": "cc77f8d3-44e9-49dd-8ea3-395331818bcf",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "0acb0ece-d8f4-4571-8eb8-635ae9d0d041",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "f3954849-3a81-47e5-8d27-de77f74f0668",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 39
                  }
                ]
              },
              {
                "id": "f74ddc2e-7d88-458e-802f-dfb0b065c8b4",
                "name": "Inpatient Period 2 (Day 40)",
                "instanceType": "Encounter",
                "type": {
                  "id": "bf6b4e4e-7fdc-4f1d-9cb7-51d81f3ec043",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "8866aa20-2dbf-4344-b3c6-f69f7b7586dc",
                "extensionAttributes": [
                  {
                    "id": "2dc5b584-f2e9-4145-be2d-24f0ea6ca8ef",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4a7733ff-9344-4b9b-8b2b-9e48a3c42f03",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "a073a861-61d6-40eb-b996-5cb711695dfd",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 40
                  }
                ]
              },
              {
                "id": "7c21b6db-6a2e-4316-963d-b9c0d809be67",
                "name": "EOS Day 54+/-2",
                "instanceType": "Encounter",
                "type": {
                  "id": "e49b26dc-0915-4595-b32b-6861cab9f140",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "End of Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "4e0fe673-f9be-4e80-8aa0-88cfc78319fa",
                "extensionAttributes": [
                  {
                    "id": "3820ef6e-60b0-422c-9f8b-c8ad3f6535e6",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d07b5e6c-b308-4a98-bf58-9ba291f25d22",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "d20b981e-6e65-4e4a-8f80-7e27b31ea011",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 54
                  }
                ]
              },
              {
                "id": "69a6e403-9a8e-4741-9d04-6ed37fe76b97",
                "name": "Unscheduled Visit",
                "instanceType": "Encounter",
                "type": {
                  "id": "c5177329-ef80-4873-8f23-9218caaa60b4",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Unscheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "778933b2-8764-4d4d-a845-ad7210b5a7b1",
                "extensionAttributes": [
                  {
                    "id": "dfcb6126-1c01-4f53-be57-efeeb64ee09f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "97b45b82-0af1-4125-a41a-69074505226f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              }
            ],
            "activities": [
              {
                "id": "e165d841-2182-4332-b365-aad1e15e8852",
                "name": "12-lead ECG",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "e165d841-2182-4332-b365-aad1e15e8852",
                    "name": "12-lead ECG",
                    "procedureType": "Diagnostic Procedure",
                    "code": {
                      "id": "b5e4bc36-701c-4565-b803-eab8314e159c",
                      "code": "93000",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Electrocardiogram, routine ECG with at least 12 leads",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Electrocardiogram",
                    "description": "Triplicate 12-lead electrocardiogram to monitor heart rate and intervals (PR, QRS, QT, QTc)"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "8e2a10ee-78e9-44e7-8d83-e727b065a789",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "66d3d93d-d4b4-40cf-8970-c6986dc1b880",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "561042b7-1354-4f97-9bc7-0510fbe01a43",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "6f840b08-1ea8-4290-9c04-2c9c4719d6c1",
                "name": "12-lead ECG (triplicate)",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "e165d841-2182-4332-b365-aad1e15e8852",
                    "name": "12-lead ECG",
                    "procedureType": "Diagnostic Procedure",
                    "code": {
                      "id": "b5e4bc36-701c-4565-b803-eab8314e159c",
                      "code": "93000",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Electrocardiogram, routine ECG with at least 12 leads",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Electrocardiogram",
                    "description": "Triplicate 12-lead electrocardiogram to monitor heart rate and intervals (PR, QRS, QT, QTc)"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "68e0bea4-5f1a-4342-9b71-da29c7dae31f",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "156b44b0-13e7-4da3-a5b3-f502005c8ecb",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "59f549a7-91f5-4358-9acd-d4c592b3abc1",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "f241c07a-7a26-440f-9c73-9cf52f3e3d3d",
                "name": "24-hour urine collection",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "f241c07a-7a26-440f-9c73-9cf52f3e3d3d",
                    "name": "24-hour urine collection",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "473fc0b3-f6ef-4093-a3ea-0db2dc7429b9",
                      "code": "C70793",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Biospecimen Collection",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Urine Collection",
                    "description": "Collection of urine for measurement of copper and molybdenum content"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "56c4c9cd-5a9c-4a42-ab06-f4bce41d6fab",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "70a1d9d8-9f54-49fb-86bd-02942a2c5ffb",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "9d6457fc-7ac3-4456-9a67-51fb779e84bb",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "36e59d41-e065-44e8-b91a-5f16699cfa1f",
                "name": "24-hour urine for Cu and Mo",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "1e799a7c-9aaf-4ba8-b959-c597bb271f20",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "7a8544e9-b56a-46c3-b6d9-75b8a211a2d0",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "35dbb40e-0c27-474c-a880-7aaaefebe406",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "ea994424-deba-4e26-a84a-4557d942a173",
                "name": "ALXN1840 15 mg/day",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "8c1cdf6f-88d0-4dbd-878e-eff851f94ab3",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "7e84ee5b-3826-43af-a30b-816376ac29cb",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "93b86656-dd8b-4cb0-aa4d-8c9e3a74d025",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "8f77a8c3-1ebd-4c43-b776-f7769ed32c55",
                "name": "ALXN1840 30 mg/day",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b5e70619-b0fa-408f-ae6b-8f90bc3ca71e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "889759af-e931-41ef-b0e7-b7e48e023cf9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "52089abd-5782-4f50-818f-45e9f7a8a2f5",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "153847fb-d939-4a3e-aca4-34c3fdb5d735",
                "name": "Admit to unit",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "27fa639f-25fa-43e7-8a77-a25daf671f70",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4cd3604f-25c8-4bf9-8fd4-a9377128e711",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "56e4ea41-dc12-4126-94a5-924bf182b245",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "3e1d336a-ad3a-4ab9-92d9-02c26402c144",
                "name": "Adverse events",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "30379067-6d38-4a2d-abf6-401faaeeba06",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "733c345e-6ec7-4ef5-b52a-4d04bf15be7c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "f410ceb7-b39c-45af-81fb-a9a9ac3ad6cb",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "ef37d001-a448-41b4-bc4d-ed31e8ecb092",
                "name": "Alcohol test",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "020887a4-8753-4ce8-937e-d7b79dc5e430",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "41efd908-b1e9-4788-b822-ac65f08fb99a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "ca7c7cf4-1e81-4be6-9c58-b48426a0a44b",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "24decd27-23c1-43b9-8b7c-900057276b21",
                "name": "Blood sampling for PK/PD",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "24decd27-23c1-43b9-8b7c-900057276b21",
                    "name": "Blood sampling for PK/PD",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "abfcad9d-76b7-4f41-b151-071047435fa0",
                      "code": "36415",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Collection of venous blood by venipuncture",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Pharmacokinetic and Pharmacodynamic Blood Draw",
                    "description": "Collection of blood for plasma total Mo, PUF-Mo, plasma total and PUF-Cu, LBC, ceruloplasmin, and ceruloplasmin-bound Cu"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "1e6911a9-8f8e-47e3-9adc-aa081b44bcb6",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "004def0c-c19a-4858-b0af-bfdc059ebdef",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "3b907758-5596-43e2-9c91-f25145290ed3",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "e6a2afad-c0ca-4f46-9769-921725016179",
                "name": "Blood sampling for PK: Plasma total Mo and PUF-Mo",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "64fdf5cb-4e09-49a0-8b6f-1406933b5fc5",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "97f9089c-68ce-4a58-b96d-31c5168c5517",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "5e85182b-2792-4a74-8acb-b565ed829a96",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424",
                "name": "Chemistry, hematology, Coagulation",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "582cabd9-4e05-4ac2-9e60-2318793a4c1a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "42d3b0d0-54f7-45ca-88d8-46728391fe44",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "16427720-e201-4754-940a-a85bef21ac16",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "553bb4c2-c383-43b1-9e58-533287a502a7",
                "name": "Concomitant medication and non-pharmacologic therapy/procedure",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "697d2d13-edd5-4f84-ad8e-0bc0481e81a2",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "eff326e2-395a-40d0-99fc-e4f98c60639c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "b60c56ac-25ba-43bb-b5d5-62abe923bd50",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "3e676ade-fb1a-49be-ad73-415ed117f94e",
                "name": "Cu/Mo-controlled meals",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "f5f91e98-ba20-4d7a-9f6d-cc75b0dd0c85",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "abc852fd-03a6-4f0a-ac72-317161f04521",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "4b9f24d2-e8a6-41cf-801d-568f8487ba5b",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "6610c275-e6f3-4043-93ff-60831ad5ea5d",
                "name": "Discharge from unit",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "855a143e-2d12-4277-af09-6dba0c04ff6e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "641e0c00-dc2c-4a1d-8807-301e700e3137",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "2c1abbd5-8558-4d84-865a-78f3c44b8df0",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "98509a6d-7634-4bdd-af34-60334b12b32c",
                "name": "Discontinue chelation therapy",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "11c7d27a-0f27-4d0c-b295-5cac642710b9",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "89f8cc1e-be2b-4066-90b9-9a0e8856311e",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "4a018574-95cc-4c3b-98a5-e782c56773ac",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "fcd57369-1ef5-4d3f-b63f-d90264281374",
                "name": "Discontinue zinc therapy",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "348be98f-7ed3-40b3-985f-f1c8b2113c1f",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ecd4cce7-5107-4d63-9b92-e2ff4ad103a9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "7e4709fd-7e2f-4cbc-9a70-cc78079a75fe",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "f1a61cfd-0d72-475e-89de-e1ba29c0d15d",
                "name": "Discuss/document contraception",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "51d4c040-c9f5-46cd-9319-1d8f79f04d51",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "c239f32f-f8b9-4e93-afec-4bb43f7c6eb2",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "1b56f202-d97a-4628-8d81-8ac72cb90bd9",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "8b54e2ab-2acc-4536-b0f3-d331d2574e43",
                "name": "Enrollment/inclusion",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "33f460b6-458f-4790-9b39-09aea040b0f5",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "f1745963-90d5-4b3f-a636-bf8b635df605",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "documentation"
                  },
                  {
                    "id": "832375d3-513d-4288-997a-34212b981c47",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "849704ea-0b1e-457d-bbd3-1f13815a70af",
                "name": "Fecal collection",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "849704ea-0b1e-457d-bbd3-1f13815a70af",
                    "name": "Fecal collection",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "1a42328a-322e-4878-920e-dff1e455c4bd",
                      "code": "C70793",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Biospecimen Collection",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Stool Collection",
                    "description": "Individual collection of fecal samples for copper and molybdenum content analysis"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "f63f533b-794f-453c-aa1a-2fb08b9540ad",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "c0f53293-db44-4a15-a865-a375a300c4b0",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "e917de00-bdea-4e0d-a979-8d4e8ff5a78d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1",
                "name": "Feces for Cu and Mo",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "7e6d9820-178e-4581-ad91-025720276378",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ea8e0590-da8a-4556-b980-82bf0a1203ff",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "d6752fad-e71f-49c3-baad-ad34fbc7a0b3",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "5faad3f6-2b83-46c8-816d-4ace6abc5381",
                "name": "Follicle-stimulating hormone (post-menopausal females only)",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "52a364ec-0a0b-4a74-bdc2-1f8a29990fbe",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "00d72142-a2d8-4337-b8f5-c6e10bfff5b9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "625c77b3-79ce-4485-8530-3e53848c2160",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "c5f7f4af-321b-487d-8367-e7f64930c782",
                "name": "HIV, hepatitis B and C screen",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6d24ce38-77b4-49e5-885c-291d151d1672",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "fd795292-0d37-4c39-abcc-f9d836ae583a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "d0b8c8a4-5c27-4fd2-ad1b-4ac3bc18a37d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "73d6e759-c678-49c2-aada-c053c3b851b2",
                "name": "Height, weight, and BMI",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d243c4f3-df31-42e1-953b-9ead2afb581e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "3f242e81-cda3-4010-8d8f-5f97d08ff157",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "4b1152d3-e6a9-4ba8-9f57-93c6ab19b5e2",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "6a843cd3-19dc-4619-9fb3-8d904686bbc8",
                "name": "Inclusion/exclusion",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "f016223f-9480-4a5b-beb5-b1674b0619db",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "bdf71ccf-5707-41a0-a116-a781db494d11",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "de6d2a80-3ee6-481a-a768-557110b7d870",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a8deb9b9-b7b0-41d0-80ab-4af6909d3a43",
                "name": "Inductively coupled plasma mass spectrometry",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "a8deb9b9-b7b0-41d0-80ab-4af6909d3a43",
                    "name": "Inductively coupled plasma mass spectrometry",
                    "procedureType": "Diagnostic Procedure",
                    "code": {
                      "id": "97c2b117-7a4b-4276-8e9a-32bec4743903",
                      "code": "C25391",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Diagnostic Procedure",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "ICP-MS",
                    "description": "Laboratory analysis to determine copper and molybdenum concentrations in samples"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "869c546e-5641-44f3-8670-5e9fc263c0bf",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "9e7ac12b-2410-4c3d-bc37-de84846c1ad9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "eb54c081-3df6-4969-83aa-bc607acf421f",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "5305c784-10dd-4d7a-9c79-6f5c340e32e5",
                "name": "Informed consent",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b99689a5-830b-47db-b122-5b5935a8ad30",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b2b3540a-ef89-44ab-951a-9b7bb4681b1b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "documentation"
                  },
                  {
                    "id": "ddb767ab-68ca-444b-9e04-5d65e7da5dce",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "beb465a9-633b-4ba6-861f-8ebbdb4da1b8",
                "name": "Light exercise regimen",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "ed25f96b-90cf-498d-ba03-c18a06576d52",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6f0bbff0-02ad-41f6-9b9b-79bd7b223e58",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "0b825403-2625-4f9f-8c3d-e65b46b8f776",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "13dc7b44-1063-4555-bd7a-c190da52131e",
                "name": "Medical history/demographics",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "44d4c557-e6e8-4665-aa2f-0b9ec18f5143",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "90903942-a0b9-41aa-98e0-abcf41ae15e6",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "0ff66b9d-6217-4f16-adcc-d6ff2ecf71fb",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "1708b8e7-b182-4172-8f2c-9bd62015af1a",
                "name": "Outpatient visit or phone call",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "a04349f1-c89d-4c7d-9b90-75335309a468",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "0ab22629-dee8-4140-9565-186a84a3081d",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "59a4683f-b3f1-4713-9d3e-920af29eaa5d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "79de9a46-95ba-4cd1-b1b9-e344a7167dc3",
                "name": "PD: Plasma total and PUF-Cu, LBC, ceruloplasmin, ceruloplasmin-bound Cu",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6127f0ab-7980-40cf-823d-b38f7432d37b",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d1316926-33fb-45d9-b034-b79b6c52e91d",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "4a42d566-e54c-494c-8d48-f22e03f321ee",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "0f414ebf-d42c-40ad-8b57-0ba36b1a7e23",
                "name": "Physical examination",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "1be43fec-3d98-4e0f-9d34-a58ed1ac1c74",
                    "name": "Physical examination",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "107a668d-b610-4aeb-97fd-30756af8275a",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Physical Exam",
                    "description": "Assessments of cardiovascular, respiratory, gastrointestinal, and neurological systems"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "dae481c5-0c74-4da2-a89d-a97bd51c08f5",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures,soa"
                  },
                  {
                    "id": "8ae5672a-69ff-4e19-8b62-32c2eb4b51b1",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "a9cc29dc-b3cd-43d8-84d1-67f3e2b65815",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "5fd9167b-7b61-4d18-a173-c31b06444479",
                "name": "Pregnancy testing",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "5fd9167b-7b61-4d18-a173-c31b06444479",
                    "name": "Pregnancy testing",
                    "procedureType": "Diagnostic Procedure",
                    "code": {
                      "id": "29c9954f-7f7b-4d5f-b01a-29b1c0784bf0",
                      "code": "C25391",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Diagnostic Procedure",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Pregnancy Test",
                    "description": "Urine or serum pregnancy tests for females of childbearing potential"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "df206bcc-3400-4e4d-b583-bef8200f1128",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "a281df2d-5f36-4222-aa57-0b1740291edf",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "a523c3a6-0cd8-46c2-a22e-2e54a23efcd7",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "44625ba9-8e87-4aaf-a000-fe1cfd0cee3f",
                "name": "Prior WD treatment",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "73e9882f-ee47-4a88-808c-33c0b184f60d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "704378a4-954c-4eff-aec1-15c4ddee3e97",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "1fa487bb-14e9-4348-b127-b8cf055187f5",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "041d2c05-695c-45ab-98c7-77f18949e879",
                "name": "Retained serum sample (safety)",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "add39db8-32e9-4b9f-b52c-f2cdb9f2323b",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "52004777-a9bb-4262-8bf2-09310e67690f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "6ebf2ad7-90ce-4a1b-b1ac-7fa22410c41f",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "10e2d3bc-40c0-4b49-9c91-084cd735996b",
                "name": "Study intervention compliance",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6e227cb6-1f0c-490a-b5df-e27492f29476",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "c0e5d05f-5f2c-40f2-8bb4-0033b7c89780",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "6b3e6e5f-099b-420e-b4f3-4cada2b85722",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "6197c352-60bf-4f51-876e-373344f5ca28",
                "name": "Urinalysis",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "69a3bfc3-9950-45d4-aedd-18193fbb84e8",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4a1322ff-1072-4698-9b24-1635193be291",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "d3d79699-6d02-42e9-9939-fb7fb6f63544",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "468b2bb3-7af5-421d-a550-5c54d876fba6",
                "name": "Urination and bowel movement monitoring, menstruation check",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "1d4c894e-bd5a-414b-aa0a-0c9233c7d569",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b7d9a51f-f1ee-4c3f-be74-ca620bfba8b3",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "a1376e2f-1302-4a9d-a899-ebf681003c2c",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a08930fc-ae5c-40fc-b468-a8d8d5e1b31b",
                "name": "Urine drug screen",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "9370b8ca-b4ff-4e66-8fd6-961128118369",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "94f660f1-79ea-485a-8cce-65aa2e4da60a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "3f0b6b3e-9af0-49bf-9473-8c8f816fdc12",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "82ae0e2d-6367-40c3-933d-23becc413381",
                "name": "Urine/serum pregnancy test",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "70179b9b-07de-4e4c-9277-3631880f7f42",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "a80b0162-864a-4cc9-9906-932ab5911c57",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "aaf1f5c6-219c-4408-a927-91b26e484fff",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "855b90ee-fcb6-4844-ad61-4a43127caa56",
                "name": "Vital sign measurements",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "855b90ee-fcb6-4844-ad61-4a43127caa56",
                    "name": "Vital sign measurements",
                    "procedureType": "Monitoring",
                    "code": {
                      "id": "a4df63ff-6f8b-41ef-adf5-00efbe0b7b70",
                      "code": "C25548",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Monitoring",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Vital Signs",
                    "description": "Assessment of body temperature, heart rate, respiratory rate, and systolic/diastolic blood pressure"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d1995792-d722-4931-97da-e2c44be7cd18",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "1f97225a-ed3a-4a45-80fd-7b0182f905a6",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "31cb1733-a58a-4bb7-9a89-8c0a26b6c0d8",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "eed510fb-92ae-4758-87ce-38f6c63e1511",
                "name": "Vitals sign measurements",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "8586c96b-30df-4b55-a922-d47b049dc2f0",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6899d6b3-1cfb-4f51-ad86-9957140daaef",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "a1d687df-d324-426c-8e71-dcaba2f71f95",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "ee790981-6f50-4074-a528-d18d2002d1d6",
                "name": "WD history",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b5b00676-13c5-48df-b845-fd9490cbf561",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "f0a5310c-70a5-4859-a0b2-0a7e842eec3d",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "1489b20d-e158-4dbe-9cd2-5f7eec07e40e",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              }
            ],
            "activityGroups": [
              {
                "id": "2ec86e6a-bce8-47ba-9d4b-ed06ee235daf",
                "name": "Eligibility",
                "description": null,
                "childIds": [
                  "5305c784-10dd-4d7a-9c79-6f5c340e32e5",
                  "153847fb-d939-4a3e-aca4-34c3fdb5d735",
                  "6610c275-e6f3-4043-93ff-60831ad5ea5d",
                  "1708b8e7-b182-4172-8f2c-9bd62015af1a",
                  "6a843cd3-19dc-4619-9fb3-8d904686bbc8",
                  "f1a61cfd-0d72-475e-89de-e1ba29c0d15d",
                  "5faad3f6-2b83-46c8-816d-4ace6abc5381",
                  "ef37d001-a448-41b4-bc4d-ed31e8ecb092",
                  "a08930fc-ae5c-40fc-b468-a8d8d5e1b31b",
                  "c5f7f4af-321b-487d-8367-e7f64930c782"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Informed consent",
                  "Admit to unit",
                  "Discharge from unit",
                  "Outpatient visit or phone call",
                  "Inclusion/exclusion",
                  "Discuss/document contraception",
                  "Follicle-stimulating hormone (post-menopausal females only)",
                  "Alcohol test",
                  "Urine drug screen",
                  "HIV, hepatitis B and C screen"
                ]
              },
              {
                "id": "382fe30e-bbb7-4ea4-a6a3-3d5ddef8e030",
                "name": "Study Administration",
                "description": null,
                "childIds": [
                  "13dc7b44-1063-4555-bd7a-c190da52131e",
                  "ee790981-6f50-4074-a528-d18d2002d1d6",
                  "44625ba9-8e87-4aaf-a000-fe1cfd0cee3f",
                  "0f414ebf-d42c-40ad-8b57-0ba36b1a7e23",
                  "73d6e759-c678-49c2-aada-c053c3b851b2"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Medical history/demographics",
                  "WD history",
                  "Prior WD treatment",
                  "Physical examination",
                  "Height, weight, and BMI"
                ]
              },
              {
                "id": "6c911525-133b-46e0-8f09-eb989fc17cf9",
                "name": "Enrollment",
                "description": null,
                "childIds": [
                  "8b54e2ab-2acc-4536-b0f3-d331d2574e43",
                  "98509a6d-7634-4bdd-af34-60334b12b32c",
                  "fcd57369-1ef5-4d3f-b63f-d90264281374"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Enrollment/inclusion",
                  "Discontinue chelation therapy",
                  "Discontinue zinc therapy"
                ]
              },
              {
                "id": "97b50fee-c394-43ea-8ab2-82a187722c2a",
                "name": "Administration of Study Intervention",
                "description": null,
                "childIds": [
                  "ea994424-deba-4e26-a84a-4557d942a173",
                  "8f77a8c3-1ebd-4c43-b776-f7769ed32c55",
                  "10e2d3bc-40c0-4b49-9c91-084cd735996b"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "ALXN1840 15 mg/day",
                  "ALXN1840 30 mg/day",
                  "Study intervention compliance"
                ]
              },
              {
                "id": "9ca6d3c4-0d3f-4c50-986d-e6ca348070f3",
                "name": "PK/PD Analyses",
                "description": null,
                "childIds": [
                  "e6a2afad-c0ca-4f46-9769-921725016179",
                  "79de9a46-95ba-4cd1-b1b9-e344a7167dc3"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Blood sampling for PK: Plasma total Mo and PUF-Mo",
                  "PD: Plasma total and PUF-Cu, LBC, ceruloplasmin, ceruloplasmin-bound Cu"
                ]
              },
              {
                "id": "0d6aee78-3ca6-421a-822f-1c43ea8fb3aa",
                "name": "Safety Assessments / Laboratory Analyses",
                "description": null,
                "childIds": [
                  "bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424",
                  "6197c352-60bf-4f51-876e-373344f5ca28",
                  "82ae0e2d-6367-40c3-933d-23becc413381",
                  "041d2c05-695c-45ab-98c7-77f18949e879",
                  "eed510fb-92ae-4758-87ce-38f6c63e1511",
                  "6f840b08-1ea8-4290-9c04-2c9c4719d6c1",
                  "3e1d336a-ad3a-4ab9-92d9-02c26402c144"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Chemistry, hematology, Coagulation",
                  "Urinalysis",
                  "Urine/serum pregnancy test",
                  "Retained serum sample (safety)",
                  "Vitals sign measurements",
                  "12-lead ECG (triplicate)",
                  "Adverse events"
                ]
              },
              {
                "id": "44e4cb98-5386-4a9d-9d4d-b6930d1d30c8",
                "name": "Balance assessments",
                "description": null,
                "childIds": [
                  "3e676ade-fb1a-49be-ad73-415ed117f94e",
                  "beb465a9-633b-4ba6-861f-8ebbdb4da1b8",
                  "468b2bb3-7af5-421d-a550-5c54d876fba6",
                  "36e59d41-e065-44e8-b91a-5f16699cfa1f",
                  "2ef2fa9e-3fe3-46fc-a014-f21cef7631e1"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Cu/Mo-controlled meals",
                  "Light exercise regimen",
                  "Urination and bowel movement monitoring, menstruation check",
                  "24-hour urine for Cu and Mo",
                  "Feces for Cu and Mo"
                ]
              },
              {
                "id": "0e3e1534-3c86-4470-8eb0-2f09210b1686",
                "name": "Other",
                "description": null,
                "childIds": [
                  "553bb4c2-c383-43b1-9e58-533287a502a7"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Concomitant medication and non-pharmacologic therapy/procedure"
                ]
              }
            ],
            "notes": [
              {
                "id": "694cba7d-26ed-4312-994f-93987d96e6c8",
                "text": "a. Within 42 days of ALXN1840 administration. Details of procedures that may be performed by sites designated as \"screening sites\" (only in the US) are detailed in Section 8.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "c66a7eff-dd4a-41be-b47f-993bdf3dd323",
                "text": "b. Participants will be admitted to the clinical research unit (CRU) at least 10 hours prior to enrollment and initiation of copper- and molybdenum-controlled diet.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "385a0391-14d6-463b-96dc-40dc9a06d4a0",
                "text": "c. At the CRU's discretion, participants may remain in the CRU or be readmitted on Day 22 with all procedures starting on Day 23.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "f362d75b-9a0d-421a-ad57-e08fb911d836",
                "text": "d. Unscheduled study visits may occur at any time during the study and may include any study procedure as deemed necessary by the Investigator.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "4e30c9ad-3053-4b15-8476-47de2acb08a7",
                "text": "e. Participants are required to return to the CRU Day 54+/-2; participants will be discontinued from ALXN1840 medication by their physician at the latest by the Day 54 follow-up.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "3bb39d60-8754-451b-9c64-2c99294896ad",
                "text": "f. Discharge from the unit may occur after completion of all procedures on Day 9 and on Day 40 and after the Investigator has reviewed all safety assessment (including safety laboratory tests) and confirmed that the participant is appropriate for discharge.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "5e6511e3-39b6-4418-9a0e-54de4382445c",
                "text": "g. A single outpatient visit or phone call and safety laboratory assessment should occur between Day 14 and Day 18. A phone call may take place on a different day than the blood draw within the Day 14 through Day 18 period.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "dfa51f8f-d5f6-4818-9282-0a93ad47e45d",
                "text": "h. If needed to confirm menopause.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "f57acdac-4d9f-4b07-ac46-b4f6cacad6ad",
                "text": "i. Parameters include age and sex. Race and ethnicity will be collected where permitted by local regulations.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "79e8af44-3331-4903-9412-58a308dcb166",
                "text": "j. Wilson disease history will include diagnosis date, method of diagnosis, history of cirrhosis, details of any previous liver biopsies performed, and treatment received.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "5f876fc8-2f87-462e-8f68-8f46c7960083",
                "text": "k. A full physical examination will be performed at Screening, at check-in for the study, and at the End of the study/Early Termination Visit. A physical examination should also be performed on any participants with ongoing adverse events prior to discharge from the unit. Otherwise, a symptom-driven physical examination may be performed at other times, at the Principal Investigator's discretion.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "7e739dcf-7f7b-418a-9535-af3a29291fa6",
                "text": "l. Height at screening only.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "bcb77ee1-5b16-497d-8661-e01f8e21867f",
                "text": "m. While in the CRU, study intervention will be administered after an overnight fast (ie, at least 10 hours) at the same time every morning; drug is to be administered with 240 mL of water and meals should be delayed a minimum of 2 hours after dosing. As an outpatient, participants are expected to take ALXN1840 at approximately the same time daily (+/-1 hour). Participants should take the medication with a glass of water on an empty stomach; meals should be delayed a minimum of 2 hours after dosing.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "7db107dd-24ba-41a3-b7be-6acd39f9a0dd",
                "text": "n. During the outpatient period, participants will use SMS text messaging to confirm study intervention administration.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "f382b739-8f7f-4de4-a0c7-43cd554fb73e",
                "text": "o. Blood sampling for PK/PD will occur before ALXN1840 administration and represents a predose trough. See Table 2 for PK/PD sampling on Days 1, 25, 29, and 39.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "ac8e2c1c-84e7-4207-a538-665de11f1a48",
                "text": "p. PK/PD collection will include timepoints described in the schedule of PK/PD assessment for Days 1, 25, 29, and 39 (Table 2).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "fe5928be-f7d4-4478-9f03-787ce981d495",
                "text": "q. Samples for serum chemistry will be obtained following a fast of at least 8 hours at the Screening Visit and at check-in. In case of rechecks, and postdose serum chemistry, participants may not have fasted for 6 or 8 hours before the serum chemistry sample is taken.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "23a4d0b4-2414-4462-af2a-19c4b48ad38b",
                "text": "r. Laboratory assessment including chemistry, hematology, and coagulation parameters should be performed on Days -8, -1, 8, 23, and 28 only.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "c6772162-1559-42eb-91e4-9f7765c7bb20",
                "text": "s. Menstruation check is for women only; women of childbearing potential should only be enrolled after a negative serum pregnancy test result at Screening. Additional urine pregnancy testing will be standard for the protocol unless serum testing is required by site policies, local regulation, or Institutional Review Boards (IRBs)/Independent Ethics Committees (IECs) (Section 10.2). In addition to pregnancy tests detailed at the visits in the SoA, females of childbearing potential will be required to perform urine pregnancy tests at least every 4 weeks at their home or the study site throughout their time in the study.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "2814d251-9592-44df-948d-9df0020b830a",
                "text": "t. A single 15 mL serum sample will be retained for evaluation in the event of an unexpected safety finding; retained samples may be destroyed after completion of the clinical report.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "bd309772-d828-4e71-873f-42974be9d26e",
                "text": "u. Vital signs measurements and ECGs should be performed predose, unless otherwise specified. Vitals signs include body temperature, heart rate, respiratory rate, and systolic and diastolic blood pressure.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "a2f83423-23db-434b-9cbb-9e010eb8418b",
                "text": "v. Copper- and molybdenum-controlled diet will be initiated after registration/inclusion. Participants will remain on a copper/molybdenum controlled diet throughout both the inpatient Period 1 (Day -8 to Day 9) and inpatient Period 2 (Day 23 to Day 40); during this time participants will be strongly encouraged to complete all meals. While not in the CRU, participants will be encouraged to adhere to their usual copper-controlled diet.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "781a9a54-f781-4ecf-931c-363869ff57f9",
                "text": "w. For each input/output balance period, 24-hour urine samples are to be collected for measurement of copper and molybdenum.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "7370e376-66ff-4785-bd9b-c2f56b3a6e2e",
                "text": "x. For fecal samples, each individual sample will be independently collected with record of date, time, and weight of the sample.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "a92a9c59-8b8f-4c9f-8ce1-6242fee2cfb5",
                "text": "h. If needed to confirm menopause.",
                "instanceType": "Note"
              },
              {
                "id": "b8dd0665-29d7-4264-b4fb-54e248bb3681",
                "text": "i. Parameters include age and sex. Race and ethnicity will be collected where permitted by local regulations.",
                "instanceType": "Note"
              },
              {
                "id": "6706653c-3c79-451c-9711-74a04cda6305",
                "text": "4. Participants will have 3 intake and output collection periods including:  Baseline Day -4 through Day -1  Day 1 through Day 8 (I/O for 15 mg)  Day 25 through Day 39 (Days 25 through 28, I/O for 15 mg; Days 29 through 39, I/O for 30 mg)",
                "instanceType": "Note"
              }
            ],
            "indications": [
              {
                "id": "92e2b934-98c9-454e-876f-a436c40ad889",
                "name": "Wilson Disease",
                "isRareDisease": false,
                "instanceType": "Indication",
                "description": "Participants with Wilson Disease treated with ALXN1840"
              }
            ],
            "studySites": [
              {
                "id": "a3dc261e-e48d-4628-8188-399ce9768dc7",
                "name": "Massachusetts General Hospital",
                "status": "Active",
                "instanceType": "StudySite",
                "siteNumber": "1",
                "organizationId": "1574d108-1fc3-4f9f-bd8e-11fcea61326a",
                "country": "United States"
              },
              {
                "id": "82d4576e-4fd0-42a5-91c3-04108085706c",
                "name": "Yale University Medical Center",
                "status": "Active",
                "instanceType": "StudySite",
                "siteNumber": "2",
                "organizationId": "2f0582f6-3ed3-4ea0-a682-65f315b03acd",
                "country": "United States"
              },
              {
                "id": "21bd72c5-2ffc-4de6-91b6-1e347978b557",
                "name": "University of Michigan Health",
                "status": "Active",
                "instanceType": "StudySite",
                "siteNumber": "3",
                "organizationId": "9f4df669-7333-4bf5-948f-26ed8ee756f6",
                "country": "United States"
              },
              {
                "id": "fc3e7b7a-39db-4a76-819e-80a9dead8cdc",
                "name": "Cleveland Clinic",
                "status": "Active",
                "instanceType": "StudySite",
                "siteNumber": "4",
                "organizationId": "6ab8008b-84d1-4b19-892e-c145bf7cab3b",
                "country": "United States"
              },
              {
                "id": "cbd0c5fc-7619-4bd8-949e-c9576779fc1b",
                "name": "Mount Sinai Hospital",
                "status": "Active",
                "instanceType": "StudySite",
                "siteNumber": "5",
                "organizationId": "2960683c-520c-45ee-8b7f-ad6a92094674",
                "country": "United States"
              },
              {
                "id": "c4ecf499-3d9b-45d3-8000-34f5b0441ca6",
                "name": "University of California San Francisco",
                "status": "Active",
                "instanceType": "StudySite",
                "siteNumber": "6",
                "organizationId": "0aaa3423-5f80-4b86-b534-128d1744b9da",
                "country": "United States"
              },
              {
                "id": "e0022d1a-793c-479a-b070-86546e36992f",
                "name": "King's College Hospital",
                "status": "Active",
                "instanceType": "StudySite",
                "siteNumber": "7",
                "organizationId": "92fbbfa9-e82a-4a73-811e-a43af98cbb35",
                "country": "United Kingdom"
              },
              {
                "id": "a194b98c-fb27-4449-8424-f522ce50b800",
                "name": "Charit University Hospital",
                "status": "Active",
                "instanceType": "StudySite",
                "siteNumber": "8",
                "organizationId": "541e78cf-7ea6-4e0a-b358-8ac6060a5b30",
                "country": "Germany"
              },
              {
                "id": "a285051f-c802-4612-a115-67b762e2b403",
                "name": "Hpital Beaujon",
                "status": "Active",
                "instanceType": "StudySite",
                "siteNumber": "9",
                "organizationId": "1e27822c-9844-49fd-ba17-5744e05ae43d",
                "country": "France"
              },
              {
                "id": "dd4cf600-18f1-4bdd-ba62-9f43fb09b706",
                "name": "Hospital Clinic Barcelona",
                "status": "Active",
                "instanceType": "StudySite",
                "siteNumber": "10",
                "organizationId": "c4faf32c-36b9-48ac-871c-c7c4474a2989",
                "country": "Spain"
              },
              {
                "id": "bae7a1a7-5358-4dd6-a4d4-a48bc8d0eabc",
                "name": "University Hospital Zurich",
                "status": "Active",
                "instanceType": "StudySite",
                "siteNumber": "11",
                "organizationId": "3bc6f930-d746-4acf-9541-bbb508632c67",
                "country": "Switzerland"
              },
              {
                "id": "2f641194-7012-446e-9bb1-7c2ce8bbad79",
                "name": "Tokyo University Hospital",
                "status": "Active",
                "instanceType": "StudySite",
                "siteNumber": "12",
                "organizationId": "1a4bb3dd-cfe4-4805-8846-0b9420b19089",
                "country": "Japan"
              }
            ],
            "extensionAttributes": [
              {
                "id": "cb37e222-10ff-4383-8740-224067ce1531",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-entityMaps",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"epochAliases\": {\"SCREENING\": \"epoch_1\", \"C-I\": \"epoch_2\", \"INPATIENT PERIOD 1\": \"epoch_3\", \"INPATIENT_PERIOD_1\": \"epoch_3\", \"PERIOD_1\": \"epoch_3\", \"OP\": \"epoch_4\", \"INPATIENT PERIOD 2\": \"epoch_5\", \"INPATIENT_PERIOD_2\": \"epoch_5\", \"PERIOD_2\": \"epoch_5\", \"UNS\": \"epoch_6\", \"EOS OR ET\": \"epoch_7\", \"EOS_OR_ET\": \"epoch_7\"}, \"visitAliases\": {\"SCREENING (DAY -42 TO -9)\": \"enc_1\", \"SCREENING_(DAY_-42_TO_-9)\": \"enc_1\", \"SCREENING (DAY -21)\": \"enc_2\", \"SCREENING_(DAY_-21)\": \"enc_2\", \"C-I (DAY -8)\": \"enc_3\", \"C-I_(DAY_-8)\": \"enc_3\", \"INPATIENT PERIOD 1 (DAY -7)\": \"enc_4\", \"INPATIENT_PERIOD_1_(DAY_-7)\": \"enc_4\", \"INPATIENT PERIOD 1 (DAY -6 THROUGH -5)\": \"enc_5\", \"INPATIENT_PERIOD_1_(DAY_-6_THROUGH_-5)\": \"enc_5\", \"INPATIENT PERIOD 1 (DAY -4 THROUGH -1)\": \"enc_6\", \"INPATIENT_PERIOD_1_(DAY_-4_THROUGH_-1)\": \"enc_6\", \"INPATIENT PERIOD 1 (DAY 1)\": \"enc_7\", \"INPATIENT_PERIOD_1_(DAY_1)\": \"enc_7\", \"INPATIENT PERIOD 1 (DAY 2-3)\": \"enc_8\", \"INPATIENT_PERIOD_1_(DAY_2-3)\": \"enc_8\", \"INPATIENT PERIOD 1 (DAY 4-7)\": \"enc_9\", \"INPATIENT_PERIOD_1_(DAY_4-7)\": \"enc_9\", \"INPATIENT PERIOD 1 (DAY 8)\": \"enc_10\", \"INPATIENT_PERIOD_1_(DAY_8)\": \"enc_10\", \"INPATIENT PERIOD 1 (DAY 9)\": \"enc_11\", \"INPATIENT_PERIOD_1_(DAY_9)\": \"enc_11\", \"OP (DAY 10-22)\": \"enc_12\", \"OP_(DAY_10-22)\": \"enc_12\", \"INPATIENT PERIOD 2 (DAY 23)\": \"enc_13\", \"INPATIENT_PERIOD_2_(DAY_23)\": \"enc_13\", \"INPATIENT PERIOD 2 (DAY 24)\": \"enc_14\", \"INPATIENT_PERIOD_2_(DAY_24)\": \"enc_14\", \"INPATIENT PERIOD 2 (DAY 25)\": \"enc_15\", \"INPATIENT_PERIOD_2_(DAY_25)\": \"enc_15\", \"INPATIENT PERIOD 2 (DAY 26-28)\": \"enc_16\", \"INPATIENT_PERIOD_2_(DAY_26-28)\": \"enc_16\", \"INPATIENT PERIOD 2 (DAY 29)\": \"enc_17\", \"INPATIENT_PERIOD_2_(DAY_29)\": \"enc_17\", \"INPATIENT PERIOD 2 (DAY 30-35)\": \"enc_18\", \"INPATIENT_PERIOD_2_(DAY_30-35)\": \"enc_18\", \"INPATIENT PERIOD 2 (DAY 36)\": \"enc_19\", \"INPATIENT_PERIOD_2_(DAY_36)\": \"enc_19\", \"INPATIENT PERIOD 2 (DAY 37-38)\": \"enc_20\", \"INPATIENT_PERIOD_2_(DAY_37-38)\": \"enc_20\", \"INPATIENT PERIOD 2 (DAY 39)\": \"enc_21\", \"INPATIENT_PERIOD_2_(DAY_39)\": \"enc_21\", \"INPATIENT PERIOD 2 (DAY 40)\": \"enc_22\", \"INPATIENT_PERIOD_2_(DAY_40)\": \"enc_22\", \"UNSCHEDULED VISIT\": \"enc_23\", \"UNSCHEDULED_VISIT\": \"enc_23\", \"EOS DAY 54+/-2\": \"enc_24\", \"EOS_DAY_54+/-2\": \"enc_24\", \"screening\": \"enc_1\", \"Day 1\": \"enc_7\", \"Day 7\": \"enc_4\", \"Day 8\": \"enc_10\", \"Day 9\": \"enc_11\", \"Day 23\": \"enc_13\", \"Day 25\": \"enc_15\", \"Day 29\": \"enc_17\", \"Day 36\": \"enc_19\", \"Day 39\": \"enc_21\", \"Day 40\": \"enc_22\", \"Day 54\": \"enc_24\"}}"
              },
              {
                "id": "2a5f152d-f04a-4fdb-ae3c-48481ffd8107",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-timeAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"193c2a04-7cd2-48c4-802a-9857b788eebd\", \"definition\": \"Initiation of ALXN1840 treatment\", \"anchorType\": \"FirstDose\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 60, \"sourceText\": \"The accumulation period refers to time from initiation of ALXN1840 (Day 1) to expected steady state at Day 10\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"e761b5f0-c6ec-4748-9545-37d444ca85e7\", \"definition\": \"Baseline visit/assessment\", \"anchorType\": \"Baseline\", \"classification\": \"Visit\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 50, \"sourceText\": \"Baseline Day\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"a3249766-7eae-4fe6-8bee-be5482d1c19c\", \"definition\": \"Informed consent obtained\", \"anchorType\": \"InformedConsent\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 10, \"sourceText\": \"informed consent\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"61daf6b7-2b43-432d-8174-6782ced3c801\", \"definition\": \"procedure\", \"anchorType\": \"Custom\", \"classification\": \"Conceptual\", \"timelineId\": null, \"dayValue\": 9, \"intraDayOrder\": 100, \"sourceText\": \"procedure\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"1c51c7fc-a948-497d-9cf8-2fc1a0efbb80\", \"definition\": \"24-hour collection period\", \"anchorType\": \"CollectionDay\", \"classification\": \"Conceptual\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 90, \"sourceText\": \"24-hour urine\", \"encounterId\": null, \"activityId\": null}]"
              },
              {
                "id": "b31b146d-3e2e-4e1a-bd73-5b6af203f6b8",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-repetitions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"b77b2d57-f875-4089-9796-65b78e6fa239\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"daily urine\"}, {\"id\": \"1cd49872-fef2-4596-ba2c-b1672ce132ee\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"once daily\"}, {\"id\": \"2d1b2800-e77a-41e9-943d-ae3bcca0f25e\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"od\"}, {\"id\": \"157e2505-4d71-4a89-82a6-b03490c24bde\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"OD\"}, {\"id\": \"b4dfe38a-4690-4989-a4d4-0bd9c9de32d4\", \"type\": \"Interval\", \"interval\": \"PT8H\", \"sourceText\": \"every \\n8 hours\"}, {\"id\": \"f74d7422-595b-46f7-af7c-8663e532a089\", \"type\": \"Continuous\", \"startOffset\": \"-P4D\", \"endOffset\": \"-P1D\", \"sourceText\": \"Days -4 through -1\"}, {\"id\": \"004546ca-566d-400b-b698-c2fe9f3853ba\", \"type\": \"Continuous\", \"startOffset\": \"-P7D\", \"endOffset\": \"-P5D\", \"sourceText\": \"Day -7 through Day -5\"}, {\"id\": \"7aaf6bf1-e459-444e-9b9f-106c867bb26c\", \"type\": \"Continuous\", \"startOffset\": \"-P4D\", \"endOffset\": \"-P1D\", \"sourceText\": \"Day -4 through Day -1\"}, {\"id\": \"d9926ff6-97cd-4ab7-995f-2802372bf659\", \"type\": \"Continuous\", \"startOffset\": \"P1D\", \"endOffset\": \"P8D\", \"sourceText\": \"Day 1 through Day 8\"}, {\"id\": \"1dcbd22b-1df2-45af-a60d-d440fc2de553\", \"type\": \"Continuous\", \"startOffset\": \"P25D\", \"endOffset\": \"P39D\", \"sourceText\": \"Day 25 through Day 39\"}, {\"id\": \"15bb313d-b062-40c6-b225-39b8899dbc2c\", \"type\": \"Continuous\", \"startOffset\": \"P1D\", \"endOffset\": \"P28D\", \"sourceText\": \"Day 1 through Day 28\"}, {\"id\": \"3ec0bab8-719d-4aef-a77e-df4207fded88\", \"type\": \"Continuous\", \"startOffset\": \"P29D\", \"endOffset\": \"P39D\", \"sourceText\": \"Day 29 through Day 39\"}, {\"id\": \"5f969028-d316-481a-a5ff-872a78cf2491\", \"type\": \"Continuous\", \"startOffset\": \"P25D\", \"endOffset\": \"P28D\", \"sourceText\": \"Days 25 through 28\"}, {\"id\": \"71ec8d1b-bb0c-4722-8d91-f703d3eb17f0\", \"type\": \"Continuous\", \"startOffset\": \"P29D\", \"endOffset\": \"P39D\", \"sourceText\": \"Days 29 through 39\"}, {\"id\": \"65b8f9bf-c6b3-4af5-826d-81e5640e53d2\", \"type\": \"Continuous\", \"startOffset\": \"P4D\", \"endOffset\": \"P7D\", \"sourceText\": \"Days 4 - 7\"}, {\"id\": \"fd608c77-5d08-438a-be09-c130b2c31600\", \"type\": \"Continuous\", \"startOffset\": \"P26D\", \"endOffset\": \"P28D\", \"sourceText\": \"Days 26 - 28\"}, {\"id\": \"aca948e5-ccc1-49a9-b735-67e383b65b24\", \"type\": \"Continuous\", \"startOffset\": \"P30D\", \"endOffset\": \"P38D\", \"sourceText\": \"Days 30 - 38\"}, {\"id\": \"d24bb9cf-8f38-4817-b12d-21db5da40042\", \"type\": \"Continuous\", \"startOffset\": \"-P8D\", \"endOffset\": \"P9D\", \"sourceText\": \"Day -8 to Day 9\"}, {\"id\": \"61340b0e-d443-401e-8258-86560298c284\", \"type\": \"Continuous\", \"startOffset\": \"P23D\", \"endOffset\": \"P40D\", \"sourceText\": \"Day 23 to Day 40\"}, {\"id\": \"f2e7314e-3933-42a5-9e36-3648a8ecfac7\", \"type\": \"Continuous\", \"startOffset\": \"P25D\", \"endOffset\": \"P28D\", \"sourceText\": \"Day 25 through Day 28\"}, {\"id\": \"ae2e0ddc-eba4-4709-b1ae-0ada2b01f14a\", \"type\": \"Continuous\", \"startOffset\": \"P36D\", \"endOffset\": \"P39D\", \"sourceText\": \"Day 36 through Day 39\"}, {\"id\": \"60fa67a4-b544-4847-aadb-dafde5ec8a86\", \"type\": \"Continuous\", \"startOffset\": \"-P7D\", \"endOffset\": \"-P5D\", \"sourceText\": \"Day -7 through \\nDay -5\"}, {\"id\": \"a39221ee-5c02-4831-93c5-87580c1372a4\", \"type\": \"Continuous\", \"startOffset\": \"P1D\", \"endOffset\": \"P9D\", \"sourceText\": \"Days 1 through 9\"}, {\"id\": \"546f3a9a-dd08-4e80-bebe-834dc8b1966d\", \"type\": \"Continuous\", \"startOffset\": \"P31D\", \"endOffset\": \"P35D\", \"sourceText\": \"Days 31 through 35\"}, {\"id\": \"446245cc-7364-428d-b231-d3a202a4346d\", \"type\": \"Continuous\", \"startOffset\": \"P36D\", \"endOffset\": \"P39D\", \"sourceText\": \"Days 36 through 39\"}, {\"id\": \"e7ac2616-5a17-4e63-849a-01ba449a4e18\", \"type\": \"Continuous\", \"startOffset\": \"P9D\", \"endOffset\": \"P23D\", \"sourceText\": \"Day 9 to Day 23\"}, {\"id\": \"8b3d2f77-ab92-4613-b20f-82c410d05a78\", \"type\": \"Continuous\", \"sourceText\": \"Run-in Period\"}, {\"id\": \"a71c5afa-303f-4100-be1c-75f8f68edf8a\", \"type\": \"Continuous\", \"sourceText\": \"treatment period\"}, {\"id\": \"20cbf8b1-65b4-4e31-92e6-133df3cdd0cb\", \"type\": \"Continuous\", \"sourceText\": \"Treatment Period\"}, {\"id\": \"b3f5807c-a3c6-4e1b-858f-50639932ccbf\", \"type\": \"Continuous\", \"sourceText\": \"treatment \\nperiod\"}, {\"id\": \"3098f99a-8bb4-4e1d-9954-7333f6e10f36\", \"type\": \"Continuous\", \"sourceText\": \"dosing period\"}, {\"id\": \"2637c606-fcd7-4167-8cdc-1511cb4d15a3\", \"type\": \"Continuous\", \"sourceText\": \"pretreatment period\"}, {\"id\": \"c312d50a-bfe4-47ba-aa1d-f82a1a710d96\", \"type\": \"Continuous\", \"sourceText\": \"post-treatment period\"}, {\"id\": \"a8643313-a18f-44ca-9d00-4e494cf5b768\", \"type\": \"Continuous\", \"sourceText\": \"2 hours after\"}, {\"id\": \"044600e9-ac82-40e7-b0dd-7876dd452f99\", \"type\": \"Continuous\", \"sourceText\": \"8 hours before\"}, {\"id\": \"e0bce017-f323-4299-95d4-47e44a95bad9\", \"type\": \"Continuous\", \"sourceText\": \"4 hours post\"}, {\"id\": \"2217bbde-55cc-468b-a001-aa211e6ccc6d\", \"type\": \"Continuous\", \"sourceText\": \"21 days after\"}, {\"id\": \"bd68805a-a620-4223-b1a0-e6c48135d45c\", \"type\": \"Continuous\", \"sourceText\": \"Inpatient Period\"}, {\"id\": \"e022bdf7-9c71-49e1-aa18-48454d5f654c\", \"type\": \"Continuous\", \"sourceText\": \"inpatient Period\"}, {\"id\": \"7ca9433f-92ad-4c96-8fe2-a54908f4235b\", \"type\": \"Continuous\", \"sourceText\": \"Inpatient \\nPeriod\"}, {\"id\": \"978e0fa9-c4f8-41d9-a4e4-4b3aa3e02e99\", \"type\": \"Continuous\", \"sourceText\": \"inpatient period\"}, {\"id\": \"7daab93e-2b29-4ab5-9167-91df252f48bc\", \"type\": \"Continuous\", \"sourceText\": \"inpatient \\nperiod\"}, {\"id\": \"ef11c46d-5bb1-400f-a972-849a68a481c8\", \"type\": \"Continuous\", \"sourceText\": \"balance period\"}, {\"id\": \"c61560f3-eb44-4377-8027-091ade02f8d7\", \"type\": \"Continuous\", \"sourceText\": \"24-hour urine\"}, {\"id\": \"39a0d48b-1bdd-4639-a35c-034b68b8cf3d\", \"type\": \"Continuous\", \"sourceText\": \"24-hour collection\"}, {\"id\": \"d79eb9fc-8790-4c30-af83-d7d8832e81a0\", \"type\": \"Daily\", \"startOffset\": \"-P8D\", \"endOffset\": \"P9D\", \"interval\": \"P1D\", \"count\": 18, \"sourceText\": \"controlled diet (Day -8 to Day 9)\"}, {\"id\": \"f14a5cab-2c6d-4360-91b4-188726aa36a1\", \"type\": \"Daily\", \"startOffset\": \"P23D\", \"endOffset\": \"P40D\", \"interval\": \"P1D\", \"count\": 18, \"sourceText\": \"controlled diet (Day 23 to Day 40)\"}, {\"id\": \"dea2e812-6b13-47b3-8adf-55f3aa6d6353\", \"type\": \"Daily\", \"startOffset\": \"-P7D\", \"endOffset\": \"-P5D\", \"interval\": \"P1D\", \"count\": 3, \"sourceText\": \"controlled diet (Day -7 through \\nDay -5)\"}, {\"id\": \"5a84fd6b-f695-4727-b9bf-029963f2e812\", \"type\": \"Daily\", \"startOffset\": \"-P4D\", \"endOffset\": \"-P1D\", \"interval\": \"P1D\", \"count\": 4, \"sourceText\": \"controlled diet (Day -4 through Day -1)\"}, {\"id\": \"828ba9ec-73d5-4c61-b99a-a036dc58c668\", \"type\": \"Daily\", \"startOffset\": \"P3D\", \"endOffset\": \"P15D\", \"interval\": \"P1D\", \"count\": 13, \"sourceText\": \"controlled diet (3 to 15)\"}, {\"id\": \"a3c9dacf-fc56-4902-800d-8ff5becccfa2\", \"type\": \"Daily\", \"startOffset\": \"P101D\", \"endOffset\": \"P201D\", \"interval\": \"P1D\", \"count\": 101, \"sourceText\": \"copper balance (101-201)\"}, {\"id\": \"0e0cd7d8-6f9e-4316-8e6c-5b4200cca22e\", \"type\": \"Daily\", \"startOffset\": \"-P4D\", \"endOffset\": \"-P1D\", \"interval\": \"P1D\", \"count\": 4, \"sourceText\": \"copper balance (Days -4 through -1)\"}, {\"id\": \"c98dd808-a12e-4754-a880-953f08591e87\", \"type\": \"Daily\", \"startOffset\": \"-P7D\", \"endOffset\": \"-P5D\", \"interval\": \"P1D\", \"count\": 3, \"sourceText\": \"molybdenum balance (Day -7 through Day -5)\"}, {\"id\": \"9a6e4520-9857-4e49-ad44-84dc9e745da8\", \"type\": \"Daily\", \"startOffset\": \"-P4D\", \"endOffset\": \"-P1D\", \"interval\": \"P1D\", \"count\": 4, \"sourceText\": \"molybdenum balance (Day -4 through Day -1)\"}, {\"id\": \"89d07524-1e6a-4ef6-95ad-36f94dec1463\", \"type\": \"Daily\", \"startOffset\": \"P1D\", \"endOffset\": \"P8D\", \"interval\": \"P1D\", \"count\": 8, \"sourceText\": \"molybdenum balance (Day 1 through Day 8)\"}, {\"id\": \"5453bc5a-b7b5-4aa3-b432-360e0c6a9523\", \"type\": \"Daily\", \"startOffset\": \"P25D\", \"endOffset\": \"P39D\", \"interval\": \"P1D\", \"count\": 15, \"sourceText\": \"molybdenum balance (Day 25 through Day 39)\"}, {\"id\": \"b51c9686-1832-47bd-b7a1-49eac3913cdd\", \"type\": \"Daily\", \"startOffset\": \"-P7D\", \"endOffset\": \"-P5D\", \"interval\": \"P1D\", \"count\": 3, \"sourceText\": \"molybdenum balance (Day -7 through \\nDay -5)\"}, {\"id\": \"f691e9e9-83d5-4e0b-a252-708ea0d8b6cf\", \"type\": \"Daily\", \"startOffset\": \"-P8D\", \"endOffset\": \"P9D\", \"interval\": \"P1D\", \"count\": 18, \"sourceText\": \"molybdenum balance (Day -8 to Day 9)\"}, {\"id\": \"e7cce900-3bbb-4e8d-9b80-00e23816f736\", \"type\": \"Daily\", \"startOffset\": \"P23D\", \"endOffset\": \"P40D\", \"interval\": \"P1D\", \"count\": 18, \"sourceText\": \"molybdenum balance (Day 23 to Day 40)\"}, {\"id\": \"362f8b89-50c5-4d2e-893d-144b703b0aad\", \"type\": \"Daily\", \"startOffset\": \"P3D\", \"endOffset\": \"P15D\", \"interval\": \"P1D\", \"count\": 13, \"sourceText\": \"copper balance (3 to 15)\"}, {\"id\": \"468d64e7-e3eb-43a3-be41-7cc683ba8423\", \"type\": \"Daily\", \"startOffset\": \"P3D\", \"endOffset\": \"P15D\", \"interval\": \"P1D\", \"count\": 13, \"sourceText\": \"molybdenum balance (3 to 15)\"}, {\"id\": \"892050c2-082b-45cc-8b72-9e899b6efb90\", \"type\": \"Daily\", \"startOffset\": \"P101D\", \"endOffset\": \"P301D\", \"interval\": \"P1D\", \"count\": 201, \"sourceText\": \"molybdenum balance (101-301)\"}, {\"id\": \"2cdb60cd-bff7-48b2-8c83-a1dde56dd7e7\", \"type\": \"Daily\", \"startOffset\": \"P3D\", \"endOffset\": \"P5D\", \"interval\": \"P1D\", \"count\": 3, \"sourceText\": \"copper \\nbalance (3 - 5)\"}, {\"id\": \"25a26600-debd-46b9-8985-42de9a36e863\", \"type\": \"Continuous\", \"startOffset\": \"P0D\", \"endOffset\": \"P1D\", \"interval\": \"P1D\", \"minObservations\": 1, \"exitCondition\": \"End of study\", \"sourceText\": \"A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840\"}]"
              },
              {
                "id": "dad1f13a-a3bd-464b-a3df-3d954c694adc",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-traversalConstraints",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"455fdd72-bee3-4f90-9da1-098c2ca71cb6\", \"requiredSequence\": [\"epoch_1\", \"epoch_2\", \"epoch_3\", \"epoch_4\", \"epoch_5\", \"epoch_6\", \"epoch_7\"], \"allowEarlyExit\": true, \"exitEpochIds\": [], \"mandatoryVisits\": [\"enc_24\", \"enc_1\", \"enc_7\"], \"sourceText\": \"[{'condition': 'If subject is on zinc therapy at screening', 'path': ['ZINC_DISCONTINUATION_21_DAYS', 'BASELINE']}, {'condition': 'If subject experiences AE requiring discontinuation', 'path': ['DISCONTINUATION_OF_INTERVENTION', 'EARLY_TERMINATION_VISIT', 'FOLLOW_UP']}, {'condition': 'US-specific recruitment model', 'path': ['SCREENING_SITE_PROCEDURES', 'TRANSFER_TO_STUDY_SITE']}]\"}]"
              },
              {
                "id": "69ff094d-f79b-4b72-9e81-09a91a1f11de",
                "url": "https://protocol2usdm.io/extensions/x-footnoteConditions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"e3b53f3c-ef30-4bb5-9c41-7202440e9875\", \"conditionType\": \"general\", \"text\": \"a. Within 42 days of ALXN1840 administration. Details of procedures that may be performed by sites designated as \\\"screening sites\\\" (only in the US) are detailed in Section 8.\", \"footnoteId\": \"46c181f2-2b32-42c3-b9f2-6dba2d0b578b\", \"structuredCondition\": \"timing.before(ALXN1840_administration, P42D)\", \"appliesToActivityIds\": [\"382fe30e-bbb7-4ea4-a6a3-3d5ddef8e030\", \"eed510fb-92ae-4758-87ce-38f6c63e1511\", \"ea994424-deba-4e26-a84a-4557d942a173\", \"a08930fc-ae5c-40fc-b468-a8d8d5e1b31b\"], \"sourceText\": \"a. Within 42 days of ALXN1840 administration. Details of procedures that may be performed by sites d\"}, {\"id\": \"779429bc-60a7-49fb-891d-8c493b1a43a2\", \"conditionType\": \"timing_before\", \"text\": \"b. Participants will be admitted to the clinical research unit (CRU) at least 10 hours prior to enrollment and initiation of copper- and molybdenum-controlled diet.\", \"footnoteId\": \"05bc70de-72c8-4033-991d-5cfd3f6116eb\", \"structuredCondition\": \"timing.before(enrollment and initiation of copper- and molybdenum-controlled diet., PT10M)\", \"appliesToActivityIds\": [\"44625ba9-8e87-4aaf-a000-fe1cfd0cee3f\", \"153847fb-d939-4a3e-aca4-34c3fdb5d735\", \"6c911525-133b-46e0-8f09-eb989fc17cf9\"], \"timingConstraint\": \"PT10H\", \"sourceText\": \"b. Participants will be admitted to the clinical research unit (CRU) at least 10 hours prior to enro\"}, {\"id\": \"78c14966-1f05-4ace-8b7f-64fc55d0050f\", \"conditionType\": \"timing_at\", \"text\": \"c. At the CRU's discretion, participants may remain in the CRU or be readmitted on Day 22 with all procedures starting on Day 23.\", \"footnoteId\": \"71f91d01-067e-4dcf-8586-2c3a4f772116\", \"sourceText\": \"c. At the CRU's discretion, participants may remain in the CRU or be readmitted on Day 22 with all p\", \"appliesToActivityIds\": [\"153847fb-d939-4a3e-aca4-34c3fdb5d735\"]}, {\"id\": \"d0a03760-c2c9-4c2f-99c7-377418270883\", \"conditionType\": \"general\", \"text\": \"d. Unscheduled study visits may occur at any time during the study and may include any study procedure as deemed necessary by the Investigator.\", \"footnoteId\": \"f49f57b3-805e-461b-b652-5263ac4e2f37\", \"sourceText\": \"d. Unscheduled study visits may occur at any time during the study and may include any study procedu\", \"appliesToActivityIds\": [\"382fe30e-bbb7-4ea4-a6a3-3d5ddef8e030\", \"1708b8e7-b182-4172-8f2c-9bd62015af1a\"]}, {\"id\": \"25a44192-09a4-44f5-9fac-8accc48a0128\", \"conditionType\": \"general\", \"text\": \"e. Participants are required to return to the CRU Day 54+/-2; participants will be discontinued from ALXN1840 medication by their physician at the latest by the Day 54 follow-up.\", \"footnoteId\": \"0771a36f-cc6c-4458-a1c3-a7d453a082c8\", \"structuredCondition\": \"timing.at(Day54).window(P2D)\", \"appliesToActivityIds\": [\"553bb4c2-c383-43b1-9e58-533287a502a7\", \"6610c275-e6f3-4043-93ff-60831ad5ea5d\", \"ea994424-deba-4e26-a84a-4557d942a173\", \"98509a6d-7634-4bdd-af34-60334b12b32c\", \"ef37d001-a448-41b4-bc4d-ed31e8ecb092\"], \"sourceText\": \"e. Participants are required to return to the CRU Day 54+/-2; participants will be discontinued from\"}, {\"id\": \"2c12f051-9608-4858-8292-8e53cae46f18\", \"conditionType\": \"timing_after\", \"text\": \"f. Discharge from the unit may occur after completion of all procedures on Day 9 and on Day 40 and after the Investigator has reviewed all safety assessment (including safety laboratory tests) and confirmed that the participant is appropriate for discharge.\", \"footnoteId\": \"99ca5c15-27e8-4be8-b2ba-ebdd3ba9eed0\", \"structuredCondition\": \"sequence.after(all_procedures).after(investigator_review)\", \"appliesToActivityIds\": [\"6610c275-e6f3-4043-93ff-60831ad5ea5d\"], \"sourceText\": \"f. Discharge from the unit may occur after completion of all procedures on Day 9 and on Day 40 and a\"}, {\"id\": \"b7b42a31-ea68-4d85-ad97-53e0b4963e7f\", \"conditionType\": \"general\", \"text\": \"g. A single outpatient visit or phone call and safety laboratory assessment should occur between Day 14 and Day 18. A phone call may take place on a different day than the blood draw within the Day 14 through Day 18 period.\", \"footnoteId\": \"11b7e9db-6755-4f57-ad68-8e71c25a5bd5\", \"sourceText\": \"g. A single outpatient visit or phone call and safety laboratory assessment should occur between Day\", \"appliesToActivityIds\": [\"e6a2afad-c0ca-4f46-9769-921725016179\", \"0d6aee78-3ca6-421a-822f-1c43ea8fb3aa\", \"1708b8e7-b182-4172-8f2c-9bd62015af1a\"]}, {\"id\": \"1f0c26cb-1b99-414a-9929-cd237e139149\", \"conditionType\": \"general\", \"text\": \"h. If needed to confirm menopause.\", \"footnoteId\": \"b3ef97cd-c167-4075-bf81-28e845869874\", \"structuredCondition\": \"if(needed_to_confirm_menopause)\", \"appliesToActivityIds\": [\"FSH Test\"], \"sourceText\": \"h. If needed to confirm menopause.\"}, {\"id\": \"d284d9f9-d39e-43f8-8b10-1a7e8fb1234f\", \"conditionType\": \"general\", \"text\": \"i. Parameters include age and sex. Race and ethnicity will be collected where permitted by local regulations.\", \"footnoteId\": \"b4298e86-ba45-4550-8e4c-00d4fbc7bad1\", \"sourceText\": \"i. Parameters include age and sex. Race and ethnicity will be collected where permitted by local reg\"}, {\"id\": \"8110a13d-0f11-4cae-8987-8ac79ca21992\", \"conditionType\": \"general\", \"text\": \"j. Wilson disease history will include diagnosis date, method of diagnosis, history of cirrhosis, details of any previous liver biopsies performed, and treatment received.\", \"footnoteId\": \"f6538cd8-26cd-4e25-acff-2defe2137f22\", \"sourceText\": \"j. Wilson disease history will include diagnosis date, method of diagnosis, history of cirrhosis, de\", \"appliesToActivityIds\": [\"44625ba9-8e87-4aaf-a000-fe1cfd0cee3f\", \"ee790981-6f50-4074-a528-d18d2002d1d6\"]}, {\"id\": \"3ae21f3e-e68f-4f28-b13d-c4a3214843ec\", \"conditionType\": \"timing_before\", \"text\": \"k. A full physical examination will be performed at Screening, at check-in for the study, and at the End of the study/Early Termination Visit. A physical examination should also be performed on any participants with ongoing adverse events prior to discharge from the unit. Otherwise, a symptom-driven physical examination may be performed at other times, at the Principal Investigator's discretion.\", \"footnoteId\": \"6909bdf8-e524-4818-991b-80b8b8f8a73c\", \"structuredCondition\": \"if(ongoing_adverse_events) then(full_exam) else(symptom_driven)\", \"appliesToActivityIds\": [\"0f414ebf-d42c-40ad-8b57-0ba36b1a7e23\"], \"sourceText\": \"k. A full physical examination will be performed at Screening, at check-in for the study, and at the\"}, {\"id\": \"44c9a1c1-ee78-4d9f-a85f-049e1ac5bee1\", \"conditionType\": \"general\", \"text\": \"l. Height at screening only.\", \"footnoteId\": \"310f76a8-3dd6-471a-a04e-8b152fcac71d\", \"sourceText\": \"l. Height at screening only.\", \"appliesToActivityIds\": [\"a08930fc-ae5c-40fc-b468-a8d8d5e1b31b\"]}, {\"id\": \"4683290c-ed74-4c94-87a6-285603e1590e\", \"conditionType\": \"timing_after\", \"text\": \"m. While in the CRU, study intervention will be administered after an overnight fast (ie, at least 10 hours) at the same time every morning; drug is to be administered with 240 mL of water and meals should be delayed a minimum of 2 hours after dosing. As an outpatient, participants are expected to take ALXN1840 at approximately the same time daily (+/-1 hour). Participants should take the medication with a glass of water on an empty stomach; meals should be delayed a minimum of 2 hours after dosing.\", \"footnoteId\": \"5a429885-b368-4e5c-b944-6cf4846f0101\", \"structuredCondition\": \"timing.after(dosing. as an outpatient, participants are expected to take alxn1840 at approximately the same time daily (+/-1 hour). participants should take the medication with a glass of water on an empty stomach; meals should be delayed a minimum of 2 hours after dosing., PT2M)\", \"appliesToActivityIds\": [\"97b50fee-c394-43ea-8ab2-82a187722c2a\", \"553bb4c2-c383-43b1-9e58-533287a502a7\", \"1708b8e7-b182-4172-8f2c-9bd62015af1a\", \"ea994424-deba-4e26-a84a-4557d942a173\", \"3e676ade-fb1a-49be-ad73-415ed117f94e\", \"a08930fc-ae5c-40fc-b468-a8d8d5e1b31b\", \"382fe30e-bbb7-4ea4-a6a3-3d5ddef8e030\"], \"timingConstraint\": \"PT10H\", \"sourceText\": \"m. While in the CRU, study intervention will be administered after an overnight fast (ie, at least 1\"}, {\"id\": \"96ed998b-c240-47dc-bfcd-2ac56e287ac9\", \"conditionType\": \"general\", \"text\": \"n. During the outpatient period, participants will use SMS text messaging to confirm study intervention administration.\", \"footnoteId\": \"a822f844-0f24-418d-a202-1951ca482c35\", \"sourceText\": \"n. During the outpatient period, participants will use SMS text messaging to confirm study intervent\", \"appliesToActivityIds\": [\"382fe30e-bbb7-4ea4-a6a3-3d5ddef8e030\", \"97b50fee-c394-43ea-8ab2-82a187722c2a\", \"1708b8e7-b182-4172-8f2c-9bd62015af1a\"]}, {\"id\": \"c8d5be24-ca81-4132-bb61-e6c8cb7360f2\", \"conditionType\": \"timing_before\", \"text\": \"o. Blood sampling for PK/PD will occur before ALXN1840 administration and represents a predose trough. See Table 2 for PK/PD sampling on Days 1, 25, 29, and 39.\", \"footnoteId\": \"c640f288-e406-488e-9414-3048533d32d2\", \"structuredCondition\": \"timing.before(ALXN1840_administration)\", \"appliesToActivityIds\": [\"382fe30e-bbb7-4ea4-a6a3-3d5ddef8e030\", \"9ca6d3c4-0d3f-4c50-986d-e6ca348070f3\", \"ea994424-deba-4e26-a84a-4557d942a173\", \"e6a2afad-c0ca-4f46-9769-921725016179\"], \"sourceText\": \"o. Blood sampling for PK/PD will occur before ALXN1840 administration and represents a predose troug\"}, {\"id\": \"76a8da47-14b4-451a-bbe2-35425b92e76c\", \"conditionType\": \"general\", \"text\": \"p. PK/PD collection will include timepoints described in the schedule of PK/PD assessment for Days 1, 25, 29, and 39 (Table 2).\", \"footnoteId\": \"fee1a07b-ca81-4c74-888a-19f948848469\", \"sourceText\": \"p. PK/PD collection will include timepoints described in the schedule of PK/PD assessment for Days 1\", \"appliesToActivityIds\": [\"9ca6d3c4-0d3f-4c50-986d-e6ca348070f3\"]}, {\"id\": \"dd571303-3724-4143-8d8a-065763efea20\", \"conditionType\": \"timing_before\", \"text\": \"q. Samples for serum chemistry will be obtained following a fast of at least 8 hours at the Screening Visit and at check-in. In case of rechecks, and postdose serum chemistry, participants may not have fasted for 6 or 8 hours before the serum chemistry sample is taken.\", \"footnoteId\": \"719bd6ec-a597-477d-aee3-6c3964468e72\", \"structuredCondition\": \"timing.before(the serum chemistry sample is taken., PT8M)\", \"appliesToActivityIds\": [\"bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424\", \"1708b8e7-b182-4172-8f2c-9bd62015af1a\", \"468b2bb3-7af5-421d-a550-5c54d876fba6\", \"a08930fc-ae5c-40fc-b468-a8d8d5e1b31b\", \"041d2c05-695c-45ab-98c7-77f18949e879\"], \"timingConstraint\": \"PT8H\", \"sourceText\": \"q. Samples for serum chemistry will be obtained following a fast of at least 8 hours at the Screenin\"}, {\"id\": \"e5b0793a-b07e-478e-8e49-f90441344af5\", \"conditionType\": \"general\", \"text\": \"r. Laboratory assessment including chemistry, hematology, and coagulation parameters should be performed on Days -8, -1, 8, 23, and 28 only.\", \"footnoteId\": \"f7e2cb04-f186-4e8c-bf60-1f2061da1bd4\", \"sourceText\": \"r. Laboratory assessment including chemistry, hematology, and coagulation parameters should be perfo\", \"appliesToActivityIds\": [\"0d6aee78-3ca6-421a-822f-1c43ea8fb3aa\", \"bcf49f8d-5d33-4fd8-8f99-0ac6d59a9424\"]}, {\"id\": \"01940510-237c-483d-bd02-00231a70db97\", \"conditionType\": \"timing_after\", \"text\": \"s. Menstruation check is for women only; women of childbearing potential should only be enrolled after a negative serum pregnancy test result at Screening. Additional urine pregnancy testing will be standard for the protocol unless serum testing is required by site policies, local regulation, or Institutional Review Boards (IRBs)/Independent Ethics Committees (IECs) (Section 10.2). In addition to pregnancy tests detailed at the visits in the SoA, females of childbearing potential will be required to perform urine pregnancy tests at least every 4 weeks at their home or the study site throughout their time in the study.\", \"footnoteId\": \"60b69526-271e-4958-8b71-087e53425199\", \"structuredCondition\": \"frequency.every(P4W)\", \"appliesToActivityIds\": [\"5faad3f6-2b83-46c8-816d-4ace6abc5381\", \"1708b8e7-b182-4172-8f2c-9bd62015af1a\", \"468b2bb3-7af5-421d-a550-5c54d876fba6\", \"041d2c05-695c-45ab-98c7-77f18949e879\", \"a08930fc-ae5c-40fc-b468-a8d8d5e1b31b\", \"82ae0e2d-6367-40c3-933d-23becc413381\", \"382fe30e-bbb7-4ea4-a6a3-3d5ddef8e030\", \"ef37d001-a448-41b4-bc4d-ed31e8ecb092\"], \"sourceText\": \"s. Menstruation check is for women only; women of childbearing potential should only be enrolled aft\"}, {\"id\": \"dada385a-c8e4-4b24-bf61-b0ee38d16991\", \"conditionType\": \"timing_after\", \"text\": \"t. A single 15 mL serum sample will be retained for evaluation in the event of an unexpected safety finding; retained samples may be destroyed after completion of the clinical report.\", \"footnoteId\": \"6cdaa85a-5bf5-40e7-8957-2765d76b13c7\", \"sourceText\": \"t. A single 15 mL serum sample will be retained for evaluation in the event of an unexpected safety \", \"appliesToActivityIds\": [\"041d2c05-695c-45ab-98c7-77f18949e879\", \"0d6aee78-3ca6-421a-822f-1c43ea8fb3aa\"]}, {\"id\": \"e8a6f94f-f57e-47d5-9f92-cc94b29644cd\", \"conditionType\": \"general\", \"text\": \"u. Vital signs measurements and ECGs should be performed predose, unless otherwise specified. Vitals signs include body temperature, heart rate, respiratory rate, and systolic and diastolic blood pressure.\", \"footnoteId\": \"7254f67f-ec22-43df-a701-155cf535d951\", \"structuredCondition\": \"timing.before(dose)\", \"appliesToActivityIds\": [\"6f840b08-1ea8-4290-9c04-2c9c4719d6c1\"], \"sourceText\": \"u. Vital signs measurements and ECGs should be performed predose, unless otherwise specified. Vitals\"}, {\"id\": \"6770bafa-35a6-4779-9fef-80ffea75a3fd\", \"conditionType\": \"timing_after\", \"text\": \"v. Copper- and molybdenum-controlled diet will be initiated after registration/inclusion. Participants will remain on a copper/molybdenum controlled diet throughout both the inpatient Period 1 (Day -8 to Day 9) and inpatient Period 2 (Day 23 to Day 40); during this time participants will be strongly encouraged to complete all meals. While not in the CRU, participants will be encouraged to adhere to their usual copper-controlled diet.\", \"footnoteId\": \"538ee389-f215-4770-8ffe-1a46599bb702\", \"sourceText\": \"v. Copper- and molybdenum-controlled diet will be initiated after registration/inclusion. Participan\", \"appliesToActivityIds\": [\"3e676ade-fb1a-49be-ad73-415ed117f94e\"]}, {\"id\": \"1502b8d3-27f9-41f5-8a93-6e4233b6bb9d\", \"conditionType\": \"general\", \"text\": \"w. For each input/output balance period, 24-hour urine samples are to be collected for measurement of copper and molybdenum.\", \"footnoteId\": \"0aca45f5-ed1d-473c-8048-7ae0582840c0\", \"structuredCondition\": \"frequency.duration(P1D)\", \"appliesToActivityIds\": [\"041d2c05-695c-45ab-98c7-77f18949e879\", \"36e59d41-e065-44e8-b91a-5f16699cfa1f\", \"44e4cb98-5386-4a9d-9d4d-b6930d1d30c8\", \"a08930fc-ae5c-40fc-b468-a8d8d5e1b31b\"], \"sourceText\": \"w. For each input/output balance period, 24-hour urine samples are to be collected for measurement o\"}, {\"id\": \"2638f6fc-162f-4f45-8da1-6a3d45f960a5\", \"conditionType\": \"general\", \"text\": \"x. For fecal samples, each individual sample will be independently collected with record of date, time, and weight of the sample.\", \"footnoteId\": \"f0adc8c9-8a6f-4fd7-a7d9-79f273cd443c\", \"sourceText\": \"x. For fecal samples, each individual sample will be independently collected with record of date, ti\", \"appliesToActivityIds\": [\"041d2c05-695c-45ab-98c7-77f18949e879\"]}, {\"id\": \"940c22e9-3a80-4fd5-9024-80841f41e24a\", \"conditionType\": \"frequency_continuous\", \"text\": \"1. Participants eligible for the study will be enrolled on Day -7 and initiated on a copper- and molybdenum- controlled diet, which will be continued during Treatment Period 1 and Treatment Period 2 when in the CRU, through Day 39.\", \"footnoteId\": \"9815d01f-751c-4128-9fd8-0b290cb0e938\", \"sourceText\": \"1. Participants eligible for the study will be enrolled on Day -7 and initiated on a copper- and mol\", \"appliesToActivityIds\": [\"44625ba9-8e87-4aaf-a000-fe1cfd0cee3f\", \"382fe30e-bbb7-4ea4-a6a3-3d5ddef8e030\"]}, {\"id\": \"c008e31b-487a-4c82-bc5c-bd62da7bb61c\", \"conditionType\": \"timing_at\", \"text\": \"2. Participants will be admitted to the CRU for Treatment Period 1 on Day -8 and may be discharged on Day 9 or remain in the CRU for their own safety or to maintain the integrity of the conduct of the study. Participants who are discharged will be re-admitted on Day 22 or Day 23 for Treatment Period 2 and will remain in house until Day 40. To ensure flexibility, the Outpatient Period may be extended up to an additional 14 days with Investigator approval. In this situation, participants will be given additional investigational product to support daily dosing throughout the Outpatient Period. In such cases, the actual Outpatient Period duration will be recorded and the participant will continue Inpatient Period 2 at Day 23.\", \"footnoteId\": \"9393646f-7bf9-4c3f-8f91-69127c350b94\", \"structuredCondition\": \"extension.allowed(P14D).if(investigator_approval)\", \"appliesToActivityIds\": [\"44625ba9-8e87-4aaf-a000-fe1cfd0cee3f\", \"6610c275-e6f3-4043-93ff-60831ad5ea5d\", \"153847fb-d939-4a3e-aca4-34c3fdb5d735\", \"1708b8e7-b182-4172-8f2c-9bd62015af1a\", \"382fe30e-bbb7-4ea4-a6a3-3d5ddef8e030\", \"0d6aee78-3ca6-421a-822f-1c43ea8fb3aa\"], \"sourceText\": \"2. Participants will be admitted to the CRU for Treatment Period 1 on Day -8 and may be discharged o\"}, {\"id\": \"07e06f22-5837-43c7-8051-fe5270fe3555\", \"conditionType\": \"timing_at\", \"text\": \"3. Participants will be administered ALXN1840 at a dose of 15 mg/day on Day 1 through Day 28 and then increase to 30 mg/day on Day 29 through Day 39. During the Outpatient Period, participants will use SMS text messaging to confirm study intervention administration.\", \"footnoteId\": \"a851207c-d9de-4661-9d6a-f5d6357b31a2\", \"sourceText\": \"3. Participants will be administered ALXN1840 at a dose of 15 mg/day on Day 1 through Day 28 and the\", \"appliesToActivityIds\": [\"382fe30e-bbb7-4ea4-a6a3-3d5ddef8e030\", \"ea994424-deba-4e26-a84a-4557d942a173\", \"97b50fee-c394-43ea-8ab2-82a187722c2a\", \"1708b8e7-b182-4172-8f2c-9bd62015af1a\"]}, {\"id\": \"536402e5-ee38-4168-920d-4eb04724c148\", \"conditionType\": \"general\", \"text\": \"4. Participants will have 3 intake and output collection periods including: \\u2022 Baseline Day -4 through Day -1 \\u2022 Day 1 through Day 8 (I/O for 15 mg) \\u2022 Day 25 through Day 39 (Days 25 through 28, I/O for 15 mg; Days 29 through 39, I/O for 30 mg)\", \"footnoteId\": \"aaea1e8b-86db-415b-b0b9-a7de8884b8b3\", \"sourceText\": \"4. Participants will have 3 intake and output collection periods including: \\u2022 Baseline Day -4 throug\"}, {\"id\": \"d25f91af-eabd-4320-b2c0-3d7f43514df7\", \"conditionType\": \"general\", \"text\": \"5. During these periods all intake (including food and drink) and output (including urine and feces) will be collected and assessed for copper and molybdenum.\", \"footnoteId\": \"63749941-f258-4750-955d-cc97cb18aaa5\", \"sourceText\": \"5. During these periods all intake (including food and drink) and output (including urine and feces)\", \"appliesToActivityIds\": [\"2ef2fa9e-3fe3-46fc-a014-f21cef7631e1\", \"a08930fc-ae5c-40fc-b468-a8d8d5e1b31b\"]}, {\"id\": \"ffa21a6a-bb73-4af2-8191-2b8cc60678e7\", \"conditionType\": \"general\", \"text\": \"6. Blood sampling for PK/PD will be as follows: \\u2022 PK/PD collection (24-hour): Days 1, 25, 29, and 39 \\u2022 Predose PK/PD sampling days: Days 4 - 7, Days 26 - 28, Days 30 - 38 \\u2022 End of Study Visit Day 54 +/- 2 days Abbreviations: AP = accumulation period; CRU = clinical research unit; EOS = End of Study; I/O = input/output; PD = pharmacodynamic; PK = pharmacokinetic; SS = steady state.\", \"footnoteId\": \"2da2f3f0-3dfd-41b3-aaea-2b69af62a5d5\", \"sourceText\": \"6. Blood sampling for PK/PD will be as follows: \\u2022 PK/PD collection (24-hour): Days 1, 25, 29, and 39\", \"appliesToActivityIds\": [\"9ca6d3c4-0d3f-4c50-986d-e6ca348070f3\", \"36e59d41-e065-44e8-b91a-5f16699cfa1f\", \"153847fb-d939-4a3e-aca4-34c3fdb5d735\", \"1708b8e7-b182-4172-8f2c-9bd62015af1a\", \"382fe30e-bbb7-4ea4-a6a3-3d5ddef8e030\", \"e6a2afad-c0ca-4f46-9769-921725016179\"]}]"
              },
              {
                "id": "40beefb0-0f18-4555-bf7e-1572062da99d",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-endpointAlgorithms",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"86538238-4f49-4eb3-b09d-82a4ef9384d7\", \"name\": \"Primary: Net Negative Copper Balance\", \"endpointType\": \"Primary\", \"inputs\": [\"copper intake (food and drink)\", \"copper output (feces)\", \"copper output (urine)\"], \"timeWindow\": {\"reference\": \"Baseline to post-Baseline visits\", \"duration\": \"Duration of daily repeat-dose ALXN1840 treatment\"}, \"algorithm\": \"Net Copper Balance = (Copper Intake) - (Copper Output in Feces + Copper Output in Urine)\", \"successCriteria\": \"Net Copper Balance < 0 (Net Negative)\", \"sourceText\": \"The primary objective of this study is to demonstrate a net negative copper balance with daily repeat-dose ALXN1840 treatment (15 mg and 30 mg) in participants with WD.\"}]"
              },
              {
                "id": "0e4e21c3-ab3c-4ca3-be3e-08d7aaef0dcc",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-derivedVariables",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"436c51fb-a275-4d40-88f4-384395b9cd51\", \"name\": \"Mean daily copper balance\", \"variableType\": \"Custom\", \"sourceVariables\": [\"Copper intake in food\", \"Copper intake in drink\", \"Copper output in feces\", \"Copper output in urine\"], \"derivationRule\": \"(Copper intake in food + Copper intake in drink) - (Copper output in feces + Copper output in urine)\", \"baselineDefinition\": \"Days -4 through -1\", \"baselineVisit\": \"Pretreatment\", \"analysisWindow\": \"Accumulation and steady-state periods\", \"imputationRule\": \"Not specified\", \"unit\": \"mg/day\"}, {\"id\": \"922622e3-6df3-4c77-9264-dc79ca0ab173\", \"name\": \"Change in mean daily copper balance\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"Mean daily copper balance\"], \"derivationRule\": \"Post-baseline mean daily copper balance - Pretreatment baseline mean daily copper balance\", \"baselineDefinition\": \"Mean daily copper balance calculated from Days -4 through -1\", \"baselineVisit\": \"Pretreatment\", \"analysisWindow\": \"Accumulation and steady-state periods for each dose\", \"imputationRule\": \"Not specified\", \"unit\": \"mg/day\"}, {\"id\": \"a9d1fc75-93e2-4447-8f13-76cab92cd87d\", \"name\": \"Mean daily molybdenum balance\", \"variableType\": \"Custom\", \"sourceVariables\": [\"Molybdenum intake in food\", \"Molybdenum intake in drink\", \"Molybdenum intake in ALXN1840\", \"Molybdenum output in feces\", \"Molybdenum output in urine\"], \"derivationRule\": \"(Molybdenum intake in food + drink + ALXN1840) - (Molybdenum output in feces + urine)\", \"baselineDefinition\": \"Not applicable\", \"baselineVisit\": \"null\", \"analysisWindow\": \"ALXN1840 steady state\", \"imputationRule\": \"Not specified\", \"unit\": \"mg/day\"}, {\"id\": \"7416c5bf-e3dd-4b86-bded-97702d4a2c3e\", \"name\": \"NCCcorrected\", \"variableType\": \"Custom\", \"sourceVariables\": [\"Plasma non-ceruloplasmin-bound copper (NCC)\", \"Tetrathiomolybdate-copper-albumin tripartite complex (TPC)\"], \"derivationRule\": \"NCC corrected for the stable TPC\", \"baselineDefinition\": \"Not specified\", \"baselineVisit\": \"null\", \"analysisWindow\": \"Not specified\", \"imputationRule\": \"Not specified\", \"unit\": \"Not specified\"}, {\"id\": \"b4d41d5f-bd99-4352-a20d-216a2e70be43\", \"name\": \"Change in ceruloplasmin\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"Ceruloplasmin\"], \"derivationRule\": \"Post-baseline value - Predose value\", \"baselineDefinition\": \"Predose value\", \"baselineVisit\": \"Day 1 (Predose)\", \"analysisWindow\": \"Days 1, 8, 25, 29, 36, and 39\", \"imputationRule\": \"Not specified\", \"unit\": \"Not specified\"}]"
              },
              {
                "id": "3297eab3-e323-4a34-9623-77df9c22198a",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-stateMachine",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"dff24aa8-0e00-4521-99a7-f0454611416d\", \"initialState\": \"Screening\", \"terminalStates\": [\"Early Termination\", \"Completed\"], \"states\": [\"Screening\", \"C-I\", \"Inpatient Period 1\", \"OP\", \"Inpatient Period 2\", \"UNS\", \"EOS or ET\", \"Early Termination\"], \"transitions\": [{\"fromState\": \"Screening\", \"toState\": \"C-I\", \"trigger\": \"Progress to C-I\"}, {\"fromState\": \"C-I\", \"toState\": \"Inpatient Period 1\", \"trigger\": \"Progress to Inpatient Period 1\"}, {\"fromState\": \"Inpatient Period 1\", \"toState\": \"OP\", \"trigger\": \"Progress to OP\"}, {\"fromState\": \"OP\", \"toState\": \"Inpatient Period 2\", \"trigger\": \"Progress to Inpatient Period 2\"}, {\"fromState\": \"Inpatient Period 2\", \"toState\": \"UNS\", \"trigger\": \"Progress to UNS\"}, {\"fromState\": \"UNS\", \"toState\": \"EOS or ET\", \"trigger\": \"Progress to EOS or ET\"}, {\"fromState\": \"Inpatient Period 1\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}, {\"fromState\": \"Inpatient Period 2\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}], \"epochIds\": {\"Screening\": \"epoch_1\", \"C_I\": \"epoch_2\", \"Inpatient_Period_1\": \"epoch_3\", \"OP\": \"epoch_4\", \"Inpatient_Period_2\": \"epoch_5\", \"UNS\": \"epoch_6\", \"EOS_or_ET\": \"epoch_7\", \"Early_Termination\": \"EARLY_TERMINATION\"}}"
              },
              {
                "id": "19d8660b-a0e5-4f8f-860a-f2187f3ec23a",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-dosingRegimens",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"9bdb455b-deda-409a-9189-52770b9e9f72\", \"treatmentName\": \"ALXN1840\", \"frequency\": \"QD\", \"route\": \"Oral\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 30.0, \"unit\": \"mg\"}, {\"amount\": 15.0, \"unit\": \"mg\"}], \"doseModifications\": [\"Dose modification details are located in Section 6.6\"], \"sourceText\": \"Administration of Study Interventionm ALXN1840 15 mg/day           ALXN1840 30 mg/day      Study intervention compliance Xn  PK/PD Analyseso\"}, {\"id\": \"f4241bf4-ddcb-47a2-b03b-a0e5eb57998c\", \"treatmentName\": \"Zinc\", \"frequency\": \"TID\", \"route\": \"Oral\", \"startDay\": 1, \"doseModifications\": [\"Discontinued at least 21 days prior to certain assessments as per Section 4.2\"]}]"
              },
              {
                "id": "a9558917-d658-42a6-b1e0-98c11bbe1841",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-visitWindows",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"cea4281e-6a7d-4b3b-a06d-114c67da23ae\", \"visitName\": \"screening\", \"targetDay\": -14, \"windowBefore\": 7, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 1, \"epoch\": \"Screening\", \"sourceText\": \"treatment-na\\u00efve participants are eligible for this study. Following screening and enrollment, participants will have a Run-in Period to support diet equilibration (Day -7 through Day -5) and measureme\"}, {\"id\": \"03902cc3-4b59-46fc-852a-844360cd2d27\", \"visitName\": \"Early Termination\", \"targetDay\": null, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 4, \"sourceText\": \"Assess net copper balance with daily repeat-dose ALXN1840 treatment (15 mg and 30 mg) in participants with Wilson disease (WD)\"}, {\"id\": \"d5b43f59-9664-405a-bc3c-142f9957a40a\", \"visitName\": \"baseline\", \"targetDay\": 0, \"windowBefore\": 1, \"windowAfter\": 1, \"isRequired\": true, \"visitNumber\": 5, \"sourceText\": \"periods versus the pretreatment baseline in participants with WD Change in mean daily copper balance as measured by the\"}, {\"id\": \"655e4332-24c7-410f-9615-294e67794fb5\", \"visitName\": \"End of Study\", \"targetDay\": null, \"windowBefore\": 2, \"windowAfter\": 2, \"isRequired\": true, \"visitNumber\": 6, \"sourceText\": \"End of Study Visit Day 54 +/- 2 days Abbreviations: AP = accumulation period; CRU = clinical research unit; EOS = End of Study; I/O = input/output; PD = pharmacodynamic; PK = pharmacokinetic; SS = ste\"}, {\"id\": \"4422bebc-d33c-496f-b987-1b41b3d80380\", \"visitName\": \"Day 1\", \"targetDay\": 1, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 7, \"epoch\": \"Treatment Period 1\", \"sourceText\": \"Note: The accumulation period refers to time from initiation of ALXN1840 (Day 1) to expected steady state at Day 10, based on 5 times the half-life of 2 days. Overall Design\"}, {\"id\": \"1d983a91-9e22-4a6a-bcd8-0d2e5041d3c8\", \"visitName\": \"Day 7\", \"targetDay\": 7, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 8, \"sourceText\": \"Day 7, indicating the possibility of tissue accumulation, particularly in the setting of high liver copper concentration (Plitz, 2019). If the half-life of ALXN1840 in liver were longer than that of t\"}, {\"id\": \"2df38835-a375-407d-8aeb-0e053af087c6\", \"visitName\": \"Day 8\", \"targetDay\": 8, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 5, \"targetWeek\": 2, \"epoch\": \"Treatment Period 1\"}, {\"id\": \"2d40f300-ca4a-42be-8d89-d065580933cc\", \"visitName\": \"Day 9\", \"targetDay\": 9, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 10, \"epoch\": \"Treatment Period 1\", \"sourceText\": \"Participants may be discharged from the clinical research unit (CRU) on Day 9 to return on Day 22 or Day 23 (predose); all procedures will start on Day 23. To ensure flexibility, the Outpatient Period\"}, {\"id\": \"264448cd-1e8c-46e0-98cd-cac0e6313342\", \"visitName\": \"Day 14\", \"targetDay\": 14, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 11, \"sourceText\": \"g A single outpatient visit or phone call and safety laboratory assessment should occur between Day 14 and Day 18. A phone call may take place on a different day than the blood draw within the Day 14 \"}, {\"id\": \"3a025cb5-b154-40a9-95d3-131a691c6f1f\", \"visitName\": \"Day 22\", \"targetDay\": 22, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 12, \"sourceText\": \"who are discharged will be re-admitted on Day 22 or Day 23 for Treatment Period 2 and will remain in house until Day 40. To ensure flexibility, the Outpatient Period may be extended up to an additiona\"}, {\"id\": \"b2a6d454-8826-4dfe-a756-887eec252eb2\", \"visitName\": \"Day 23\", \"targetDay\": 23, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 13, \"epoch\": \"Treatment Period 1\", \"sourceText\": \"data through Day 23 for each participant. Participants will have intake and output collection periods from Day -4 through Day -1, from Day 1 through Day 8 (initial 15 mg/day collection period), and Da\"}, {\"id\": \"be2d25bb-6839-4a13-aedd-1b21deccd6fd\", \"visitName\": \"Day 25\", \"targetDay\": 25, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 14, \"epoch\": \"Treatment Period 1\", \"sourceText\": \"Day 25 through Day 39 (Days 25 through 28, I/O for 15 mg; Days 29 through 39, I/O for 30 mg) 5. During these periods all intake (including food and drink) and output (including urine and feces) will b\"}, {\"id\": \"a89b6de9-571c-42f8-bbfc-688b456fb338\", \"visitName\": \"Day 29\", \"targetDay\": 29, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 15, \"epoch\": \"Treatment Period 2\", \"sourceText\": \"treatment period of approximately 28 days followed by titration up to 30 mg/day on Day 29. Before titration to 30 mg/day, the Safety Review Committee (SRC) will review available safety data through Da\"}, {\"id\": \"27835a5b-498a-45c1-ad7a-79cf17376040\", \"visitName\": \"Day 36\", \"targetDay\": 36, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 16, \"epoch\": \"Treatment Period 2\", \"sourceText\": \"Day 36 through Day 39 for the 30 mg/day dose: if steady state is achieved, molybdenum(out) will equal molybdenum(in). 2.2.\"}, {\"id\": \"412a0377-84d1-443e-8101-20a97142b2c3\", \"visitName\": \"Day 39\", \"targetDay\": 39, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 17, \"epoch\": \"Treatment Period 2\", \"sourceText\": \"through Day 39. 2. Participants will be admitted to the CRU for Treatment Period 1 on Day -8 and may be discharged on Day 9 or remain in the CRU for their own safety or to maintain the integrity of th\"}, {\"id\": \"b2140a89-9222-4577-a829-42a1d7b35c3e\", \"visitName\": \"Day 40\", \"targetDay\": 40, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 18, \"sourceText\": \"until Day 40. To ensure flexibility, the Outpatient Period may be extended up to an additional 14 days with Investigator approval. In this situation, participants will be given additional investigatio\"}, {\"id\": \"954065da-cf6c-4448-aa0d-5320afdb157a\", \"visitName\": \"Day 54\", \"targetDay\": 54, \"windowBefore\": 2, \"windowAfter\": 2, \"isRequired\": true, \"visitNumber\": 19, \"sourceText\": \"End of Study Visit Day 54 +/- 2 days Abbreviations: AP = accumulation period; CRU = clinical research unit; EOS = End of Study; I/O = input/output; PD = pharmacodynamic; PK = pharmacokinetic; SS = ste\"}, {\"id\": \"8f4c0400-4116-450e-98a3-f25126223034\", \"visitName\": \"Week 24\", \"targetDay\": 162, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 20, \"targetWeek\": 24, \"sourceText\": \"for 9 participants at Week 24 when the primary endpoint assessment was conducted, or at the last dose received for participants with early discontinuation. The 15 to 60 mg/day dose range has been demo\"}, {\"id\": \"9017e3ee-183f-4b75-b2ee-20748c2800c4\", \"visitName\": \"Follow-up\", \"targetDay\": 365, \"windowBefore\": 7, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 21, \"sourceText\": \"Day 54 follow-up. f Discharge from the unit may occur after completion of all procedures on Day 9 and on Day 40 and after the Investigator has reviewed all safety assessment (including safety laborato\"}]"
              },
              {
                "id": "5ae8faa1-dfd4-4e7b-81d7-e37a755d7f3b",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-activityBindings",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"ea0d092b-ec86-4215-bdc6-a0728c36a84c\", \"activityId\": \"2ca9c619-8869-49d2-928f-e01c454198c8\", \"activityName\": \"controlled diet\", \"repetitionId\": \"d79eb9fc-8790-4c30-af83-d7d8832e81a0\", \"expectedOccurrences\": 18, \"sourceText\": \"Daily controlled_meal from Day -8 to Day 9\"}, {\"id\": \"3685ff5c-739b-412c-9931-4b72837160ec\", \"activityId\": \"2ca9c619-8869-49d2-928f-e01c454198c8\", \"activityName\": \"controlled diet\", \"repetitionId\": \"0ccb25d0-1b47-4319-ae4c-7a444ef208ef\", \"expectedOccurrences\": 18, \"sourceText\": \"Daily controlled_meal from Day -8 to Day 9\"}, {\"id\": \"a84730cd-620f-4041-84e4-d94db5f00a78\", \"activityId\": \"2ca9c619-8869-49d2-928f-e01c454198c8\", \"activityName\": \"controlled diet\", \"repetitionId\": \"f14a5cab-2c6d-4360-91b4-188726aa36a1\", \"expectedOccurrences\": 18, \"sourceText\": \"Daily controlled_meal from Day 23 to Day 40\"}, {\"id\": \"8b4bf7cc-7ce1-4fef-a45b-54b3ee198f8e\", \"activityId\": \"2ca9c619-8869-49d2-928f-e01c454198c8\", \"activityName\": \"controlled diet\", \"repetitionId\": \"d365f7b5-b8e4-4a82-8abd-a65458a2194e\", \"expectedOccurrences\": 18, \"sourceText\": \"Daily controlled_meal from Day 23 to Day 40\"}, {\"id\": \"b49c67b3-48db-4ac3-b0d3-daf22dc78554\", \"activityId\": \"2ca9c619-8869-49d2-928f-e01c454198c8\", \"activityName\": \"controlled diet\", \"repetitionId\": \"dea2e812-6b13-47b3-8adf-55f3aa6d6353\", \"expectedOccurrences\": 3, \"sourceText\": \"Daily controlled_meal from Day -7 to Day -5\"}, {\"id\": \"82e33b3d-67bb-43d6-a9c2-e5c3213f84ee\", \"activityId\": \"2ca9c619-8869-49d2-928f-e01c454198c8\", \"activityName\": \"controlled diet\", \"repetitionId\": \"5a84fd6b-f695-4727-b9bf-029963f2e812\", \"expectedOccurrences\": 4, \"sourceText\": \"Daily controlled_meal from Day -4 to Day -1\"}, {\"id\": \"5fe60093-9139-49ae-a38a-7fbec892f448\", \"activityId\": \"2ca9c619-8869-49d2-928f-e01c454198c8\", \"activityName\": \"controlled diet\", \"repetitionId\": \"63e9864e-4bea-48a7-8c28-2d23a26c1d8d\", \"expectedOccurrences\": 18, \"sourceText\": \"Daily controlled_meal from Day -8 to Day 9\"}, {\"id\": \"bc68a253-7695-4e96-a12a-71bdf75742d8\", \"activityId\": \"2ca9c619-8869-49d2-928f-e01c454198c8\", \"activityName\": \"controlled diet\", \"repetitionId\": \"aa8a89a9-ea69-44da-a6fa-304197d683c9\", \"expectedOccurrences\": 18, \"sourceText\": \"Daily controlled_meal from Day 23 to Day 40\"}, {\"id\": \"a0f553c0-5c52-4a63-90a8-492d808b7f6c\", \"activityId\": \"2ca9c619-8869-49d2-928f-e01c454198c8\", \"activityName\": \"controlled diet\", \"repetitionId\": \"3a33db6c-ce19-463e-9fb7-929009e1e676\", \"expectedOccurrences\": 18, \"sourceText\": \"Daily controlled_meal from Day -8 to Day 9\"}, {\"id\": \"5a82bc3b-6491-4500-9b5d-f2bbeb0ea808\", \"activityId\": \"2ca9c619-8869-49d2-928f-e01c454198c8\", \"activityName\": \"controlled diet\", \"repetitionId\": \"de949150-c43f-4e52-8e4b-f196a3376b7d\", \"expectedOccurrences\": 18, \"sourceText\": \"Daily controlled_meal from Day 23 to Day 40\"}, {\"id\": \"ec8dbca6-bdd3-4e02-b1e4-965614fef9a3\", \"activityId\": \"2ca9c619-8869-49d2-928f-e01c454198c8\", \"activityName\": \"controlled diet\", \"repetitionId\": \"828ba9ec-73d5-4c61-b99a-a036dc58c668\", \"expectedOccurrences\": 13, \"sourceText\": \"Daily controlled_meal from Day 3 to Day 15\"}, {\"id\": \"8403c02d-6c72-4d75-9b65-06209afca12d\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"copper balance\", \"repetitionId\": \"a3c9dacf-fc56-4902-800d-8ff5becccfa2\", \"expectedOccurrences\": 101, \"sourceText\": \"Daily balance_collection from Day 101 to Day 201\"}, {\"id\": \"5aa6d7da-ba3d-4469-a54a-cb03ab1677b7\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"copper balance\", \"repetitionId\": \"0e0cd7d8-6f9e-4316-8e6c-5b4200cca22e\", \"expectedOccurrences\": 4, \"sourceText\": \"Daily balance_collection from Day -4 to Day -1\"}, {\"id\": \"32005cee-be3f-4d80-b15e-f406b359b51d\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"c98dd808-a12e-4754-a880-953f08591e87\", \"expectedOccurrences\": 3, \"sourceText\": \"Daily balance_collection from Day -7 to Day -5\"}, {\"id\": \"26513f5d-f9e5-4ed3-b53c-38e0a33844d1\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"9a6e4520-9857-4e49-ad44-84dc9e745da8\", \"expectedOccurrences\": 4, \"sourceText\": \"Daily balance_collection from Day -4 to Day -1\"}, {\"id\": \"eb465bde-222b-4b09-9025-3a4ca55de3bc\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"d67c95db-4620-4413-9c34-3cde4c60a0b3\", \"expectedOccurrences\": 4, \"sourceText\": \"Daily balance_collection from Day -4 to Day -1\"}, {\"id\": \"3a94d88e-5577-4c12-878a-744ef436b7a2\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"89d07524-1e6a-4ef6-95ad-36f94dec1463\", \"expectedOccurrences\": 8, \"sourceText\": \"Daily balance_collection from Day 1 to Day 8\"}, {\"id\": \"60961045-4064-4d5f-a07d-9148a518a77e\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"5453bc5a-b7b5-4aa3-b432-360e0c6a9523\", \"expectedOccurrences\": 15, \"sourceText\": \"Daily balance_collection from Day 25 to Day 39\"}, {\"id\": \"50b40865-5e62-4b4c-a9cc-44abd4f6d092\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"copper balance\", \"repetitionId\": \"2722fb71-6ed4-4c25-9ff1-8a59162bc3a8\", \"expectedOccurrences\": 101, \"sourceText\": \"Daily balance_collection from Day 101 to Day 201\"}, {\"id\": \"029bc3b1-bcc6-4ecd-8bf0-a461f93c06e0\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"copper balance\", \"repetitionId\": \"70f29675-b8de-40df-b5b1-5f3c69cfd09f\", \"expectedOccurrences\": 101, \"sourceText\": \"Daily balance_collection from Day 101 to Day 201\"}, {\"id\": \"a969502f-b975-43ae-91a5-4c2a929cf529\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"copper balance\", \"repetitionId\": \"464ba990-5a8a-4d05-9028-8a516b23ff98\", \"expectedOccurrences\": 4, \"sourceText\": \"Daily balance_collection from Day -4 to Day -1\"}, {\"id\": \"49fe1837-c8e5-4c16-827e-89c83406a5a6\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"b51c9686-1832-47bd-b7a1-49eac3913cdd\", \"expectedOccurrences\": 3, \"sourceText\": \"Daily balance_collection from Day -7 to Day -5\"}, {\"id\": \"11803a96-6884-405f-8786-3d5f52749701\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"d9e0618c-6f08-423b-ba2d-c7ec4b9eed39\", \"expectedOccurrences\": 4, \"sourceText\": \"Daily balance_collection from Day -4 to Day -1\"}, {\"id\": \"96cf5d72-082d-4a08-9ab5-ee435429ff6c\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"f691e9e9-83d5-4e0b-a252-708ea0d8b6cf\", \"expectedOccurrences\": 18, \"sourceText\": \"Daily balance_collection from Day -8 to Day 9\"}, {\"id\": \"98b2b4fb-6c70-4d73-8288-0b34726f397c\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"e7cce900-3bbb-4e8d-9b80-00e23816f736\", \"expectedOccurrences\": 18, \"sourceText\": \"Daily balance_collection from Day 23 to Day 40\"}, {\"id\": \"e00c82be-c4ee-4fc3-a2de-82997db62c87\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"fd03a90b-9b29-4323-b5ec-3e06f6724b0c\", \"expectedOccurrences\": 4, \"sourceText\": \"Daily balance_collection from Day -4 to Day -1\"}, {\"id\": \"189288f9-a71f-4d05-a736-7decff5ee308\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"368b35fc-5e52-488e-8abc-6dfc4bb51339\", \"expectedOccurrences\": 8, \"sourceText\": \"Daily balance_collection from Day 1 to Day 8\"}, {\"id\": \"9f3fc172-2dc9-4b4a-86bd-68ec7498217a\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"c59e2693-5be4-4aba-9bf3-18b13e3a8432\", \"expectedOccurrences\": 15, \"sourceText\": \"Daily balance_collection from Day 25 to Day 39\"}, {\"id\": \"73c1cde0-ceb9-4730-967d-4631a5d5a7e1\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"copper balance\", \"repetitionId\": \"362f8b89-50c5-4d2e-893d-144b703b0aad\", \"expectedOccurrences\": 13, \"sourceText\": \"Daily balance_collection from Day 3 to Day 15\"}, {\"id\": \"79af4c4e-2265-4f57-b985-0925d34068ad\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"468d64e7-e3eb-43a3-be41-7cc683ba8423\", \"expectedOccurrences\": 13, \"sourceText\": \"Daily balance_collection from Day 3 to Day 15\"}, {\"id\": \"40b4c016-e8e3-44ad-ae4d-ec508718fc5b\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"molybdenum balance\", \"repetitionId\": \"892050c2-082b-45cc-8b72-9e899b6efb90\", \"expectedOccurrences\": 201, \"sourceText\": \"Daily balance_collection from Day 101 to Day 301\"}, {\"id\": \"7a7ff9dd-7bca-4c9b-af11-072d1c3d81f9\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"copper \\nbalance\", \"repetitionId\": \"2cdb60cd-bff7-48b2-8c83-a1dde56dd7e7\", \"expectedOccurrences\": 3, \"sourceText\": \"Daily balance_collection from Day 3 to Day 5\"}, {\"id\": \"cbdd7eb3-9a89-4265-96ec-3e6e018134e5\", \"activityId\": \"ab55af48-3616-458c-a94e-79ce93c75d09\", \"activityName\": \"copper balance\", \"repetitionId\": \"58ab48f1-f118-4463-99ae-9d8c17b82b41\", \"expectedOccurrences\": 101, \"sourceText\": \"Daily balance_collection from Day 101 to Day 201\"}]"
              },
              {
                "id": "11f9cf6d-e99f-4a6c-8303-f6ce83bfadda",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-titrationSchedules",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"67339792-b2fd-48a1-8ee4-5410f26a1428\", \"titrationType\": \"escalation\", \"doseLevels\": [{\"doseValue\": \"15 mg\", \"startDay\": 1, \"endDay\": 28, \"sourceText\": \"15 mg/day for approximately 28 days, followed by titration to 30 mg\"}, {\"doseValue\": \"30 mg\", \"startDay\": 29, \"requiresPriorDose\": \"15 mg\", \"transitionRule\": \"After 28 days on 15 mg\", \"sourceText\": \"15 mg/day for approximately 28 days, followed by titration to 30 mg\"}], \"interventionName\": \"ALXN1840 Treatment\", \"sourceText\": \"15 mg/day for approximately 28 days, followed by titration to 30 mg\"}]"
              },
              {
                "id": "995c7ef3-375b-42ca-bdac-a2038e2a1db8",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-analysisWindows",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"99143e92-348b-4103-a20a-a16488f0f065\", \"windowType\": \"baseline\", \"name\": \"Baseline Period\", \"startDay\": 4, \"endDay\": -1, \"description\": \"Pre-treatment baseline from Day 4 to Day -1\", \"sourceText\": \"Baseline Day -4 through Day -1\"}]"
              },
              {
                "id": "ext_execution_model_1a9a8c4d-50ca-4040-b76e-28d3ab6b402f",
                "url": "https://protocol2usdm.io/extensions/x-executionModel",
                "instanceType": "ExtensionAttribute",
                "valueObject": {
                  "schemaVersion": "1.0.0",
                  "extractionTimestamp": "2026-01-30T11:02:39.192622",
                  "executionModel": {
                    "timeAnchors": [
                      {
                        "id": "193c2a04-7cd2-48c4-802a-9857b788eebd",
                        "definition": "Initiation of ALXN1840 treatment",
                        "anchorType": "FirstDose",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 60,
                        "sourceText": "The accumulation period refers to time from initiation of ALXN1840 (Day 1) to expected steady state at Day 10",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "e761b5f0-c6ec-4748-9545-37d444ca85e7",
                        "definition": "Baseline visit/assessment",
                        "anchorType": "Baseline",
                        "classification": "Visit",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 50,
                        "sourceText": "Baseline Day",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "a3249766-7eae-4fe6-8bee-be5482d1c19c",
                        "definition": "Informed consent obtained",
                        "anchorType": "InformedConsent",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 10,
                        "sourceText": "informed consent",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "61daf6b7-2b43-432d-8174-6782ced3c801",
                        "definition": "procedure",
                        "anchorType": "Custom",
                        "classification": "Conceptual",
                        "timelineId": null,
                        "dayValue": 9,
                        "intraDayOrder": 100,
                        "sourceText": "procedure",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "1c51c7fc-a948-497d-9cf8-2fc1a0efbb80",
                        "definition": "24-hour collection period",
                        "anchorType": "CollectionDay",
                        "classification": "Conceptual",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 90,
                        "sourceText": "24-hour urine",
                        "encounterId": null,
                        "activityId": null
                      }
                    ],
                    "repetitions": [
                      {
                        "id": "b77b2d57-f875-4089-9796-65b78e6fa239",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "daily urine"
                      },
                      {
                        "id": "1cd49872-fef2-4596-ba2c-b1672ce132ee",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "once daily"
                      },
                      {
                        "id": "2d1b2800-e77a-41e9-943d-ae3bcca0f25e",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "od"
                      },
                      {
                        "id": "157e2505-4d71-4a89-82a6-b03490c24bde",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "OD"
                      },
                      {
                        "id": "b4dfe38a-4690-4989-a4d4-0bd9c9de32d4",
                        "type": "Interval",
                        "interval": "PT8H",
                        "sourceText": "every \n8 hours"
                      },
                      {
                        "id": "f74d7422-595b-46f7-af7c-8663e532a089",
                        "type": "Continuous",
                        "startOffset": "-P4D",
                        "endOffset": "-P1D",
                        "sourceText": "Days -4 through -1"
                      },
                      {
                        "id": "004546ca-566d-400b-b698-c2fe9f3853ba",
                        "type": "Continuous",
                        "startOffset": "-P7D",
                        "endOffset": "-P5D",
                        "sourceText": "Day -7 through Day -5"
                      },
                      {
                        "id": "7aaf6bf1-e459-444e-9b9f-106c867bb26c",
                        "type": "Continuous",
                        "startOffset": "-P4D",
                        "endOffset": "-P1D",
                        "sourceText": "Day -4 through Day -1"
                      },
                      {
                        "id": "d9926ff6-97cd-4ab7-995f-2802372bf659",
                        "type": "Continuous",
                        "startOffset": "P1D",
                        "endOffset": "P8D",
                        "sourceText": "Day 1 through Day 8"
                      },
                      {
                        "id": "1dcbd22b-1df2-45af-a60d-d440fc2de553",
                        "type": "Continuous",
                        "startOffset": "P25D",
                        "endOffset": "P39D",
                        "sourceText": "Day 25 through Day 39"
                      },
                      {
                        "id": "15bb313d-b062-40c6-b225-39b8899dbc2c",
                        "type": "Continuous",
                        "startOffset": "P1D",
                        "endOffset": "P28D",
                        "sourceText": "Day 1 through Day 28"
                      },
                      {
                        "id": "3ec0bab8-719d-4aef-a77e-df4207fded88",
                        "type": "Continuous",
                        "startOffset": "P29D",
                        "endOffset": "P39D",
                        "sourceText": "Day 29 through Day 39"
                      },
                      {
                        "id": "5f969028-d316-481a-a5ff-872a78cf2491",
                        "type": "Continuous",
                        "startOffset": "P25D",
                        "endOffset": "P28D",
                        "sourceText": "Days 25 through 28"
                      },
                      {
                        "id": "71ec8d1b-bb0c-4722-8d91-f703d3eb17f0",
                        "type": "Continuous",
                        "startOffset": "P29D",
                        "endOffset": "P39D",
                        "sourceText": "Days 29 through 39"
                      },
                      {
                        "id": "65b8f9bf-c6b3-4af5-826d-81e5640e53d2",
                        "type": "Continuous",
                        "startOffset": "P4D",
                        "endOffset": "P7D",
                        "sourceText": "Days 4 - 7"
                      },
                      {
                        "id": "fd608c77-5d08-438a-be09-c130b2c31600",
                        "type": "Continuous",
                        "startOffset": "P26D",
                        "endOffset": "P28D",
                        "sourceText": "Days 26 - 28"
                      },
                      {
                        "id": "aca948e5-ccc1-49a9-b735-67e383b65b24",
                        "type": "Continuous",
                        "startOffset": "P30D",
                        "endOffset": "P38D",
                        "sourceText": "Days 30 - 38"
                      },
                      {
                        "id": "d24bb9cf-8f38-4817-b12d-21db5da40042",
                        "type": "Continuous",
                        "startOffset": "-P8D",
                        "endOffset": "P9D",
                        "sourceText": "Day -8 to Day 9"
                      },
                      {
                        "id": "61340b0e-d443-401e-8258-86560298c284",
                        "type": "Continuous",
                        "startOffset": "P23D",
                        "endOffset": "P40D",
                        "sourceText": "Day 23 to Day 40"
                      },
                      {
                        "id": "f2e7314e-3933-42a5-9e36-3648a8ecfac7",
                        "type": "Continuous",
                        "startOffset": "P25D",
                        "endOffset": "P28D",
                        "sourceText": "Day 25 through Day 28"
                      },
                      {
                        "id": "ae2e0ddc-eba4-4709-b1ae-0ada2b01f14a",
                        "type": "Continuous",
                        "startOffset": "P36D",
                        "endOffset": "P39D",
                        "sourceText": "Day 36 through Day 39"
                      },
                      {
                        "id": "60fa67a4-b544-4847-aadb-dafde5ec8a86",
                        "type": "Continuous",
                        "startOffset": "-P7D",
                        "endOffset": "-P5D",
                        "sourceText": "Day -7 through \nDay -5"
                      },
                      {
                        "id": "a39221ee-5c02-4831-93c5-87580c1372a4",
                        "type": "Continuous",
                        "startOffset": "P1D",
                        "endOffset": "P9D",
                        "sourceText": "Days 1 through 9"
                      },
                      {
                        "id": "546f3a9a-dd08-4e80-bebe-834dc8b1966d",
                        "type": "Continuous",
                        "startOffset": "P31D",
                        "endOffset": "P35D",
                        "sourceText": "Days 31 through 35"
                      },
                      {
                        "id": "446245cc-7364-428d-b231-d3a202a4346d",
                        "type": "Continuous",
                        "startOffset": "P36D",
                        "endOffset": "P39D",
                        "sourceText": "Days 36 through 39"
                      },
                      {
                        "id": "e7ac2616-5a17-4e63-849a-01ba449a4e18",
                        "type": "Continuous",
                        "startOffset": "P9D",
                        "endOffset": "P23D",
                        "sourceText": "Day 9 to Day 23"
                      },
                      {
                        "id": "8b3d2f77-ab92-4613-b20f-82c410d05a78",
                        "type": "Continuous",
                        "sourceText": "Run-in Period"
                      },
                      {
                        "id": "a71c5afa-303f-4100-be1c-75f8f68edf8a",
                        "type": "Continuous",
                        "sourceText": "treatment period"
                      },
                      {
                        "id": "20cbf8b1-65b4-4e31-92e6-133df3cdd0cb",
                        "type": "Continuous",
                        "sourceText": "Treatment Period"
                      },
                      {
                        "id": "b3f5807c-a3c6-4e1b-858f-50639932ccbf",
                        "type": "Continuous",
                        "sourceText": "treatment \nperiod"
                      },
                      {
                        "id": "3098f99a-8bb4-4e1d-9954-7333f6e10f36",
                        "type": "Continuous",
                        "sourceText": "dosing period"
                      },
                      {
                        "id": "2637c606-fcd7-4167-8cdc-1511cb4d15a3",
                        "type": "Continuous",
                        "sourceText": "pretreatment period"
                      },
                      {
                        "id": "c312d50a-bfe4-47ba-aa1d-f82a1a710d96",
                        "type": "Continuous",
                        "sourceText": "post-treatment period"
                      },
                      {
                        "id": "a8643313-a18f-44ca-9d00-4e494cf5b768",
                        "type": "Continuous",
                        "sourceText": "2 hours after"
                      },
                      {
                        "id": "044600e9-ac82-40e7-b0dd-7876dd452f99",
                        "type": "Continuous",
                        "sourceText": "8 hours before"
                      },
                      {
                        "id": "e0bce017-f323-4299-95d4-47e44a95bad9",
                        "type": "Continuous",
                        "sourceText": "4 hours post"
                      },
                      {
                        "id": "2217bbde-55cc-468b-a001-aa211e6ccc6d",
                        "type": "Continuous",
                        "sourceText": "21 days after"
                      },
                      {
                        "id": "bd68805a-a620-4223-b1a0-e6c48135d45c",
                        "type": "Continuous",
                        "sourceText": "Inpatient Period"
                      },
                      {
                        "id": "e022bdf7-9c71-49e1-aa18-48454d5f654c",
                        "type": "Continuous",
                        "sourceText": "inpatient Period"
                      },
                      {
                        "id": "7ca9433f-92ad-4c96-8fe2-a54908f4235b",
                        "type": "Continuous",
                        "sourceText": "Inpatient \nPeriod"
                      },
                      {
                        "id": "978e0fa9-c4f8-41d9-a4e4-4b3aa3e02e99",
                        "type": "Continuous",
                        "sourceText": "inpatient period"
                      },
                      {
                        "id": "7daab93e-2b29-4ab5-9167-91df252f48bc",
                        "type": "Continuous",
                        "sourceText": "inpatient \nperiod"
                      },
                      {
                        "id": "ef11c46d-5bb1-400f-a972-849a68a481c8",
                        "type": "Continuous",
                        "sourceText": "balance period"
                      },
                      {
                        "id": "c61560f3-eb44-4377-8027-091ade02f8d7",
                        "type": "Continuous",
                        "sourceText": "24-hour urine"
                      },
                      {
                        "id": "39a0d48b-1bdd-4639-a35c-034b68b8cf3d",
                        "type": "Continuous",
                        "sourceText": "24-hour collection"
                      },
                      {
                        "id": "d79eb9fc-8790-4c30-af83-d7d8832e81a0",
                        "type": "Daily",
                        "startOffset": "-P8D",
                        "endOffset": "P9D",
                        "interval": "P1D",
                        "count": 18,
                        "sourceText": "controlled diet (Day -8 to Day 9)"
                      },
                      {
                        "id": "f14a5cab-2c6d-4360-91b4-188726aa36a1",
                        "type": "Daily",
                        "startOffset": "P23D",
                        "endOffset": "P40D",
                        "interval": "P1D",
                        "count": 18,
                        "sourceText": "controlled diet (Day 23 to Day 40)"
                      },
                      {
                        "id": "dea2e812-6b13-47b3-8adf-55f3aa6d6353",
                        "type": "Daily",
                        "startOffset": "-P7D",
                        "endOffset": "-P5D",
                        "interval": "P1D",
                        "count": 3,
                        "sourceText": "controlled diet (Day -7 through \nDay -5)"
                      },
                      {
                        "id": "5a84fd6b-f695-4727-b9bf-029963f2e812",
                        "type": "Daily",
                        "startOffset": "-P4D",
                        "endOffset": "-P1D",
                        "interval": "P1D",
                        "count": 4,
                        "sourceText": "controlled diet (Day -4 through Day -1)"
                      },
                      {
                        "id": "828ba9ec-73d5-4c61-b99a-a036dc58c668",
                        "type": "Daily",
                        "startOffset": "P3D",
                        "endOffset": "P15D",
                        "interval": "P1D",
                        "count": 13,
                        "sourceText": "controlled diet (3 to 15)"
                      },
                      {
                        "id": "a3c9dacf-fc56-4902-800d-8ff5becccfa2",
                        "type": "Daily",
                        "startOffset": "P101D",
                        "endOffset": "P201D",
                        "interval": "P1D",
                        "count": 101,
                        "sourceText": "copper balance (101-201)"
                      },
                      {
                        "id": "0e0cd7d8-6f9e-4316-8e6c-5b4200cca22e",
                        "type": "Daily",
                        "startOffset": "-P4D",
                        "endOffset": "-P1D",
                        "interval": "P1D",
                        "count": 4,
                        "sourceText": "copper balance (Days -4 through -1)"
                      },
                      {
                        "id": "c98dd808-a12e-4754-a880-953f08591e87",
                        "type": "Daily",
                        "startOffset": "-P7D",
                        "endOffset": "-P5D",
                        "interval": "P1D",
                        "count": 3,
                        "sourceText": "molybdenum balance (Day -7 through Day -5)"
                      },
                      {
                        "id": "9a6e4520-9857-4e49-ad44-84dc9e745da8",
                        "type": "Daily",
                        "startOffset": "-P4D",
                        "endOffset": "-P1D",
                        "interval": "P1D",
                        "count": 4,
                        "sourceText": "molybdenum balance (Day -4 through Day -1)"
                      },
                      {
                        "id": "89d07524-1e6a-4ef6-95ad-36f94dec1463",
                        "type": "Daily",
                        "startOffset": "P1D",
                        "endOffset": "P8D",
                        "interval": "P1D",
                        "count": 8,
                        "sourceText": "molybdenum balance (Day 1 through Day 8)"
                      },
                      {
                        "id": "5453bc5a-b7b5-4aa3-b432-360e0c6a9523",
                        "type": "Daily",
                        "startOffset": "P25D",
                        "endOffset": "P39D",
                        "interval": "P1D",
                        "count": 15,
                        "sourceText": "molybdenum balance (Day 25 through Day 39)"
                      },
                      {
                        "id": "b51c9686-1832-47bd-b7a1-49eac3913cdd",
                        "type": "Daily",
                        "startOffset": "-P7D",
                        "endOffset": "-P5D",
                        "interval": "P1D",
                        "count": 3,
                        "sourceText": "molybdenum balance (Day -7 through \nDay -5)"
                      },
                      {
                        "id": "f691e9e9-83d5-4e0b-a252-708ea0d8b6cf",
                        "type": "Daily",
                        "startOffset": "-P8D",
                        "endOffset": "P9D",
                        "interval": "P1D",
                        "count": 18,
                        "sourceText": "molybdenum balance (Day -8 to Day 9)"
                      },
                      {
                        "id": "e7cce900-3bbb-4e8d-9b80-00e23816f736",
                        "type": "Daily",
                        "startOffset": "P23D",
                        "endOffset": "P40D",
                        "interval": "P1D",
                        "count": 18,
                        "sourceText": "molybdenum balance (Day 23 to Day 40)"
                      },
                      {
                        "id": "362f8b89-50c5-4d2e-893d-144b703b0aad",
                        "type": "Daily",
                        "startOffset": "P3D",
                        "endOffset": "P15D",
                        "interval": "P1D",
                        "count": 13,
                        "sourceText": "copper balance (3 to 15)"
                      },
                      {
                        "id": "468d64e7-e3eb-43a3-be41-7cc683ba8423",
                        "type": "Daily",
                        "startOffset": "P3D",
                        "endOffset": "P15D",
                        "interval": "P1D",
                        "count": 13,
                        "sourceText": "molybdenum balance (3 to 15)"
                      },
                      {
                        "id": "892050c2-082b-45cc-8b72-9e899b6efb90",
                        "type": "Daily",
                        "startOffset": "P101D",
                        "endOffset": "P301D",
                        "interval": "P1D",
                        "count": 201,
                        "sourceText": "molybdenum balance (101-301)"
                      },
                      {
                        "id": "2cdb60cd-bff7-48b2-8c83-a1dde56dd7e7",
                        "type": "Daily",
                        "startOffset": "P3D",
                        "endOffset": "P5D",
                        "interval": "P1D",
                        "count": 3,
                        "sourceText": "copper \nbalance (3 - 5)"
                      },
                      {
                        "id": "25a26600-debd-46b9-8985-42de9a36e863",
                        "type": "Continuous",
                        "startOffset": "P0D",
                        "endOffset": "P1D",
                        "interval": "P1D",
                        "minObservations": 1,
                        "exitCondition": "End of study",
                        "sourceText": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840"
                      },
                      {
                        "id": "0ccb25d0-1b47-4319-ae4c-7a444ef208ef",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 18,
                        "sourceText": "Auto-generated from binding: Daily controlled_meal from Day -8 to Day 9"
                      },
                      {
                        "id": "d365f7b5-b8e4-4a82-8abd-a65458a2194e",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 18,
                        "sourceText": "Auto-generated from binding: Daily controlled_meal from Day 23 to Day 40"
                      },
                      {
                        "id": "63e9864e-4bea-48a7-8c28-2d23a26c1d8d",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 18,
                        "sourceText": "Auto-generated from binding: Daily controlled_meal from Day -8 to Day 9"
                      },
                      {
                        "id": "aa8a89a9-ea69-44da-a6fa-304197d683c9",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 18,
                        "sourceText": "Auto-generated from binding: Daily controlled_meal from Day 23 to Day 40"
                      },
                      {
                        "id": "3a33db6c-ce19-463e-9fb7-929009e1e676",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 18,
                        "sourceText": "Auto-generated from binding: Daily controlled_meal from Day -8 to Day 9"
                      },
                      {
                        "id": "de949150-c43f-4e52-8e4b-f196a3376b7d",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 18,
                        "sourceText": "Auto-generated from binding: Daily controlled_meal from Day 23 to Day 40"
                      },
                      {
                        "id": "d67c95db-4620-4413-9c34-3cde4c60a0b3",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 4,
                        "sourceText": "Auto-generated from binding: Daily balance_collection from Day -4 to Day -1"
                      },
                      {
                        "id": "2722fb71-6ed4-4c25-9ff1-8a59162bc3a8",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 101,
                        "sourceText": "Auto-generated from binding: Daily balance_collection from Day 101 to Day 201"
                      },
                      {
                        "id": "70f29675-b8de-40df-b5b1-5f3c69cfd09f",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 101,
                        "sourceText": "Auto-generated from binding: Daily balance_collection from Day 101 to Day 201"
                      },
                      {
                        "id": "464ba990-5a8a-4d05-9028-8a516b23ff98",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 4,
                        "sourceText": "Auto-generated from binding: Daily balance_collection from Day -4 to Day -1"
                      },
                      {
                        "id": "d9e0618c-6f08-423b-ba2d-c7ec4b9eed39",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 4,
                        "sourceText": "Auto-generated from binding: Daily balance_collection from Day -4 to Day -1"
                      },
                      {
                        "id": "fd03a90b-9b29-4323-b5ec-3e06f6724b0c",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 4,
                        "sourceText": "Auto-generated from binding: Daily balance_collection from Day -4 to Day -1"
                      },
                      {
                        "id": "368b35fc-5e52-488e-8abc-6dfc4bb51339",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 8,
                        "sourceText": "Auto-generated from binding: Daily balance_collection from Day 1 to Day 8"
                      },
                      {
                        "id": "c59e2693-5be4-4aba-9bf3-18b13e3a8432",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 15,
                        "sourceText": "Auto-generated from binding: Daily balance_collection from Day 25 to Day 39"
                      },
                      {
                        "id": "58ab48f1-f118-4463-99ae-9d8c17b82b41",
                        "type": "Daily",
                        "interval": "P1D",
                        "count": 101,
                        "sourceText": "Auto-generated from binding: Daily balance_collection from Day 101 to Day 201"
                      }
                    ],
                    "samplingConstraints": [],
                    "traversalConstraints": [
                      {
                        "id": "455fdd72-bee3-4f90-9da1-098c2ca71cb6",
                        "requiredSequence": [
                          "epoch_1",
                          "epoch_2",
                          "epoch_3",
                          "epoch_4",
                          "epoch_5",
                          "epoch_6",
                          "epoch_7"
                        ],
                        "allowEarlyExit": true,
                        "exitEpochIds": [
                          "4ee5dc7f-5ab7-4a06-b86e-f1eaf095a375"
                        ],
                        "mandatoryVisits": [
                          "End of Study",
                          "Screening",
                          "Day 1"
                        ],
                        "sourceText": "[{'condition': 'If subject is on zinc therapy at screening', 'path': ['ZINC_DISCONTINUATION_21_DAYS', 'BASELINE']}, {'condition': 'If subject experiences AE requiring discontinuation', 'path': ['DISCONTINUATION_OF_INTERVENTION', 'EARLY_TERMINATION_VISIT', 'FOLLOW_UP']}, {'condition': 'US-specific recruitment model', 'path': ['SCREENING_SITE_PROCEDURES', 'TRANSFER_TO_STUDY_SITE']}]"
                      }
                    ],
                    "executionTypes": [
                      {
                        "activityId": "Urine Collection",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 1"
                      },
                      {
                        "activityId": "Vital Signs",
                        "executionType": "Window",
                        "rationale": "WINDOW signals: 5; EPISODE signals: 2; SINGLE signals: 1; RECURRING signals: 1"
                      },
                      {
                        "activityId": "Electrocardiogram",
                        "executionType": "Window",
                        "rationale": "WINDOW signals: 7"
                      },
                      {
                        "activityId": "Pe",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Adverse Events",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Concomitant Medication",
                        "executionType": "Single",
                        "rationale": "WINDOW signals: 1; SINGLE signals: 4; RECURRING signals: 2"
                      },
                      {
                        "activityId": "Laboratory Assessments",
                        "executionType": "Window",
                        "rationale": "WINDOW signals: 3; EPISODE signals: 1"
                      },
                      {
                        "activityId": "Pharmacokinetic",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Pharmacodynamic",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Drug Administration",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 1"
                      },
                      {
                        "activityId": "Screening Procedures",
                        "executionType": "Single",
                        "rationale": "The protocol specifies screening procedures as a distinct phase occurring only at the start to determine eligibility, with some sites in the US performing only these procedures."
                      },
                      {
                        "activityId": "Zinc Discontinuation",
                        "executionType": "Single",
                        "rationale": "The protocol describes a one-time discontinuation of zinc therapy 21 days prior to study procedures to minimize inhibitory effects on copper absorption."
                      },
                      {
                        "activityId": "Copper and Molybdenum Balance Assessment",
                        "executionType": "Single",
                        "rationale": "The study title and rationale indicate a balance study, which typically requires continuous collection of excreta over a multi-day period to assess intake vs. output."
                      },
                      {
                        "activityId": "Study Visit Procedures",
                        "executionType": "Single",
                        "rationale": "The Schedule of Activities (SoA) and Section 1.3 references indicate procedures that occur across multiple scheduled visits throughout the study duration."
                      }
                    ],
                    "footnoteConditions": [
                      {
                        "id": "e3b53f3c-ef30-4bb5-9c41-7202440e9875",
                        "conditionType": "general",
                        "text": "a. Within 42 days of ALXN1840 administration. Details of procedures that may be performed by sites designated as \"screening sites\" (only in the US) are detailed in Section 8.",
                        "footnoteId": "46c181f2-2b32-42c3-b9f2-6dba2d0b578b",
                        "structuredCondition": "timing.before(ALXN1840_administration, P42D)",
                        "appliesToActivityIds": [
                          "Screening Procedures"
                        ],
                        "sourceText": "a. Within 42 days of ALXN1840 administration. Details of procedures that may be performed by sites d"
                      },
                      {
                        "id": "779429bc-60a7-49fb-891d-8c493b1a43a2",
                        "conditionType": "timing_before",
                        "text": "b. Participants will be admitted to the clinical research unit (CRU) at least 10 hours prior to enrollment and initiation of copper- and molybdenum-controlled diet.",
                        "footnoteId": "05bc70de-72c8-4033-991d-5cfd3f6116eb",
                        "structuredCondition": "timing.before(enrollment and initiation of copper- and molybdenum-controlled diet., PT10M)",
                        "appliesToActivityIds": [
                          "CRU Admission"
                        ],
                        "timingConstraint": "PT10H",
                        "sourceText": "b. Participants will be admitted to the clinical research unit (CRU) at least 10 hours prior to enro"
                      },
                      {
                        "id": "78c14966-1f05-4ace-8b7f-64fc55d0050f",
                        "conditionType": "timing_at",
                        "text": "c. At the CRU's discretion, participants may remain in the CRU or be readmitted on Day 22 with all procedures starting on Day 23.",
                        "footnoteId": "71f91d01-067e-4dcf-8586-2c3a4f772116",
                        "sourceText": "c. At the CRU's discretion, participants may remain in the CRU or be readmitted on Day 22 with all p"
                      },
                      {
                        "id": "d0a03760-c2c9-4c2f-99c7-377418270883",
                        "conditionType": "general",
                        "text": "d. Unscheduled study visits may occur at any time during the study and may include any study procedure as deemed necessary by the Investigator.",
                        "footnoteId": "f49f57b3-805e-461b-b652-5263ac4e2f37",
                        "sourceText": "d. Unscheduled study visits may occur at any time during the study and may include any study procedu"
                      },
                      {
                        "id": "25a44192-09a4-44f5-9fac-8accc48a0128",
                        "conditionType": "general",
                        "text": "e. Participants are required to return to the CRU Day 54+/-2; participants will be discontinued from ALXN1840 medication by their physician at the latest by the Day 54 follow-up.",
                        "footnoteId": "0771a36f-cc6c-4458-a1c3-a7d453a082c8",
                        "structuredCondition": "timing.at(Day54).window(P2D)",
                        "appliesToActivityIds": [
                          "CRU Return",
                          "ALXN1840 Discontinuation"
                        ],
                        "sourceText": "e. Participants are required to return to the CRU Day 54+/-2; participants will be discontinued from"
                      },
                      {
                        "id": "2c12f051-9608-4858-8292-8e53cae46f18",
                        "conditionType": "timing_after",
                        "text": "f. Discharge from the unit may occur after completion of all procedures on Day 9 and on Day 40 and after the Investigator has reviewed all safety assessment (including safety laboratory tests) and confirmed that the participant is appropriate for discharge.",
                        "footnoteId": "99ca5c15-27e8-4be8-b2ba-ebdd3ba9eed0",
                        "structuredCondition": "sequence.after(all_procedures).after(investigator_review)",
                        "appliesToActivityIds": [
                          "Discharge"
                        ],
                        "sourceText": "f. Discharge from the unit may occur after completion of all procedures on Day 9 and on Day 40 and a"
                      },
                      {
                        "id": "b7b42a31-ea68-4d85-ad97-53e0b4963e7f",
                        "conditionType": "general",
                        "text": "g. A single outpatient visit or phone call and safety laboratory assessment should occur between Day 14 and Day 18. A phone call may take place on a different day than the blood draw within the Day 14 through Day 18 period.",
                        "footnoteId": "11b7e9db-6755-4f57-ad68-8e71c25a5bd5",
                        "sourceText": "g. A single outpatient visit or phone call and safety laboratory assessment should occur between Day"
                      },
                      {
                        "id": "1f0c26cb-1b99-414a-9929-cd237e139149",
                        "conditionType": "general",
                        "text": "h. If needed to confirm menopause.",
                        "footnoteId": "b3ef97cd-c167-4075-bf81-28e845869874",
                        "structuredCondition": "if(needed_to_confirm_menopause)",
                        "appliesToActivityIds": [
                          "FSH Test"
                        ],
                        "sourceText": "h. If needed to confirm menopause."
                      },
                      {
                        "id": "d284d9f9-d39e-43f8-8b10-1a7e8fb1234f",
                        "conditionType": "general",
                        "text": "i. Parameters include age and sex. Race and ethnicity will be collected where permitted by local regulations.",
                        "footnoteId": "b4298e86-ba45-4550-8e4c-00d4fbc7bad1",
                        "sourceText": "i. Parameters include age and sex. Race and ethnicity will be collected where permitted by local reg"
                      },
                      {
                        "id": "8110a13d-0f11-4cae-8987-8ac79ca21992",
                        "conditionType": "general",
                        "text": "j. Wilson disease history will include diagnosis date, method of diagnosis, history of cirrhosis, details of any previous liver biopsies performed, and treatment received.",
                        "footnoteId": "f6538cd8-26cd-4e25-acff-2defe2137f22",
                        "sourceText": "j. Wilson disease history will include diagnosis date, method of diagnosis, history of cirrhosis, de"
                      },
                      {
                        "id": "3ae21f3e-e68f-4f28-b13d-c4a3214843ec",
                        "conditionType": "timing_before",
                        "text": "k. A full physical examination will be performed at Screening, at check-in for the study, and at the End of the study/Early Termination Visit. A physical examination should also be performed on any participants with ongoing adverse events prior to discharge from the unit. Otherwise, a symptom-driven physical examination may be performed at other times, at the Principal Investigator's discretion.",
                        "footnoteId": "6909bdf8-e524-4818-991b-80b8b8f8a73c",
                        "structuredCondition": "if(ongoing_adverse_events) then(full_exam) else(symptom_driven)",
                        "appliesToActivityIds": [
                          "Physical Examination"
                        ],
                        "sourceText": "k. A full physical examination will be performed at Screening, at check-in for the study, and at the"
                      },
                      {
                        "id": "44c9a1c1-ee78-4d9f-a85f-049e1ac5bee1",
                        "conditionType": "general",
                        "text": "l. Height at screening only.",
                        "footnoteId": "310f76a8-3dd6-471a-a04e-8b152fcac71d",
                        "sourceText": "l. Height at screening only."
                      },
                      {
                        "id": "4683290c-ed74-4c94-87a6-285603e1590e",
                        "conditionType": "timing_after",
                        "text": "m. While in the CRU, study intervention will be administered after an overnight fast (ie, at least 10 hours) at the same time every morning; drug is to be administered with 240 mL of water and meals should be delayed a minimum of 2 hours after dosing. As an outpatient, participants are expected to take ALXN1840 at approximately the same time daily (+/-1 hour). Participants should take the medication with a glass of water on an empty stomach; meals should be delayed a minimum of 2 hours after dosing.",
                        "footnoteId": "5a429885-b368-4e5c-b944-6cf4846f0101",
                        "structuredCondition": "timing.after(dosing. as an outpatient, participants are expected to take alxn1840 at approximately the same time daily (+/-1 hour). participants should take the medication with a glass of water on an empty stomach; meals should be delayed a minimum of 2 hours after dosing., PT2M)",
                        "appliesToActivityIds": [
                          "ALXN1840 Administration"
                        ],
                        "timingConstraint": "PT10H",
                        "sourceText": "m. While in the CRU, study intervention will be administered after an overnight fast (ie, at least 1"
                      },
                      {
                        "id": "96ed998b-c240-47dc-bfcd-2ac56e287ac9",
                        "conditionType": "general",
                        "text": "n. During the outpatient period, participants will use SMS text messaging to confirm study intervention administration.",
                        "footnoteId": "a822f844-0f24-418d-a202-1951ca482c35",
                        "sourceText": "n. During the outpatient period, participants will use SMS text messaging to confirm study intervent"
                      },
                      {
                        "id": "c8d5be24-ca81-4132-bb61-e6c8cb7360f2",
                        "conditionType": "timing_before",
                        "text": "o. Blood sampling for PK/PD will occur before ALXN1840 administration and represents a predose trough. See Table 2 for PK/PD sampling on Days 1, 25, 29, and 39.",
                        "footnoteId": "c640f288-e406-488e-9414-3048533d32d2",
                        "structuredCondition": "timing.before(ALXN1840_administration)",
                        "appliesToActivityIds": [
                          "Blood sampling for PK/PD"
                        ],
                        "sourceText": "o. Blood sampling for PK/PD will occur before ALXN1840 administration and represents a predose troug"
                      },
                      {
                        "id": "76a8da47-14b4-451a-bbe2-35425b92e76c",
                        "conditionType": "general",
                        "text": "p. PK/PD collection will include timepoints described in the schedule of PK/PD assessment for Days 1, 25, 29, and 39 (Table 2).",
                        "footnoteId": "fee1a07b-ca81-4c74-888a-19f948848469",
                        "sourceText": "p. PK/PD collection will include timepoints described in the schedule of PK/PD assessment for Days 1"
                      },
                      {
                        "id": "dd571303-3724-4143-8d8a-065763efea20",
                        "conditionType": "timing_before",
                        "text": "q. Samples for serum chemistry will be obtained following a fast of at least 8 hours at the Screening Visit and at check-in. In case of rechecks, and postdose serum chemistry, participants may not have fasted for 6 or 8 hours before the serum chemistry sample is taken.",
                        "footnoteId": "719bd6ec-a597-477d-aee3-6c3964468e72",
                        "structuredCondition": "timing.before(the serum chemistry sample is taken., PT8M)",
                        "appliesToActivityIds": [
                          "Serum Chemistry"
                        ],
                        "timingConstraint": "PT8H",
                        "sourceText": "q. Samples for serum chemistry will be obtained following a fast of at least 8 hours at the Screenin"
                      },
                      {
                        "id": "e5b0793a-b07e-478e-8e49-f90441344af5",
                        "conditionType": "general",
                        "text": "r. Laboratory assessment including chemistry, hematology, and coagulation parameters should be performed on Days -8, -1, 8, 23, and 28 only.",
                        "footnoteId": "f7e2cb04-f186-4e8c-bf60-1f2061da1bd4",
                        "sourceText": "r. Laboratory assessment including chemistry, hematology, and coagulation parameters should be perfo"
                      },
                      {
                        "id": "01940510-237c-483d-bd02-00231a70db97",
                        "conditionType": "timing_after",
                        "text": "s. Menstruation check is for women only; women of childbearing potential should only be enrolled after a negative serum pregnancy test result at Screening. Additional urine pregnancy testing will be standard for the protocol unless serum testing is required by site policies, local regulation, or Institutional Review Boards (IRBs)/Independent Ethics Committees (IECs) (Section 10.2). In addition to pregnancy tests detailed at the visits in the SoA, females of childbearing potential will be required to perform urine pregnancy tests at least every 4 weeks at their home or the study site throughout their time in the study.",
                        "footnoteId": "60b69526-271e-4958-8b71-087e53425199",
                        "structuredCondition": "frequency.every(P4W)",
                        "appliesToActivityIds": [
                          "Urine Pregnancy Test"
                        ],
                        "sourceText": "s. Menstruation check is for women only; women of childbearing potential should only be enrolled aft"
                      },
                      {
                        "id": "dada385a-c8e4-4b24-bf61-b0ee38d16991",
                        "conditionType": "timing_after",
                        "text": "t. A single 15 mL serum sample will be retained for evaluation in the event of an unexpected safety finding; retained samples may be destroyed after completion of the clinical report.",
                        "footnoteId": "6cdaa85a-5bf5-40e7-8957-2765d76b13c7",
                        "sourceText": "t. A single 15 mL serum sample will be retained for evaluation in the event of an unexpected safety "
                      },
                      {
                        "id": "e8a6f94f-f57e-47d5-9f92-cc94b29644cd",
                        "conditionType": "general",
                        "text": "u. Vital signs measurements and ECGs should be performed predose, unless otherwise specified. Vitals signs include body temperature, heart rate, respiratory rate, and systolic and diastolic blood pressure.",
                        "footnoteId": "7254f67f-ec22-43df-a701-155cf535d951",
                        "structuredCondition": "timing.before(dose)",
                        "appliesToActivityIds": [
                          "Vital Signs",
                          "ECG"
                        ],
                        "sourceText": "u. Vital signs measurements and ECGs should be performed predose, unless otherwise specified. Vitals"
                      },
                      {
                        "id": "6770bafa-35a6-4779-9fef-80ffea75a3fd",
                        "conditionType": "timing_after",
                        "text": "v. Copper- and molybdenum-controlled diet will be initiated after registration/inclusion. Participants will remain on a copper/molybdenum controlled diet throughout both the inpatient Period 1 (Day -8 to Day 9) and inpatient Period 2 (Day 23 to Day 40); during this time participants will be strongly encouraged to complete all meals. While not in the CRU, participants will be encouraged to adhere to their usual copper-controlled diet.",
                        "footnoteId": "538ee389-f215-4770-8ffe-1a46599bb702",
                        "sourceText": "v. Copper- and molybdenum-controlled diet will be initiated after registration/inclusion. Participan"
                      },
                      {
                        "id": "1502b8d3-27f9-41f5-8a93-6e4233b6bb9d",
                        "conditionType": "general",
                        "text": "w. For each input/output balance period, 24-hour urine samples are to be collected for measurement of copper and molybdenum.",
                        "footnoteId": "0aca45f5-ed1d-473c-8048-7ae0582840c0",
                        "structuredCondition": "frequency.duration(P1D)",
                        "appliesToActivityIds": [
                          "e05ce530-0a14-4784-8a18-fc6fef670978"
                        ],
                        "sourceText": "w. For each input/output balance period, 24-hour urine samples are to be collected for measurement o"
                      },
                      {
                        "id": "2638f6fc-162f-4f45-8da1-6a3d45f960a5",
                        "conditionType": "general",
                        "text": "x. For fecal samples, each individual sample will be independently collected with record of date, time, and weight of the sample.",
                        "footnoteId": "f0adc8c9-8a6f-4fd7-a7d9-79f273cd443c",
                        "sourceText": "x. For fecal samples, each individual sample will be independently collected with record of date, ti"
                      },
                      {
                        "id": "940c22e9-3a80-4fd5-9024-80841f41e24a",
                        "conditionType": "frequency_continuous",
                        "text": "1. Participants eligible for the study will be enrolled on Day -7 and initiated on a copper- and molybdenum- controlled diet, which will be continued during Treatment Period 1 and Treatment Period 2 when in the CRU, through Day 39.",
                        "footnoteId": "9815d01f-751c-4128-9fd8-0b290cb0e938",
                        "sourceText": "1. Participants eligible for the study will be enrolled on Day -7 and initiated on a copper- and mol"
                      },
                      {
                        "id": "c008e31b-487a-4c82-bc5c-bd62da7bb61c",
                        "conditionType": "timing_at",
                        "text": "2. Participants will be admitted to the CRU for Treatment Period 1 on Day -8 and may be discharged on Day 9 or remain in the CRU for their own safety or to maintain the integrity of the conduct of the study. Participants who are discharged will be re-admitted on Day 22 or Day 23 for Treatment Period 2 and will remain in house until Day 40. To ensure flexibility, the Outpatient Period may be extended up to an additional 14 days with Investigator approval. In this situation, participants will be given additional investigational product to support daily dosing throughout the Outpatient Period. In such cases, the actual Outpatient Period duration will be recorded and the participant will continue Inpatient Period 2 at Day 23.",
                        "footnoteId": "9393646f-7bf9-4c3f-8f91-69127c350b94",
                        "structuredCondition": "extension.allowed(P14D).if(investigator_approval)",
                        "appliesToActivityIds": [
                          "Outpatient Period"
                        ],
                        "sourceText": "2. Participants will be admitted to the CRU for Treatment Period 1 on Day -8 and may be discharged o"
                      },
                      {
                        "id": "07e06f22-5837-43c7-8051-fe5270fe3555",
                        "conditionType": "timing_at",
                        "text": "3. Participants will be administered ALXN1840 at a dose of 15 mg/day on Day 1 through Day 28 and then increase to 30 mg/day on Day 29 through Day 39. During the Outpatient Period, participants will use SMS text messaging to confirm study intervention administration.",
                        "footnoteId": "a851207c-d9de-4661-9d6a-f5d6357b31a2",
                        "sourceText": "3. Participants will be administered ALXN1840 at a dose of 15 mg/day on Day 1 through Day 28 and the"
                      },
                      {
                        "id": "536402e5-ee38-4168-920d-4eb04724c148",
                        "conditionType": "general",
                        "text": "4. Participants will have 3 intake and output collection periods including:  Baseline Day -4 through Day -1  Day 1 through Day 8 (I/O for 15 mg)  Day 25 through Day 39 (Days 25 through 28, I/O for 15 mg; Days 29 through 39, I/O for 30 mg)",
                        "footnoteId": "aaea1e8b-86db-415b-b0b9-a7de8884b8b3",
                        "sourceText": "4. Participants will have 3 intake and output collection periods including:  Baseline Day -4 throug"
                      },
                      {
                        "id": "d25f91af-eabd-4320-b2c0-3d7f43514df7",
                        "conditionType": "general",
                        "text": "5. During these periods all intake (including food and drink) and output (including urine and feces) will be collected and assessed for copper and molybdenum.",
                        "footnoteId": "63749941-f258-4750-955d-cc97cb18aaa5",
                        "sourceText": "5. During these periods all intake (including food and drink) and output (including urine and feces)"
                      },
                      {
                        "id": "ffa21a6a-bb73-4af2-8191-2b8cc60678e7",
                        "conditionType": "general",
                        "text": "6. Blood sampling for PK/PD will be as follows:  PK/PD collection (24-hour): Days 1, 25, 29, and 39  Predose PK/PD sampling days: Days 4 - 7, Days 26 - 28, Days 30 - 38  End of Study Visit Day 54 +/- 2 days Abbreviations: AP = accumulation period; CRU = clinical research unit; EOS = End of Study; I/O = input/output; PD = pharmacodynamic; PK = pharmacokinetic; SS = steady state.",
                        "footnoteId": "2da2f3f0-3dfd-41b3-aaea-2b69af62a5d5",
                        "sourceText": "6. Blood sampling for PK/PD will be as follows:  PK/PD collection (24-hour): Days 1, 25, 29, and 39"
                      }
                    ],
                    "endpointAlgorithms": [
                      {
                        "id": "86538238-4f49-4eb3-b09d-82a4ef9384d7",
                        "name": "Primary: Net Negative Copper Balance",
                        "endpointType": "Primary",
                        "inputs": [
                          "copper intake (food and drink)",
                          "copper output (feces)",
                          "copper output (urine)"
                        ],
                        "timeWindow": {
                          "reference": "Baseline to post-Baseline visits",
                          "duration": "Duration of daily repeat-dose ALXN1840 treatment"
                        },
                        "algorithm": "Net Copper Balance = (Copper Intake) - (Copper Output in Feces + Copper Output in Urine)",
                        "successCriteria": "Net Copper Balance < 0 (Net Negative)",
                        "sourceText": "The primary objective of this study is to demonstrate a net negative copper balance with daily repeat-dose ALXN1840 treatment (15 mg and 30 mg) in participants with WD."
                      }
                    ],
                    "derivedVariables": [
                      {
                        "id": "436c51fb-a275-4d40-88f4-384395b9cd51",
                        "name": "Mean daily copper balance",
                        "variableType": "Custom",
                        "sourceVariables": [
                          "Copper intake in food",
                          "Copper intake in drink",
                          "Copper output in feces",
                          "Copper output in urine"
                        ],
                        "derivationRule": "(Copper intake in food + Copper intake in drink) - (Copper output in feces + Copper output in urine)",
                        "baselineDefinition": "Days -4 through -1",
                        "baselineVisit": "Pretreatment",
                        "analysisWindow": "Accumulation and steady-state periods",
                        "imputationRule": "Not specified",
                        "unit": "mg/day"
                      },
                      {
                        "id": "922622e3-6df3-4c77-9264-dc79ca0ab173",
                        "name": "Change in mean daily copper balance",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "Mean daily copper balance"
                        ],
                        "derivationRule": "Post-baseline mean daily copper balance - Pretreatment baseline mean daily copper balance",
                        "baselineDefinition": "Mean daily copper balance calculated from Days -4 through -1",
                        "baselineVisit": "Pretreatment",
                        "analysisWindow": "Accumulation and steady-state periods for each dose",
                        "imputationRule": "Not specified",
                        "unit": "mg/day"
                      },
                      {
                        "id": "a9d1fc75-93e2-4447-8f13-76cab92cd87d",
                        "name": "Mean daily molybdenum balance",
                        "variableType": "Custom",
                        "sourceVariables": [
                          "Molybdenum intake in food",
                          "Molybdenum intake in drink",
                          "Molybdenum intake in ALXN1840",
                          "Molybdenum output in feces",
                          "Molybdenum output in urine"
                        ],
                        "derivationRule": "(Molybdenum intake in food + drink + ALXN1840) - (Molybdenum output in feces + urine)",
                        "baselineDefinition": "Not applicable",
                        "baselineVisit": "null",
                        "analysisWindow": "ALXN1840 steady state",
                        "imputationRule": "Not specified",
                        "unit": "mg/day"
                      },
                      {
                        "id": "7416c5bf-e3dd-4b86-bded-97702d4a2c3e",
                        "name": "NCCcorrected",
                        "variableType": "Custom",
                        "sourceVariables": [
                          "Plasma non-ceruloplasmin-bound copper (NCC)",
                          "Tetrathiomolybdate-copper-albumin tripartite complex (TPC)"
                        ],
                        "derivationRule": "NCC corrected for the stable TPC",
                        "baselineDefinition": "Not specified",
                        "baselineVisit": "null",
                        "analysisWindow": "Not specified",
                        "imputationRule": "Not specified",
                        "unit": "Not specified"
                      },
                      {
                        "id": "b4d41d5f-bd99-4352-a20d-216a2e70be43",
                        "name": "Change in ceruloplasmin",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "Ceruloplasmin"
                        ],
                        "derivationRule": "Post-baseline value - Predose value",
                        "baselineDefinition": "Predose value",
                        "baselineVisit": "Day 1 (Predose)",
                        "analysisWindow": "Days 1, 8, 25, 29, 36, and 39",
                        "imputationRule": "Not specified",
                        "unit": "Not specified"
                      }
                    ],
                    "stateMachine": {
                      "id": "dff24aa8-0e00-4521-99a7-f0454611416d",
                      "initialState": "Screening",
                      "terminalStates": [
                        "Early Termination",
                        "Completed"
                      ],
                      "states": [
                        "Screening",
                        "C-I",
                        "Inpatient Period 1",
                        "OP",
                        "Inpatient Period 2",
                        "UNS",
                        "EOS or ET",
                        "Early Termination"
                      ],
                      "transitions": [
                        {
                          "fromState": "Screening",
                          "toState": "C-I",
                          "trigger": "Progress to C-I"
                        },
                        {
                          "fromState": "C-I",
                          "toState": "Inpatient Period 1",
                          "trigger": "Progress to Inpatient Period 1"
                        },
                        {
                          "fromState": "Inpatient Period 1",
                          "toState": "OP",
                          "trigger": "Progress to OP"
                        },
                        {
                          "fromState": "OP",
                          "toState": "Inpatient Period 2",
                          "trigger": "Progress to Inpatient Period 2"
                        },
                        {
                          "fromState": "Inpatient Period 2",
                          "toState": "UNS",
                          "trigger": "Progress to UNS"
                        },
                        {
                          "fromState": "UNS",
                          "toState": "EOS or ET",
                          "trigger": "Progress to EOS or ET"
                        },
                        {
                          "fromState": "Inpatient Period 1",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        },
                        {
                          "fromState": "Inpatient Period 2",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        }
                      ],
                      "epochIds": {
                        "Screening": "epoch_1",
                        "C_I": "epoch_2",
                        "Inpatient_Period_1": "epoch_3",
                        "OP": "epoch_4",
                        "Inpatient_Period_2": "epoch_5",
                        "UNS": "epoch_6",
                        "EOS_or_ET": "epoch_7",
                        "Early_Termination": "EARLY_TERMINATION"
                      }
                    },
                    "dosingRegimens": [
                      {
                        "id": "9bdb455b-deda-409a-9189-52770b9e9f72",
                        "treatmentName": "ALXN1840",
                        "frequency": "QD",
                        "route": "Oral",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 30.0,
                            "unit": "mg"
                          },
                          {
                            "amount": 15.0,
                            "unit": "mg"
                          }
                        ],
                        "doseModifications": [
                          "Dose modification details are located in Section 6.6"
                        ],
                        "sourceText": "Administration of Study Interventionm ALXN1840 15 mg/day           ALXN1840 30 mg/day      Study intervention compliance Xn  PK/PD Analyseso"
                      },
                      {
                        "id": "f4241bf4-ddcb-47a2-b03b-a0e5eb57998c",
                        "treatmentName": "Zinc",
                        "frequency": "TID",
                        "route": "Oral",
                        "startDay": 1,
                        "doseModifications": [
                          "Discontinued at least 21 days prior to certain assessments as per Section 4.2"
                        ]
                      }
                    ],
                    "visitWindows": [
                      {
                        "id": "cea4281e-6a7d-4b3b-a06d-114c67da23ae",
                        "visitName": "screening",
                        "targetDay": -14,
                        "windowBefore": 7,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 1,
                        "epoch": "Screening",
                        "sourceText": "treatment-nave participants are eligible for this study. Following screening and enrollment, participants will have a Run-in Period to support diet equilibration (Day -7 through Day -5) and measureme"
                      },
                      {
                        "id": "a8c5cc2b-735e-4455-b21d-29b78beaffe9",
                        "visitName": "Enrollment / Diet Initiation",
                        "targetDay": -7,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 2,
                        "epoch": "Run-in Period"
                      },
                      {
                        "id": "004ae2a7-4f75-478d-a0f5-fc542d1406c2",
                        "visitName": "Pretreatment Baseline Collection",
                        "targetDay": -4,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 3,
                        "epoch": "Run-in Period"
                      },
                      {
                        "id": "03902cc3-4b59-46fc-852a-844360cd2d27",
                        "visitName": "Early Termination",
                        "targetDay": null,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 4,
                        "sourceText": "Assess net copper balance with daily repeat-dose ALXN1840 treatment (15 mg and 30 mg) in participants with Wilson disease (WD)"
                      },
                      {
                        "id": "d5b43f59-9664-405a-bc3c-142f9957a40a",
                        "visitName": "baseline",
                        "targetDay": 0,
                        "windowBefore": 1,
                        "windowAfter": 1,
                        "isRequired": true,
                        "visitNumber": 5,
                        "sourceText": "periods versus the pretreatment baseline in participants with WD Change in mean daily copper balance as measured by the"
                      },
                      {
                        "id": "655e4332-24c7-410f-9615-294e67794fb5",
                        "visitName": "End of Study",
                        "targetDay": null,
                        "windowBefore": 2,
                        "windowAfter": 2,
                        "isRequired": true,
                        "visitNumber": 6,
                        "sourceText": "End of Study Visit Day 54 +/- 2 days Abbreviations: AP = accumulation period; CRU = clinical research unit; EOS = End of Study; I/O = input/output; PD = pharmacodynamic; PK = pharmacokinetic; SS = ste"
                      },
                      {
                        "id": "4422bebc-d33c-496f-b987-1b41b3d80380",
                        "visitName": "Day 1",
                        "targetDay": 1,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 7,
                        "epoch": "Treatment Period 1",
                        "sourceText": "Note: The accumulation period refers to time from initiation of ALXN1840 (Day 1) to expected steady state at Day 10, based on 5 times the half-life of 2 days. Overall Design"
                      },
                      {
                        "id": "1d983a91-9e22-4a6a-bcd8-0d2e5041d3c8",
                        "visitName": "Day 7",
                        "targetDay": 7,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 8,
                        "sourceText": "Day 7, indicating the possibility of tissue accumulation, particularly in the setting of high liver copper concentration (Plitz, 2019). If the half-life of ALXN1840 in liver were longer than that of t"
                      },
                      {
                        "id": "2df38835-a375-407d-8aeb-0e053af087c6",
                        "visitName": "Day 8",
                        "targetDay": 8,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 5,
                        "targetWeek": 2,
                        "epoch": "Treatment Period 1"
                      },
                      {
                        "id": "2d40f300-ca4a-42be-8d89-d065580933cc",
                        "visitName": "Day 9",
                        "targetDay": 9,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 10,
                        "epoch": "Treatment Period 1",
                        "sourceText": "Participants may be discharged from the clinical research unit (CRU) on Day 9 to return on Day 22 or Day 23 (predose); all procedures will start on Day 23. To ensure flexibility, the Outpatient Period"
                      },
                      {
                        "id": "264448cd-1e8c-46e0-98cd-cac0e6313342",
                        "visitName": "Day 14",
                        "targetDay": 14,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 11,
                        "sourceText": "g A single outpatient visit or phone call and safety laboratory assessment should occur between Day 14 and Day 18. A phone call may take place on a different day than the blood draw within the Day 14 "
                      },
                      {
                        "id": "3a025cb5-b154-40a9-95d3-131a691c6f1f",
                        "visitName": "Day 22",
                        "targetDay": 22,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 12,
                        "sourceText": "who are discharged will be re-admitted on Day 22 or Day 23 for Treatment Period 2 and will remain in house until Day 40. To ensure flexibility, the Outpatient Period may be extended up to an additiona"
                      },
                      {
                        "id": "b2a6d454-8826-4dfe-a756-887eec252eb2",
                        "visitName": "Day 23",
                        "targetDay": 23,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 13,
                        "epoch": "Treatment Period 1",
                        "sourceText": "data through Day 23 for each participant. Participants will have intake and output collection periods from Day -4 through Day -1, from Day 1 through Day 8 (initial 15 mg/day collection period), and Da"
                      },
                      {
                        "id": "be2d25bb-6839-4a13-aedd-1b21deccd6fd",
                        "visitName": "Day 25",
                        "targetDay": 25,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 14,
                        "epoch": "Treatment Period 1",
                        "sourceText": "Day 25 through Day 39 (Days 25 through 28, I/O for 15 mg; Days 29 through 39, I/O for 30 mg) 5. During these periods all intake (including food and drink) and output (including urine and feces) will b"
                      },
                      {
                        "id": "a89b6de9-571c-42f8-bbfc-688b456fb338",
                        "visitName": "Day 29",
                        "targetDay": 29,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 15,
                        "epoch": "Treatment Period 2",
                        "sourceText": "treatment period of approximately 28 days followed by titration up to 30 mg/day on Day 29. Before titration to 30 mg/day, the Safety Review Committee (SRC) will review available safety data through Da"
                      },
                      {
                        "id": "27835a5b-498a-45c1-ad7a-79cf17376040",
                        "visitName": "Day 36",
                        "targetDay": 36,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 16,
                        "epoch": "Treatment Period 2",
                        "sourceText": "Day 36 through Day 39 for the 30 mg/day dose: if steady state is achieved, molybdenum(out) will equal molybdenum(in). 2.2."
                      },
                      {
                        "id": "412a0377-84d1-443e-8101-20a97142b2c3",
                        "visitName": "Day 39",
                        "targetDay": 39,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 17,
                        "epoch": "Treatment Period 2",
                        "sourceText": "through Day 39. 2. Participants will be admitted to the CRU for Treatment Period 1 on Day -8 and may be discharged on Day 9 or remain in the CRU for their own safety or to maintain the integrity of th"
                      },
                      {
                        "id": "b2140a89-9222-4577-a829-42a1d7b35c3e",
                        "visitName": "Day 40",
                        "targetDay": 40,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 18,
                        "sourceText": "until Day 40. To ensure flexibility, the Outpatient Period may be extended up to an additional 14 days with Investigator approval. In this situation, participants will be given additional investigatio"
                      },
                      {
                        "id": "954065da-cf6c-4448-aa0d-5320afdb157a",
                        "visitName": "Day 54",
                        "targetDay": 54,
                        "windowBefore": 2,
                        "windowAfter": 2,
                        "isRequired": true,
                        "visitNumber": 19,
                        "sourceText": "End of Study Visit Day 54 +/- 2 days Abbreviations: AP = accumulation period; CRU = clinical research unit; EOS = End of Study; I/O = input/output; PD = pharmacodynamic; PK = pharmacokinetic; SS = ste"
                      },
                      {
                        "id": "8f4c0400-4116-450e-98a3-f25126223034",
                        "visitName": "Week 24",
                        "targetDay": 162,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 20,
                        "targetWeek": 24,
                        "sourceText": "for 9 participants at Week 24 when the primary endpoint assessment was conducted, or at the last dose received for participants with early discontinuation. The 15 to 60 mg/day dose range has been demo"
                      },
                      {
                        "id": "9017e3ee-183f-4b75-b2ee-20748c2800c4",
                        "visitName": "Follow-up",
                        "targetDay": 365,
                        "windowBefore": 7,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 21,
                        "sourceText": "Day 54 follow-up. f Discharge from the unit may occur after completion of all procedures on Day 9 and on Day 40 and after the Investigator has reviewed all safety assessment (including safety laborato"
                      }
                    ],
                    "activityBindings": [
                      {
                        "id": "ea0d092b-ec86-4215-bdc6-a0728c36a84c",
                        "activityId": "2ca9c619-8869-49d2-928f-e01c454198c8",
                        "activityName": "controlled diet",
                        "repetitionId": "d79eb9fc-8790-4c30-af83-d7d8832e81a0",
                        "expectedOccurrences": 18,
                        "sourceText": "Daily controlled_meal from Day -8 to Day 9"
                      },
                      {
                        "id": "3685ff5c-739b-412c-9931-4b72837160ec",
                        "activityId": "2ca9c619-8869-49d2-928f-e01c454198c8",
                        "activityName": "controlled diet",
                        "repetitionId": "0ccb25d0-1b47-4319-ae4c-7a444ef208ef",
                        "expectedOccurrences": 18,
                        "sourceText": "Daily controlled_meal from Day -8 to Day 9"
                      },
                      {
                        "id": "a84730cd-620f-4041-84e4-d94db5f00a78",
                        "activityId": "2ca9c619-8869-49d2-928f-e01c454198c8",
                        "activityName": "controlled diet",
                        "repetitionId": "f14a5cab-2c6d-4360-91b4-188726aa36a1",
                        "expectedOccurrences": 18,
                        "sourceText": "Daily controlled_meal from Day 23 to Day 40"
                      },
                      {
                        "id": "8b4bf7cc-7ce1-4fef-a45b-54b3ee198f8e",
                        "activityId": "2ca9c619-8869-49d2-928f-e01c454198c8",
                        "activityName": "controlled diet",
                        "repetitionId": "d365f7b5-b8e4-4a82-8abd-a65458a2194e",
                        "expectedOccurrences": 18,
                        "sourceText": "Daily controlled_meal from Day 23 to Day 40"
                      },
                      {
                        "id": "b49c67b3-48db-4ac3-b0d3-daf22dc78554",
                        "activityId": "2ca9c619-8869-49d2-928f-e01c454198c8",
                        "activityName": "controlled diet",
                        "repetitionId": "dea2e812-6b13-47b3-8adf-55f3aa6d6353",
                        "expectedOccurrences": 3,
                        "sourceText": "Daily controlled_meal from Day -7 to Day -5"
                      },
                      {
                        "id": "82e33b3d-67bb-43d6-a9c2-e5c3213f84ee",
                        "activityId": "2ca9c619-8869-49d2-928f-e01c454198c8",
                        "activityName": "controlled diet",
                        "repetitionId": "5a84fd6b-f695-4727-b9bf-029963f2e812",
                        "expectedOccurrences": 4,
                        "sourceText": "Daily controlled_meal from Day -4 to Day -1"
                      },
                      {
                        "id": "5fe60093-9139-49ae-a38a-7fbec892f448",
                        "activityId": "2ca9c619-8869-49d2-928f-e01c454198c8",
                        "activityName": "controlled diet",
                        "repetitionId": "63e9864e-4bea-48a7-8c28-2d23a26c1d8d",
                        "expectedOccurrences": 18,
                        "sourceText": "Daily controlled_meal from Day -8 to Day 9"
                      },
                      {
                        "id": "bc68a253-7695-4e96-a12a-71bdf75742d8",
                        "activityId": "2ca9c619-8869-49d2-928f-e01c454198c8",
                        "activityName": "controlled diet",
                        "repetitionId": "aa8a89a9-ea69-44da-a6fa-304197d683c9",
                        "expectedOccurrences": 18,
                        "sourceText": "Daily controlled_meal from Day 23 to Day 40"
                      },
                      {
                        "id": "a0f553c0-5c52-4a63-90a8-492d808b7f6c",
                        "activityId": "2ca9c619-8869-49d2-928f-e01c454198c8",
                        "activityName": "controlled diet",
                        "repetitionId": "3a33db6c-ce19-463e-9fb7-929009e1e676",
                        "expectedOccurrences": 18,
                        "sourceText": "Daily controlled_meal from Day -8 to Day 9"
                      },
                      {
                        "id": "5a82bc3b-6491-4500-9b5d-f2bbeb0ea808",
                        "activityId": "2ca9c619-8869-49d2-928f-e01c454198c8",
                        "activityName": "controlled diet",
                        "repetitionId": "de949150-c43f-4e52-8e4b-f196a3376b7d",
                        "expectedOccurrences": 18,
                        "sourceText": "Daily controlled_meal from Day 23 to Day 40"
                      },
                      {
                        "id": "ec8dbca6-bdd3-4e02-b1e4-965614fef9a3",
                        "activityId": "2ca9c619-8869-49d2-928f-e01c454198c8",
                        "activityName": "controlled diet",
                        "repetitionId": "828ba9ec-73d5-4c61-b99a-a036dc58c668",
                        "expectedOccurrences": 13,
                        "sourceText": "Daily controlled_meal from Day 3 to Day 15"
                      },
                      {
                        "id": "8403c02d-6c72-4d75-9b65-06209afca12d",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "copper balance",
                        "repetitionId": "a3c9dacf-fc56-4902-800d-8ff5becccfa2",
                        "expectedOccurrences": 101,
                        "sourceText": "Daily balance_collection from Day 101 to Day 201"
                      },
                      {
                        "id": "5aa6d7da-ba3d-4469-a54a-cb03ab1677b7",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "copper balance",
                        "repetitionId": "0e0cd7d8-6f9e-4316-8e6c-5b4200cca22e",
                        "expectedOccurrences": 4,
                        "sourceText": "Daily balance_collection from Day -4 to Day -1"
                      },
                      {
                        "id": "32005cee-be3f-4d80-b15e-f406b359b51d",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "c98dd808-a12e-4754-a880-953f08591e87",
                        "expectedOccurrences": 3,
                        "sourceText": "Daily balance_collection from Day -7 to Day -5"
                      },
                      {
                        "id": "26513f5d-f9e5-4ed3-b53c-38e0a33844d1",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "9a6e4520-9857-4e49-ad44-84dc9e745da8",
                        "expectedOccurrences": 4,
                        "sourceText": "Daily balance_collection from Day -4 to Day -1"
                      },
                      {
                        "id": "eb465bde-222b-4b09-9025-3a4ca55de3bc",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "d67c95db-4620-4413-9c34-3cde4c60a0b3",
                        "expectedOccurrences": 4,
                        "sourceText": "Daily balance_collection from Day -4 to Day -1"
                      },
                      {
                        "id": "3a94d88e-5577-4c12-878a-744ef436b7a2",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "89d07524-1e6a-4ef6-95ad-36f94dec1463",
                        "expectedOccurrences": 8,
                        "sourceText": "Daily balance_collection from Day 1 to Day 8"
                      },
                      {
                        "id": "60961045-4064-4d5f-a07d-9148a518a77e",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "5453bc5a-b7b5-4aa3-b432-360e0c6a9523",
                        "expectedOccurrences": 15,
                        "sourceText": "Daily balance_collection from Day 25 to Day 39"
                      },
                      {
                        "id": "50b40865-5e62-4b4c-a9cc-44abd4f6d092",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "copper balance",
                        "repetitionId": "2722fb71-6ed4-4c25-9ff1-8a59162bc3a8",
                        "expectedOccurrences": 101,
                        "sourceText": "Daily balance_collection from Day 101 to Day 201"
                      },
                      {
                        "id": "029bc3b1-bcc6-4ecd-8bf0-a461f93c06e0",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "copper balance",
                        "repetitionId": "70f29675-b8de-40df-b5b1-5f3c69cfd09f",
                        "expectedOccurrences": 101,
                        "sourceText": "Daily balance_collection from Day 101 to Day 201"
                      },
                      {
                        "id": "a969502f-b975-43ae-91a5-4c2a929cf529",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "copper balance",
                        "repetitionId": "464ba990-5a8a-4d05-9028-8a516b23ff98",
                        "expectedOccurrences": 4,
                        "sourceText": "Daily balance_collection from Day -4 to Day -1"
                      },
                      {
                        "id": "49fe1837-c8e5-4c16-827e-89c83406a5a6",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "b51c9686-1832-47bd-b7a1-49eac3913cdd",
                        "expectedOccurrences": 3,
                        "sourceText": "Daily balance_collection from Day -7 to Day -5"
                      },
                      {
                        "id": "11803a96-6884-405f-8786-3d5f52749701",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "d9e0618c-6f08-423b-ba2d-c7ec4b9eed39",
                        "expectedOccurrences": 4,
                        "sourceText": "Daily balance_collection from Day -4 to Day -1"
                      },
                      {
                        "id": "96cf5d72-082d-4a08-9ab5-ee435429ff6c",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "f691e9e9-83d5-4e0b-a252-708ea0d8b6cf",
                        "expectedOccurrences": 18,
                        "sourceText": "Daily balance_collection from Day -8 to Day 9"
                      },
                      {
                        "id": "98b2b4fb-6c70-4d73-8288-0b34726f397c",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "e7cce900-3bbb-4e8d-9b80-00e23816f736",
                        "expectedOccurrences": 18,
                        "sourceText": "Daily balance_collection from Day 23 to Day 40"
                      },
                      {
                        "id": "e00c82be-c4ee-4fc3-a2de-82997db62c87",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "fd03a90b-9b29-4323-b5ec-3e06f6724b0c",
                        "expectedOccurrences": 4,
                        "sourceText": "Daily balance_collection from Day -4 to Day -1"
                      },
                      {
                        "id": "189288f9-a71f-4d05-a736-7decff5ee308",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "368b35fc-5e52-488e-8abc-6dfc4bb51339",
                        "expectedOccurrences": 8,
                        "sourceText": "Daily balance_collection from Day 1 to Day 8"
                      },
                      {
                        "id": "9f3fc172-2dc9-4b4a-86bd-68ec7498217a",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "c59e2693-5be4-4aba-9bf3-18b13e3a8432",
                        "expectedOccurrences": 15,
                        "sourceText": "Daily balance_collection from Day 25 to Day 39"
                      },
                      {
                        "id": "73c1cde0-ceb9-4730-967d-4631a5d5a7e1",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "copper balance",
                        "repetitionId": "362f8b89-50c5-4d2e-893d-144b703b0aad",
                        "expectedOccurrences": 13,
                        "sourceText": "Daily balance_collection from Day 3 to Day 15"
                      },
                      {
                        "id": "79af4c4e-2265-4f57-b985-0925d34068ad",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "468d64e7-e3eb-43a3-be41-7cc683ba8423",
                        "expectedOccurrences": 13,
                        "sourceText": "Daily balance_collection from Day 3 to Day 15"
                      },
                      {
                        "id": "40b4c016-e8e3-44ad-ae4d-ec508718fc5b",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "molybdenum balance",
                        "repetitionId": "892050c2-082b-45cc-8b72-9e899b6efb90",
                        "expectedOccurrences": 201,
                        "sourceText": "Daily balance_collection from Day 101 to Day 301"
                      },
                      {
                        "id": "7a7ff9dd-7bca-4c9b-af11-072d1c3d81f9",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "copper \nbalance",
                        "repetitionId": "2cdb60cd-bff7-48b2-8c83-a1dde56dd7e7",
                        "expectedOccurrences": 3,
                        "sourceText": "Daily balance_collection from Day 3 to Day 5"
                      },
                      {
                        "id": "cbdd7eb3-9a89-4265-96ec-3e6e018134e5",
                        "activityId": "ab55af48-3616-458c-a94e-79ce93c75d09",
                        "activityName": "copper balance",
                        "repetitionId": "58ab48f1-f118-4463-99ae-9d8c17b82b41",
                        "expectedOccurrences": 101,
                        "sourceText": "Daily balance_collection from Day 101 to Day 201"
                      }
                    ],
                    "analysisWindows": [
                      {
                        "id": "99143e92-348b-4103-a20a-a16488f0f065",
                        "windowType": "baseline",
                        "name": "Baseline Period",
                        "startDay": 4,
                        "endDay": -1,
                        "description": "Pre-treatment baseline from Day 4 to Day -1",
                        "sourceText": "Baseline Day -4 through Day -1"
                      }
                    ],
                    "titrationSchedules": [
                      {
                        "id": "67339792-b2fd-48a1-8ee4-5410f26a1428",
                        "titrationType": "escalation",
                        "doseLevels": [
                          {
                            "doseValue": "15 mg",
                            "startDay": 1,
                            "endDay": 28,
                            "sourceText": "15 mg/day for approximately 28 days, followed by titration to 30 mg"
                          },
                          {
                            "doseValue": "30 mg",
                            "startDay": 29,
                            "requiresPriorDose": "15 mg",
                            "transitionRule": "After 28 days on 15 mg",
                            "sourceText": "15 mg/day for approximately 28 days, followed by titration to 30 mg"
                          }
                        ],
                        "interventionName": "ALXN1840 Treatment",
                        "sourceText": "15 mg/day for approximately 28 days, followed by titration to 30 mg"
                      }
                    ]
                  }
                }
              },
              {
                "id": "74c235d4-d6f7-42ea-b600-69466147b2f3",
                "url": "https://protocol2usdm.io/extensions/x-soaFootnotes",
                "valueString": "[\"a. Within 42 days of ALXN1840 administration. Details of procedures that may be performed by sites designated as \\\"screening sites\\\" (only in the US) are detailed in Section 8.\", \"b. Participants will be admitted to the clinical research unit (CRU) at least 10 hours prior to enrollment and initiation of copper- and molybdenum-controlled diet.\", \"c. At the CRU's discretion, participants may remain in the CRU or be readmitted on Day 22 with all procedures starting on Day 23.\", \"d. Unscheduled study visits may occur at any time during the study and may include any study procedure as deemed necessary by the Investigator.\", \"e. Participants are required to return to the CRU Day 54+/-2; participants will be discontinued from ALXN1840 medication by their physician at the latest by the Day 54 follow-up.\", \"f. Discharge from the unit may occur after completion of all procedures on Day 9 and on Day 40 and after the Investigator has reviewed all safety assessment (including safety laboratory tests) and confirmed that the participant is appropriate for discharge.\", \"g. A single outpatient visit or phone call and safety laboratory assessment should occur between Day 14 and Day 18. A phone call may take place on a different day than the blood draw within the Day 14 through Day 18 period.\", \"h. If needed to confirm menopause.\", \"i. Parameters include age and sex. Race and ethnicity will be collected where permitted by local regulations.\", \"j. Wilson disease history will include diagnosis date, method of diagnosis, history of cirrhosis, details of any previous liver biopsies performed, and treatment received.\", \"k. A full physical examination will be performed at Screening, at check-in for the study, and at the End of the study/Early Termination Visit. A physical examination should also be performed on any participants with ongoing adverse events prior to discharge from the unit. Otherwise, a symptom-driven physical examination may be performed at other times, at the Principal Investigator's discretion.\", \"l. Height at screening only.\", \"m. While in the CRU, study intervention will be administered after an overnight fast (ie, at least 10 hours) at the same time every morning; drug is to be administered with 240 mL of water and meals should be delayed a minimum of 2 hours after dosing. As an outpatient, participants are expected to take ALXN1840 at approximately the same time daily (+/-1 hour). Participants should take the medication with a glass of water on an empty stomach; meals should be delayed a minimum of 2 hours after dosing.\", \"n. During the outpatient period, participants will use SMS text messaging to confirm study intervention administration.\", \"o. Blood sampling for PK/PD will occur before ALXN1840 administration and represents a predose trough. See Table 2 for PK/PD sampling on Days 1, 25, 29, and 39.\", \"p. PK/PD collection will include timepoints described in the schedule of PK/PD assessment for Days 1, 25, 29, and 39 (Table 2).\", \"q. Samples for serum chemistry will be obtained following a fast of at least 8 hours at the Screening Visit and at check-in. In case of rechecks, and postdose serum chemistry, participants may not have fasted for 6 or 8 hours before the serum chemistry sample is taken.\", \"r. Laboratory assessment including chemistry, hematology, and coagulation parameters should be performed on Days -8, -1, 8, 23, and 28 only.\", \"s. Menstruation check is for women only; women of childbearing potential should only be enrolled after a negative serum pregnancy test result at Screening. Additional urine pregnancy testing will be standard for the protocol unless serum testing is required by site policies, local regulation, or Institutional Review Boards (IRBs)/Independent Ethics Committees (IECs) (Section 10.2). In addition to pregnancy tests detailed at the visits in the SoA, females of childbearing potential will be required to perform urine pregnancy tests at least every 4 weeks at their home or the study site throughout their time in the study.\", \"t. A single 15 mL serum sample will be retained for evaluation in the event of an unexpected safety finding; retained samples may be destroyed after completion of the clinical report.\", \"u. Vital signs measurements and ECGs should be performed predose, unless otherwise specified. Vitals signs include body temperature, heart rate, respiratory rate, and systolic and diastolic blood pressure.\", \"v. Copper- and molybdenum-controlled diet will be initiated after registration/inclusion. Participants will remain on a copper/molybdenum controlled diet throughout both the inpatient Period 1 (Day -8 to Day 9) and inpatient Period 2 (Day 23 to Day 40); during this time participants will be strongly encouraged to complete all meals. While not in the CRU, participants will be encouraged to adhere to their usual copper-controlled diet.\", \"w. For each input/output balance period, 24-hour urine samples are to be collected for measurement of copper and molybdenum.\", \"x. For fecal samples, each individual sample will be independently collected with record of date, time, and weight of the sample.\", \"1. Participants eligible for the study will be enrolled on Day -7 and initiated on a copper- and molybdenum- controlled diet, which will be continued during Treatment Period 1 and Treatment Period 2 when in the CRU, through Day 39.\", \"2. Participants will be admitted to the CRU for Treatment Period 1 on Day -8 and may be discharged on Day 9 or remain in the CRU for their own safety or to maintain the integrity of the conduct of the study. Participants who are discharged will be re-admitted on Day 22 or Day 23 for Treatment Period 2 and will remain in house until Day 40. To ensure flexibility, the Outpatient Period may be extended up to an additional 14 days with Investigator approval. In this situation, participants will be given additional investigational product to support daily dosing throughout the Outpatient Period. In such cases, the actual Outpatient Period duration will be recorded and the participant will continue Inpatient Period 2 at Day 23.\", \"3. Participants will be administered ALXN1840 at a dose of 15 mg/day on Day 1 through Day 28 and then increase to 30 mg/day on Day 29 through Day 39. During the Outpatient Period, participants will use SMS text messaging to confirm study intervention administration.\", \"4. Participants will have 3 intake and output collection periods including: \\u2022 Baseline Day -4 through Day -1 \\u2022 Day 1 through Day 8 (I/O for 15 mg) \\u2022 Day 25 through Day 39 (Days 25 through 28, I/O for 15 mg; Days 29 through 39, I/O for 30 mg)\", \"5. During these periods all intake (including food and drink) and output (including urine and feces) will be collected and assessed for copper and molybdenum.\", \"6. Blood sampling for PK/PD will be as follows: \\u2022 PK/PD collection (24-hour): Days 1, 25, 29, and 39 \\u2022 Predose PK/PD sampling days: Days 4 - 7, Days 26 - 28, Days 30 - 38 \\u2022 End of Study Visit Day 54 +/- 2 days Abbreviations: AP = accumulation period; CRU = clinical research unit; EOS = End of Study; I/O = input/output; PD = pharmacodynamic; PK = pharmacokinetic; SS = steady state.\"]",
                "instanceType": "ExtensionAttribute"
              }
            ],
            "conditions": [
              {
                "id": "e3b53f3c-ef30-4bb5-9c41-7202440e9875",
                "name": "General",
                "text": "a. Within 42 days of ALXN1840 administration. Details of procedures that may be performed by sites designated as \"screening sites\" (only in the US) are detailed in Section 8.",
                "instanceType": "Condition"
              },
              {
                "id": "779429bc-60a7-49fb-891d-8c493b1a43a2",
                "name": "Timing Before",
                "text": "b. Participants will be admitted to the clinical research unit (CRU) at least 10 hours prior to enrollment and initiation of copper- and molybdenum-controlled diet.",
                "instanceType": "Condition"
              },
              {
                "id": "78c14966-1f05-4ace-8b7f-64fc55d0050f",
                "name": "Timing At",
                "text": "c. At the CRU's discretion, participants may remain in the CRU or be readmitted on Day 22 with all procedures starting on Day 23.",
                "instanceType": "Condition"
              },
              {
                "id": "d0a03760-c2c9-4c2f-99c7-377418270883",
                "name": "General",
                "text": "d. Unscheduled study visits may occur at any time during the study and may include any study procedure as deemed necessary by the Investigator.",
                "instanceType": "Condition"
              },
              {
                "id": "25a44192-09a4-44f5-9fac-8accc48a0128",
                "name": "General",
                "text": "e. Participants are required to return to the CRU Day 54+/-2; participants will be discontinued from ALXN1840 medication by their physician at the latest by the Day 54 follow-up.",
                "instanceType": "Condition"
              },
              {
                "id": "2c12f051-9608-4858-8292-8e53cae46f18",
                "name": "Timing After",
                "text": "f. Discharge from the unit may occur after completion of all procedures on Day 9 and on Day 40 and after the Investigator has reviewed all safety assessment (including safety laboratory tests) and confirmed that the participant is appropriate for discharge.",
                "instanceType": "Condition"
              },
              {
                "id": "b7b42a31-ea68-4d85-ad97-53e0b4963e7f",
                "name": "General",
                "text": "g. A single outpatient visit or phone call and safety laboratory assessment should occur between Day 14 and Day 18. A phone call may take place on a different day than the blood draw within the Day 14 through Day 18 period.",
                "instanceType": "Condition"
              },
              {
                "id": "1f0c26cb-1b99-414a-9929-cd237e139149",
                "name": "General",
                "text": "h. If needed to confirm menopause.",
                "instanceType": "Condition"
              },
              {
                "id": "d284d9f9-d39e-43f8-8b10-1a7e8fb1234f",
                "name": "General",
                "text": "i. Parameters include age and sex. Race and ethnicity will be collected where permitted by local regulations.",
                "instanceType": "Condition"
              },
              {
                "id": "8110a13d-0f11-4cae-8987-8ac79ca21992",
                "name": "General",
                "text": "j. Wilson disease history will include diagnosis date, method of diagnosis, history of cirrhosis, details of any previous liver biopsies performed, and treatment received.",
                "instanceType": "Condition"
              },
              {
                "id": "3ae21f3e-e68f-4f28-b13d-c4a3214843ec",
                "name": "Timing Before",
                "text": "k. A full physical examination will be performed at Screening, at check-in for the study, and at the End of the study/Early Termination Visit. A physical examination should also be performed on any participants with ongoing adverse events prior to discharge from the unit. Otherwise, a symptom-driven physical examination may be performed at other times, at the Principal Investigator's discretion.",
                "instanceType": "Condition",
                "appliesToIds": [
                  "0f414ebf-d42c-40ad-8b57-0ba36b1a7e23"
                ]
              },
              {
                "id": "44c9a1c1-ee78-4d9f-a85f-049e1ac5bee1",
                "name": "General",
                "text": "l. Height at screening only.",
                "instanceType": "Condition"
              },
              {
                "id": "4683290c-ed74-4c94-87a6-285603e1590e",
                "name": "Timing After",
                "text": "m. While in the CRU, study intervention will be administered after an overnight fast (ie, at least 10 hours) at the same time every morning; drug is to be administered with 240 mL of water and meals should be delayed a minimum of 2 hours after dosing. As an outpatient, participants are expected to take ALXN1840 at approximately the same time daily (+/-1 hour). Participants should take the medication with a glass of water on an empty stomach; meals should be delayed a minimum of 2 hours after dosing.",
                "instanceType": "Condition"
              },
              {
                "id": "96ed998b-c240-47dc-bfcd-2ac56e287ac9",
                "name": "General",
                "text": "n. During the outpatient period, participants will use SMS text messaging to confirm study intervention administration.",
                "instanceType": "Condition"
              },
              {
                "id": "c8d5be24-ca81-4132-bb61-e6c8cb7360f2",
                "name": "Timing Before",
                "text": "o. Blood sampling for PK/PD will occur before ALXN1840 administration and represents a predose trough. See Table 2 for PK/PD sampling on Days 1, 25, 29, and 39.",
                "instanceType": "Condition"
              },
              {
                "id": "76a8da47-14b4-451a-bbe2-35425b92e76c",
                "name": "General",
                "text": "p. PK/PD collection will include timepoints described in the schedule of PK/PD assessment for Days 1, 25, 29, and 39 (Table 2).",
                "instanceType": "Condition"
              },
              {
                "id": "dd571303-3724-4143-8d8a-065763efea20",
                "name": "Timing Before",
                "text": "q. Samples for serum chemistry will be obtained following a fast of at least 8 hours at the Screening Visit and at check-in. In case of rechecks, and postdose serum chemistry, participants may not have fasted for 6 or 8 hours before the serum chemistry sample is taken.",
                "instanceType": "Condition"
              },
              {
                "id": "e5b0793a-b07e-478e-8e49-f90441344af5",
                "name": "General",
                "text": "r. Laboratory assessment including chemistry, hematology, and coagulation parameters should be performed on Days -8, -1, 8, 23, and 28 only.",
                "instanceType": "Condition"
              },
              {
                "id": "01940510-237c-483d-bd02-00231a70db97",
                "name": "Timing After",
                "text": "s. Menstruation check is for women only; women of childbearing potential should only be enrolled after a negative serum pregnancy test result at Screening. Additional urine pregnancy testing will be standard for the protocol unless serum testing is required by site policies, local regulation, or Institutional Review Boards (IRBs)/Independent Ethics Committees (IECs) (Section 10.2). In addition to pregnancy tests detailed at the visits in the SoA, females of childbearing potential will be required to perform urine pregnancy tests at least every 4 weeks at their home or the study site throughout their time in the study.",
                "instanceType": "Condition"
              },
              {
                "id": "dada385a-c8e4-4b24-bf61-b0ee38d16991",
                "name": "Timing After",
                "text": "t. A single 15 mL serum sample will be retained for evaluation in the event of an unexpected safety finding; retained samples may be destroyed after completion of the clinical report.",
                "instanceType": "Condition"
              },
              {
                "id": "e8a6f94f-f57e-47d5-9f92-cc94b29644cd",
                "name": "General",
                "text": "u. Vital signs measurements and ECGs should be performed predose, unless otherwise specified. Vitals signs include body temperature, heart rate, respiratory rate, and systolic and diastolic blood pressure.",
                "instanceType": "Condition"
              },
              {
                "id": "6770bafa-35a6-4779-9fef-80ffea75a3fd",
                "name": "Timing After",
                "text": "v. Copper- and molybdenum-controlled diet will be initiated after registration/inclusion. Participants will remain on a copper/molybdenum controlled diet throughout both the inpatient Period 1 (Day -8 to Day 9) and inpatient Period 2 (Day 23 to Day 40); during this time participants will be strongly encouraged to complete all meals. While not in the CRU, participants will be encouraged to adhere to their usual copper-controlled diet.",
                "instanceType": "Condition"
              },
              {
                "id": "1502b8d3-27f9-41f5-8a93-6e4233b6bb9d",
                "name": "General",
                "text": "w. For each input/output balance period, 24-hour urine samples are to be collected for measurement of copper and molybdenum.",
                "instanceType": "Condition"
              },
              {
                "id": "2638f6fc-162f-4f45-8da1-6a3d45f960a5",
                "name": "General",
                "text": "x. For fecal samples, each individual sample will be independently collected with record of date, time, and weight of the sample.",
                "instanceType": "Condition"
              },
              {
                "id": "940c22e9-3a80-4fd5-9024-80841f41e24a",
                "name": "Frequency Continuous",
                "text": "1. Participants eligible for the study will be enrolled on Day -7 and initiated on a copper- and molybdenum- controlled diet, which will be continued during Treatment Period 1 and Treatment Period 2 when in the CRU, through Day 39.",
                "instanceType": "Condition"
              },
              {
                "id": "c008e31b-487a-4c82-bc5c-bd62da7bb61c",
                "name": "Timing At",
                "text": "2. Participants will be admitted to the CRU for Treatment Period 1 on Day -8 and may be discharged on Day 9 or remain in the CRU for their own safety or to maintain the integrity of the conduct of the study. Participants who are discharged will be re-admitted on Day 22 or Day 23 for Treatment Period 2 and will remain in house until Day 40. To ensure flexibility, the Outpatient Period may be extended up to an additional 14 days with Investigator approval. In this situation, participants will be given additional investigational product to support daily dosing throughout the Outpatient Period. In such cases, the actual Outpatient Period duration will be recorded and the participant will continue Inpatient Period 2 at Day 23.",
                "instanceType": "Condition"
              },
              {
                "id": "07e06f22-5837-43c7-8051-fe5270fe3555",
                "name": "Timing At",
                "text": "3. Participants will be administered ALXN1840 at a dose of 15 mg/day on Day 1 through Day 28 and then increase to 30 mg/day on Day 29 through Day 39. During the Outpatient Period, participants will use SMS text messaging to confirm study intervention administration.",
                "instanceType": "Condition"
              },
              {
                "id": "536402e5-ee38-4168-920d-4eb04724c148",
                "name": "General",
                "text": "4. Participants will have 3 intake and output collection periods including:  Baseline Day -4 through Day -1  Day 1 through Day 8 (I/O for 15 mg)  Day 25 through Day 39 (Days 25 through 28, I/O for 15 mg; Days 29 through 39, I/O for 30 mg)",
                "instanceType": "Condition"
              },
              {
                "id": "d25f91af-eabd-4320-b2c0-3d7f43514df7",
                "name": "General",
                "text": "5. During these periods all intake (including food and drink) and output (including urine and feces) will be collected and assessed for copper and molybdenum.",
                "instanceType": "Condition"
              },
              {
                "id": "ffa21a6a-bb73-4af2-8191-2b8cc60678e7",
                "name": "General",
                "text": "6. Blood sampling for PK/PD will be as follows:  PK/PD collection (24-hour): Days 1, 25, 29, and 39  Predose PK/PD sampling days: Days 4 - 7, Days 26 - 28, Days 30 - 38  End of Study Visit Day 54 +/- 2 days Abbreviations: AP = accumulation period; CRU = clinical research unit; EOS = End of Study; I/O = input/output; PD = pharmacodynamic; PK = pharmacokinetic; SS = steady state.",
                "instanceType": "Condition"
              }
            ],
            "elements": [
              {
                "id": "0f3bca2a-3e39-4369-a66c-47998fbf1de3",
                "name": "Dose Step 1",
                "description": "",
                "instanceType": "StudyElement"
              },
              {
                "id": "e18e306c-2bb2-4ff1-bd3c-38cfed971672",
                "name": "Dose Step 2",
                "description": "",
                "instanceType": "StudyElement",
                "previousElementId": "0f3bca2a-3e39-4369-a66c-47998fbf1de3"
              }
            ],
            "administrations": [
              {
                "id": "ee35e37c-2698-4065-a3a2-f0b7abf4e7e5",
                "name": "ALXN1840 Administration",
                "instanceType": "Administration",
                "dose": "30.0 mg / 15.0 mg",
                "doseFrequency": "QD",
                "route": {
                  "id": "eab6865b-40f9-4aca-8e88-20491de9ba58",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "description": "Administration of Study Interventionm ALXN1840 15 mg/day           ALXN1840 30 mg/day      Study intervention compliance Xn  PK/PD Analyseso"
              },
              {
                "id": "010cf63e-6a32-4886-a6ae-996a2613d939",
                "name": "Zinc Administration",
                "instanceType": "Administration",
                "doseFrequency": "TID",
                "route": {
                  "id": "9d446b85-17c6-4450-9907-2bfba62ca9b6",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                }
              }
            ]
          }
        ],
        "eligibilityCriterionItems": [
          {
            "id": "754f4cd7-ef7b-4394-b343-7014325886c6",
            "name": "Age requirement",
            "text": "Participants aged 18 at the time of signing the ICF.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "f9af4d7f-2b70-476f-af7e-ef6a97774940",
            "name": "Diagnosis of WD",
            "text": "Diagnosis of WD by Leipzig Criteria  4 documented by testing as outlined in the 2012 European Association for the Study of Liver WD Clinical Practice Guidelines (Ferenci, 2003; EASL, 2012) or by historical test results for WD including some or all of the following: Presence of Kayser Fleischer rings, Neurological symptoms, Serum ceruloplasmin below reference range, Coombs-negative hemolytic anemia, Elevated liver or urinary copper, Presence of mutations in the ATP7B gene, or Other, as considered appropriate, may be used instead to confirm the diagnosis of WD.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "340a523a-2f47-4cc8-8d89-afc7d64590a2",
            "name": "Benefit from decoppering therapy",
            "text": "Participants who in the opinion of the referring Investigator may benefit from decoppering therapy.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "bd423c24-eabd-4a3a-b3ef-f9682ae428fc",
            "name": "Compliance with procedures",
            "text": "Participants must be able to comply with all study-related procedures.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "4ed1cf23-2f6d-4f59-8b22-9071c7f7f9e8",
            "name": "Reside in CRU",
            "text": "Participants must be able to reside in the CRU for intensive metabolic monitoring of copper and molybdenum.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "99025a75-49df-4abf-b8c7-c9c1f1be74f9",
            "name": "Discontinue chelator therapy",
            "text": "Participants willing to discontinue chelator therapy for approximately 4 days prior to initiation of ALXN1840 to allow a baseline assessment of copper balance.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "67f49933-0fa9-4eac-a460-b80e56e660c6",
            "name": "Venous access",
            "text": "Participants with adequate venous access to allow collection of required blood samples.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "30aad786-7cd2-4ceb-b375-9f83623f8f0a",
            "name": "Swallow intact tablets",
            "text": "Participants must be able to swallow intact ALXN1840 tablets.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "5847b9c0-94b6-4444-859a-a5a3d03a61df",
            "name": "Avoid mineral use",
            "text": "Participants willing to avoid use of minerals containing copper, zinc, or molybdenum throughout the study duration.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "13920a7c-9bfe-445f-a680-e7a895f4411f",
            "name": "Dietary adherence",
            "text": "Participants willing to adhere to copper/molybdenum-controlled diet during inpatient periods and willing to comply with a low copper dietary requirement during the Outpatient Period.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "9175a8c3-f3ac-47a2-ba33-b88d8b2c2276",
            "name": "Contraceptive use",
            "text": "Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies. (Including specific requirements for male and female participants as detailed in protocol section 5.1.11).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "3158767c-86ca-4aaf-be95-48fda4f3cc8a",
            "name": "Informed Consent",
            "text": "Participants capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the ICF and in this protocol.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "9ee9ffa0-41ee-4aef-a1ba-690e315157b3",
            "name": "Decompensated cirrhosis",
            "text": "Decompensated cirrhosis or model for end-stage liver disease (MELD) score > 13.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "e8cd5e45-3284-4bbf-9967-571d14db6472",
            "name": "Modified Nazer score",
            "text": "Modified Nazer score > 7 (Dhawan, 2005).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "d4ace5d1-735b-417a-bcf6-23bcf6ca80f3",
            "name": "Gastrointestinal bleed",
            "text": "Clinically significant gastrointestinal bleed within past 3 months.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "1b01300f-411a-4bde-99f7-12a9e23afdde",
            "name": "ALT elevation",
            "text": "Alanine aminotransferase (ALT) > 2  upper limit of normal (ULN).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "6905cf66-bf51-404f-a58b-484a4a0cebf9",
            "name": "Neurological disease",
            "text": "Marked neurological disease requiring assistance with self-care or activities of daily life.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "5c4d5ce3-67d4-417b-a329-6463ce38a46b",
            "name": "Hemoglobin level",
            "text": "Hemoglobin less than lower limit of the reference range for age and sex.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "39b4e4e2-104a-4e86-8baf-c17528c482bb",
            "name": "Active infection",
            "text": "Active infection with hepatitis B virus (positive hepatitis B surface antigen) or C virus (participants with positive hepatitis C antibody result would require confirmation of active disease with a positive hepatitis C polymerase chain reaction test), or seropositivity for human immunodeficiency virus (HIV).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "14fb12a6-899d-4da9-9784-8205d3719225",
            "name": "Other medical disorders",
            "text": "History or presence of/significant history of or current cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrinological, hematological, or neurological disorders, or psychiatric disorder that in the opinion of the Investigator may constitute a risk when taking the study intervention; or may interfere with the interpretation of data.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "f2b18c8d-fd46-4dda-bbde-86a363e62e5c",
            "name": "Previous ALXN1840 treatment",
            "text": "Previous treatment with ALXN1840 or other form of tetrathiomolybdate within 1 year prior to dosing.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "c2fd7780-2e7b-4791-a895-7913429445f8",
            "name": "Previous zinc treatment",
            "text": "Previous treatment with zinc within 21 days prior to Day 1.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "63a3211e-ceb1-42a9-9094-39a07f17b9a8",
            "name": "Experimental therapy",
            "text": "The use of an experimental or unapproved/unlicensed therapy at the same time or within 90 days or 5 half-lives, whichever is longer, prior to the Screening Visit.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "60dc34bb-2946-4fa5-9f41-32eb8580695d",
            "name": "Renal failure",
            "text": "Participants in renal failure, defined as in end-stage renal disease on dialysis (chronic kidney disease [CKD] stage 5) or creatinine clearance < 30 mL/min (Levey, 2006).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "70fa056f-042b-49ea-86bd-ff9c30ab1121",
            "name": "Pregnancy or breastfeeding",
            "text": "Pregnant (or females who are planning to become pregnant) or breastfeeding females (women of childbearing potential must have a negative serum pregnancy test result at screening).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "5af035f7-95e8-4fed-ab4f-6b4167026dd5",
            "name": "Known sensitivity",
            "text": "Known sensitivity to ALXN1840, ALXN1840 excipients (anhydrous dicalcium phosphate, anhydrous sodium carbonate), or any of the ingredients contained in ALXN1840 or related compounds.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "0bd6a392-8561-495e-b1ee-4ebb1705ef17",
            "name": "Non-compliance",
            "text": "In the opinion of the Investigator, the participant and/or their legal guardian is likely to be non-compliant or uncooperative during the study.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "dd8fc848-52e4-4e07-9606-bb04c49dd316",
            "name": "Substance abuse",
            "text": "History of illicit drug abuse, history of significant alcohol abuse within 1 year prior to the Screening Visit, or clinical evidence of substance and/or alcohol abuse within the 2 years before screening. Alcohol abuse is defined as regular weekly intake of more than 14 units (for both males and females).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "39412cf7-4b1a-4c3b-93de-603c514534ec",
            "name": "Positive drug screen",
            "text": "Positive urine drug toxicology screen at Screening or on Day -8 (cannabinoids will not be tested).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "536d6b83-8cbb-4f1d-90fc-46cf59095c49",
            "name": "Alcohol consumption",
            "text": "Alcohol consumption within 48 hours prior to study intervention administration or positive alcohol breath test at screening or on Day -8.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "55a2526a-5434-4c4a-bfc9-90e53132fe36",
            "name": "Meal completion",
            "text": "Participants unwilling to consistently complete every meal and tolerate a controlled, limited menu for the duration of the study.",
            "instanceType": "EligibilityCriterionItem"
          }
        ],
        "titles": [
          {
            "id": "d17156b2-b1a7-4219-b348-ad2858f164d0",
            "text": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
            "type": {
              "id": "0aab42cb-18f2-415f-964f-ad5a5170b7c2",
              "code": "Official Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Official Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          },
          {
            "id": "3bfd100f-e93d-477a-b5a8-7cb304f9319e",
            "text": "Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
            "type": {
              "id": "d3fcd65c-8bfd-4868-a5e2-6f40b27b8afa",
              "code": "Brief Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Brief Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          }
        ],
        "studyIdentifiers": [
          {
            "id": "fbbbc66a-852b-4289-8856-a284b632eb6d",
            "text": "NCT04573309",
            "instanceType": "StudyIdentifier",
            "scopeId": "9f4df669-7333-4bf5-948f-26ed8ee756f6",
            "type": {
              "code": "C172240",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinicaltrials.gov Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "53a9534d-9606-4c7f-8510-9518277e1c09",
            "text": "ALXN1840-WD-204",
            "instanceType": "StudyIdentifier",
            "scopeId": "1574d108-1fc3-4f9f-bd8e-11fcea61326a",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "51f93c80-a594-40ae-9006-2d1b35d4d300",
            "text": "2020-001104-41",
            "instanceType": "StudyIdentifier",
            "scopeId": "35f1c65d-6f97-472b-b3ec-6cb596c3eed6",
            "type": {
              "code": "C98714",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinical Trial Registry Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "2e13e481-3b8f-435b-b2f3-c9a72bf86c1d",
            "text": "119006",
            "instanceType": "StudyIdentifier",
            "scopeId": "91a6b621-5cbd-4431-905a-1348ea34186f",
            "type": {
              "code": "C218685",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "US FDA Investigational New Drug Application Number",
              "instanceType": "Code"
            }
          }
        ],
        "organizations": [
          {
            "id": "1574d108-1fc3-4f9f-bd8e-11fcea61326a",
            "name": "Alexion Pharmaceuticals, Inc.",
            "type": {
              "id": "5ecab186-24c8-4de9-97a4-0831f4d81954",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "Alexion Pharmaceuticals, Inc.",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "2f0582f6-3ed3-4ea0-a682-65f315b03acd",
            "name": "US Food and Drug Administration",
            "type": {
              "id": "74645668-b332-49a4-bde6-72c9d40b7157",
              "code": "C25461",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Regulatory Agency",
              "instanceType": "Code"
            },
            "identifier": "US Food and Drug Administration",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "9f4df669-7333-4bf5-948f-26ed8ee756f6",
            "name": "ClinicalTrials.gov",
            "type": {
              "id": "d49282b5-3df9-485f-a010-c02a9798255f",
              "code": "C19326",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Healthcare Facility",
              "instanceType": "Code"
            },
            "identifier": "ClinicalTrials.gov",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "6ab8008b-84d1-4b19-892e-c145bf7cab3b",
            "name": "Cleveland Clinic",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "4",
            "type": {
              "id": "49a80a08-4c96-4232-a636-9c81f809debe",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2960683c-520c-45ee-8b7f-ad6a92094674",
            "name": "Mount Sinai Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "5",
            "type": {
              "id": "59279210-69e2-4c31-b145-a57e37e3177a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0aaa3423-5f80-4b86-b534-128d1744b9da",
            "name": "University of California San Francisco",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "6",
            "type": {
              "id": "2068507f-0a28-4a3d-84a2-d2beb73b7834",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "92fbbfa9-e82a-4a73-811e-a43af98cbb35",
            "name": "King's College Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "7",
            "type": {
              "id": "173cc242-2167-4483-ae1e-09947a41a359",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "541e78cf-7ea6-4e0a-b358-8ac6060a5b30",
            "name": "Charit University Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "8",
            "type": {
              "id": "1a8c3f72-aa1b-420f-a02e-e1ad5360d2e7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1e27822c-9844-49fd-ba17-5744e05ae43d",
            "name": "Hpital Beaujon",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "9",
            "type": {
              "id": "5c7ecc78-244a-43b6-9b62-0844b947fd95",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c4faf32c-36b9-48ac-871c-c7c4474a2989",
            "name": "Hospital Clinic Barcelona",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "10",
            "type": {
              "id": "add58444-bc91-4d83-9f01-476f59355f39",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3bc6f930-d746-4acf-9541-bbb508632c67",
            "name": "University Hospital Zurich",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "11",
            "type": {
              "id": "cd260ea5-1254-4d9b-be7d-711e4fbb842c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1a4bb3dd-cfe4-4805-8846-0b9420b19089",
            "name": "Tokyo University Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "12",
            "type": {
              "id": "2cc66fd3-e161-4ba5-8eff-acebfcad3f44",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          }
        ],
        "studyPhase": {
          "id": "e2b9c2ae-f6c2-4c1e-b062-0dba2bf1c2c2",
          "code": "Phase2",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Phase2",
          "instanceType": "Code"
        },
        "studyInterventions": [
          {
            "id": "bcd9686a-6607-4cea-b167-7102f0ac21ba",
            "name": "ALXN1840",
            "type": {
              "id": "6dac74b7-d5c7-4dea-b32e-78ba79c25e7d",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "2b6740f0-4352-42d6-92e8-04e815f05c71",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Novel copper binding agent (bis-choline tetrathiomolybdate) for the treatment of Wilson disease.",
            "productIds": [
              "26bb181b-b083-4aee-b3b6-517b8a1a7289"
            ],
            "administrationIds": [
              "1663fa73-c0e0-410a-a237-5f4fa2144b8d",
              "bd275760-17eb-4fac-ba45-8dfd969de0c5"
            ]
          },
          {
            "id": "915fa91a-f421-4a71-a2fe-6b08b1838a7c",
            "name": "Copper-chelating therapies",
            "type": {
              "id": "e42b4524-42fe-4544-816d-fa7219ec8f08",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "a16e2ef5-c0c7-41be-8fbc-5c7b61c11c52",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Penicillamine or trientine; must be discontinued starting on Day -4.",
            "administrationIds": [
              "ce9662c8-e1fe-45fd-948a-7f93676cd0aa"
            ]
          },
          {
            "id": "48108e3d-9814-4b3d-abfc-60c9dca5dfdf",
            "name": "Zinc therapy",
            "type": {
              "id": "4a7a0dfd-88e2-4076-bf46-1f8af2df5674",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "80e1c50f-7689-47d9-a0c0-ba80acf2bd31",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Must be discontinued at least 21 days prior to Day 1.",
            "administrationIds": [
              "dedc9f58-95a0-416b-8e6a-18eb5518f6a4",
              "0e0d8df9-ab5d-489c-ace3-0d432fd83aa0"
            ]
          },
          {
            "id": "b47f0195-a424-4ce8-b2a6-80dfc1dc9b9a",
            "name": "Paracetamol/acetaminophen",
            "type": {
              "id": "3759cad2-1106-4b82-a242-d887bf6a943a",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "67f9ee58-792d-4ae4-805a-d97297ae39ba",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted up to a maximum of 1000 mg per day with Investigator approval."
          },
          {
            "id": "8c0dc2a7-e2b1-4d89-8eea-ff938bf29868",
            "name": "Ibuprofen",
            "type": {
              "id": "52ae7815-4bed-4223-a1f5-ada8f9a41db9",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "62053e4f-5990-4c32-8e3c-08089509f437",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted with caution; dose must not exceed 1200 mg in any 24-hour period."
          },
          {
            "id": "2697418e-4461-4e53-90a1-f98787846fe4",
            "name": "St Johns wort",
            "type": {
              "id": "98a07ef9-f810-41a7-82d8-68f2498afa4b",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "6925fa7e-9225-4f2b-adc6-5cf99c8a6ff2",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Prohibited; must be discontinued 2 weeks before first study intervention."
          }
        ],
        "administrableProducts": [
          {
            "id": "26bb181b-b083-4aee-b3b6-517b8a1a7289",
            "name": "ALXN1840 tablets",
            "administrableDoseForm": {
              "id": "b8a6467f-8662-4a09-a185-3d1a20454b17",
              "code": "C42998",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Tablet",
              "instanceType": "Code",
              "standardCode": {
                "id": "4b324b92-ce53-45ad-9a59-155752450d36",
                "code": "C42998",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Tablet",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "266c8628-fa0b-4bdd-9862-734667c563a0",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "15 mg",
            "substanceIds": [
              "7f5f03ed-f471-4968-8723-c5cb0451c4b3"
            ],
            "manufacturer": "Alexion Pharmaceuticals"
          }
        ],
        "narrativeContents": [
          {
            "id": "10c28485-8959-4182-a90f-6d0a8ec64ddf",
            "name": "PROTOCOL SUMMARY",
            "text": "PROTOCOL SUMMARY",
            "order": 0,
            "instanceType": "NarrativeContent",
            "sectionNumber": "1",
            "sectionTitle": "PROTOCOL SUMMARY",
            "sectionType": {
              "id": "33c42d0b-d89a-4b75-9bc3-e3a62edc7cb3",
              "code": "Synopsis",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Synopsis",
              "instanceType": "Code"
            },
            "childIds": [
              "6dfe52a7-d62f-4170-b0e7-20a89b07f718",
              "62abc3d7-0577-48b6-84d3-ba1a5990ac98",
              "0e5d39bd-b503-49aa-a3b3-54f7f54caaf6"
            ]
          },
          {
            "id": "5e56e3b2-60e2-4b77-8cb9-91be15273c4a",
            "name": "INTRODUCTION",
            "text": "INTRODUCTION",
            "order": 1,
            "instanceType": "NarrativeContent",
            "sectionNumber": "2",
            "sectionTitle": "INTRODUCTION",
            "sectionType": {
              "id": "d979ec1c-7f96-4782-b6ac-0485ebed3817",
              "code": "Introduction",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Introduction",
              "instanceType": "Code"
            },
            "childIds": [
              "ae5868d1-8b1e-4225-8ee3-6e9e3353a72c",
              "6e5561bb-418a-43f2-aa4c-b063109fce43",
              "f12ebdc7-868f-48cd-a499-ea332b9d0cf5"
            ]
          },
          {
            "id": "ea76e56b-fa8b-4b4d-a9a7-d60f34373375",
            "name": "OBJECTIVES AND ENDPOINTS",
            "text": "OBJECTIVES AND ENDPOINTS",
            "order": 2,
            "instanceType": "NarrativeContent",
            "sectionNumber": "3",
            "sectionTitle": "OBJECTIVES AND ENDPOINTS",
            "sectionType": {
              "id": "f4b11248-a752-4e0f-a835-529eef021527",
              "code": "Objectives",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Objectives",
              "instanceType": "Code"
            }
          },
          {
            "id": "e3259edd-d568-4e84-a447-2931be5632c8",
            "name": "STUDY DESIGN",
            "text": "STUDY DESIGN",
            "order": 3,
            "instanceType": "NarrativeContent",
            "sectionNumber": "4",
            "sectionTitle": "STUDY DESIGN",
            "sectionType": {
              "id": "e075b75a-350d-400d-860f-1c2b82f50403",
              "code": "Study Design",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Design",
              "instanceType": "Code"
            },
            "childIds": [
              "5afb5aeb-0176-407f-81ea-7071430a0de2",
              "46a3d9d1-09c5-487e-8430-e981599939e5",
              "3514d049-d5eb-4a24-91f3-df0ab1f2f1aa",
              "64ff2078-6f7d-4f58-9849-2781d72c0633"
            ]
          },
          {
            "id": "e34b37e7-7a94-4bae-9e1d-c443387244a8",
            "name": "STUDY POPULATION",
            "text": "STUDY POPULATION",
            "order": 4,
            "instanceType": "NarrativeContent",
            "sectionNumber": "5",
            "sectionTitle": "STUDY POPULATION",
            "sectionType": {
              "id": "aa1e1f11-0b7d-4c68-8d3e-8c77467974c0",
              "code": "Study Population",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Population",
              "instanceType": "Code"
            },
            "childIds": [
              "617223f5-a384-4e41-b6c9-3694fc29e842",
              "4622dd1a-fe94-46e0-b6ca-062c2321febe",
              "9a54db42-9fed-4509-bd30-00c452cc15ca",
              "4066a65e-cb86-466b-bc79-2de0fc35fb4f"
            ]
          },
          {
            "id": "ef90f005-c9d4-4cff-ae50-d290abb50883",
            "name": "STUDY INTERVENTION",
            "text": "STUDY INTERVENTION",
            "order": 5,
            "instanceType": "NarrativeContent",
            "sectionNumber": "6",
            "sectionTitle": "STUDY INTERVENTION",
            "sectionType": {
              "id": "46cb87f5-5197-45c8-99f0-80ca649e6f1d",
              "code": "Treatment",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Treatment",
              "instanceType": "Code"
            }
          },
          {
            "id": "65b0fbfd-9ad5-491f-a508-b235efac8840",
            "name": "Study and Site Start and Closure",
            "text": "Study and Site Start and Closure",
            "order": 6,
            "instanceType": "NarrativeContent",
            "sectionNumber": "10.1.8",
            "sectionTitle": "Study and Site Start and Closure",
            "sectionType": {
              "id": "3ff2663a-8874-42bd-b82c-815b69ae25fc",
              "code": "Other",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Other",
              "instanceType": "Code"
            }
          },
          {
            "id": "083251dc-a75b-4612-b020-ebb21f19c739",
            "name": "Publication Policy",
            "text": "Publication Policy",
            "order": 7,
            "instanceType": "NarrativeContent",
            "sectionNumber": "10.1.9",
            "sectionTitle": "Publication Policy",
            "sectionType": {
              "id": "597a5b56-66c0-4df9-ab5f-955c85cfe381",
              "code": "Other",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Other",
              "instanceType": "Code"
            }
          },
          {
            "id": "ce00b6b0-a041-4ced-bf80-57388837db1a",
            "name": "Clinical Laboratory Tests",
            "text": "Clinical Laboratory Tests",
            "order": 8,
            "instanceType": "NarrativeContent",
            "sectionNumber": "10.2",
            "sectionTitle": "Clinical Laboratory Tests",
            "sectionType": {
              "id": "5033ef30-e7e4-427f-ba96-24302bda9c65",
              "code": "Assessments",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Assessments",
              "instanceType": "Code"
            }
          },
          {
            "id": "844e2af1-98ff-47c4-a6b3-cdfa8c21fd6f",
            "name": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
            "text": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
            "order": 9,
            "instanceType": "NarrativeContent",
            "sectionNumber": "10.3",
            "sectionTitle": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
            "sectionType": {
              "id": "53c64a31-9b9e-4389-8449-14ecc8ea2e03",
              "code": "Safety",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Safety",
              "instanceType": "Code"
            },
            "childIds": [
              "9b6a1991-fa90-4e01-a34c-a8f3fe715cd7",
              "bdd5f4ec-df15-433a-9ee3-b06326201320",
              "b98270ca-5c79-4ee8-87b1-0cb5d04e01e2",
              "8b69a0d0-654f-41ba-83ad-ee4ee0765000"
            ]
          },
          {
            "id": "9475750c-7161-439e-b260-1fc1043b8450",
            "name": "Contraceptive Guidance and Collection of Pregnancy Information",
            "text": "Contraceptive Guidance and Collection of Pregnancy Information",
            "order": 10,
            "instanceType": "NarrativeContent",
            "sectionNumber": "10.4",
            "sectionTitle": "Contraceptive Guidance and Collection of Pregnancy Information",
            "sectionType": {
              "id": "64658ace-7907-4aaf-9bcc-ed0833d14070",
              "code": "Study Population",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Population",
              "instanceType": "Code"
            }
          },
          {
            "id": "39b8dd11-4643-413a-a3e5-e582317d9417",
            "name": "COVID-19 Vaccine Risk Assessment",
            "text": "COVID-19 Vaccine Risk Assessment",
            "order": 11,
            "instanceType": "NarrativeContent",
            "sectionNumber": "10.5",
            "sectionTitle": "COVID-19 Vaccine Risk Assessment",
            "sectionType": {
              "id": "1fd3e550-cbb4-4e2e-8e11-3977c7164a3b",
              "code": "Safety",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Safety",
              "instanceType": "Code"
            }
          },
          {
            "id": "8a26e71c-a067-4108-abef-8d3e8ee325a3",
            "name": "Abbreviations",
            "text": "Abbreviations",
            "order": 12,
            "instanceType": "NarrativeContent",
            "sectionNumber": "10.6",
            "sectionTitle": "Abbreviations",
            "sectionType": {
              "id": "c086c294-54fb-4997-873f-e1d74aa779ab",
              "code": "Other",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Other",
              "instanceType": "Code"
            }
          },
          {
            "id": "97c67439-693e-4926-a2d4-3994c2c0da3f",
            "name": "Protocol Amendment History",
            "text": "Protocol Amendment History",
            "order": 13,
            "instanceType": "NarrativeContent",
            "sectionNumber": "10.7",
            "sectionTitle": "Protocol Amendment History",
            "sectionType": {
              "id": "341933e7-5085-43fd-b6b3-d28e6410f964",
              "code": "Other",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Other",
              "instanceType": "Code"
            }
          },
          {
            "id": "3b4bf151-7d88-46a7-9f7e-21c1727154e6",
            "name": "REFERENCES",
            "text": "REFERENCES",
            "order": 14,
            "instanceType": "NarrativeContent",
            "sectionNumber": "11",
            "sectionTitle": "REFERENCES",
            "sectionType": {
              "id": "adfeaa89-c7b0-406f-ab65-9bbf504d7144",
              "code": "References",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "References",
              "instanceType": "Code"
            }
          }
        ],
        "narrativeContentItems": [
          {
            "id": "6dfe52a7-d62f-4170-b0e7-20a89b07f718",
            "name": "Synopsis",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.1",
            "sectionTitle": "Synopsis"
          },
          {
            "id": "62abc3d7-0577-48b6-84d3-ba1a5990ac98",
            "name": "Schema",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.2",
            "sectionTitle": "Schema"
          },
          {
            "id": "0e5d39bd-b503-49aa-a3b3-54f7f54caaf6",
            "name": "Schedule of Activities (SoA)",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.3",
            "sectionTitle": "Schedule of Activities (SoA)"
          },
          {
            "id": "ae5868d1-8b1e-4225-8ee3-6e9e3353a72c",
            "name": "Study Rationale",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.1",
            "sectionTitle": "Study Rationale"
          },
          {
            "id": "6e5561bb-418a-43f2-aa4c-b063109fce43",
            "name": "Background",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2",
            "sectionTitle": "Background"
          },
          {
            "id": "f12ebdc7-868f-48cd-a499-ea332b9d0cf5",
            "name": "Benefit-Risk Assessment",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.3",
            "sectionTitle": "Benefit-Risk Assessment"
          },
          {
            "id": "5afb5aeb-0176-407f-81ea-7071430a0de2",
            "name": "Overall Design",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.1",
            "sectionTitle": "Overall Design"
          },
          {
            "id": "46a3d9d1-09c5-487e-8430-e981599939e5",
            "name": "Scientific Rationale for Study Design",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.2",
            "sectionTitle": "Scientific Rationale for Study Design"
          },
          {
            "id": "3514d049-d5eb-4a24-91f3-df0ab1f2f1aa",
            "name": "Justification for Dose",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.3",
            "sectionTitle": "Justification for Dose"
          },
          {
            "id": "64ff2078-6f7d-4f58-9849-2781d72c0633",
            "name": "End of Study Definition",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.4",
            "sectionTitle": "End of Study Definition"
          },
          {
            "id": "617223f5-a384-4e41-b6c9-3694fc29e842",
            "name": "Inclusion Criteria",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.1",
            "sectionTitle": "Inclusion Criteria"
          },
          {
            "id": "4622dd1a-fe94-46e0-b6ca-062c2321febe",
            "name": "Exclusion Criteria",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2",
            "sectionTitle": "Exclusion Criteria"
          },
          {
            "id": "9a54db42-9fed-4509-bd30-00c452cc15ca",
            "name": "Lifestyle Considerations",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3",
            "sectionTitle": "Lifestyle Considerations"
          },
          {
            "id": "4066a65e-cb86-466b-bc79-2de0fc35fb4f",
            "name": "Screen Failures",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.4",
            "sectionTitle": "Screen Failures"
          },
          {
            "id": "9b6a1991-fa90-4e01-a34c-a8f3fe715cd7",
            "name": "Definition of AE",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "10.3.1",
            "sectionTitle": "Definition of AE"
          },
          {
            "id": "bdd5f4ec-df15-433a-9ee3-b06326201320",
            "name": "Definition of SAE",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "10.3.2",
            "sectionTitle": "Definition of SAE"
          },
          {
            "id": "b98270ca-5c79-4ee8-87b1-0cb5d04e01e2",
            "name": "Recording and Follow-Up of AE and/or SAE",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "10.3.3",
            "sectionTitle": "Recording and Follow-Up of AE and/or SAE"
          },
          {
            "id": "8b69a0d0-654f-41ba-83ad-ee4ee0765000",
            "name": "Reporting of SAEs",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "10.3.4",
            "sectionTitle": "Reporting of SAEs"
          }
        ],
        "abbreviations": [
          {
            "id": "b3b4572b-e28e-49ac-9e14-8c78a878bb0f",
            "abbreviatedText": "ADME",
            "expandedText": "absorption, distribution, metabolism, and excretion",
            "instanceType": "Abbreviation"
          },
          {
            "id": "25f46477-689e-4a1d-9a4c-336ea78e5031",
            "abbreviatedText": "AE",
            "expandedText": "adverse event",
            "instanceType": "Abbreviation"
          },
          {
            "id": "df9f1c2a-5ac6-472a-8a1a-64970f32263b",
            "abbreviatedText": "ALT",
            "expandedText": "alanine aminotransferase",
            "instanceType": "Abbreviation"
          },
          {
            "id": "e5583c24-4005-4b6f-b0f3-33ec08a05ae6",
            "abbreviatedText": "AP",
            "expandedText": "accumulation period",
            "instanceType": "Abbreviation"
          },
          {
            "id": "68e33a4a-ca0c-4105-8f68-8d13fc8b9287",
            "abbreviatedText": "AST",
            "expandedText": "aspartate aminotransferase",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9f4d1c49-010b-4d6b-aef7-5479021b5867",
            "abbreviatedText": "BMI",
            "expandedText": "body mass index",
            "instanceType": "Abbreviation"
          },
          {
            "id": "80e598d8-7712-4f57-89b1-9f5d852afab8",
            "abbreviatedText": "C-I",
            "expandedText": "check-in",
            "instanceType": "Abbreviation"
          },
          {
            "id": "47860e39-a6cd-482d-836a-f642ce0533e8",
            "abbreviatedText": "CFR",
            "expandedText": "Code of Federal Regulations",
            "instanceType": "Abbreviation"
          },
          {
            "id": "639920bf-c376-4f20-bf04-6dbf4fe90847",
            "abbreviatedText": "CRU",
            "expandedText": "clinical research unit",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9f3780ff-ec6b-4153-980a-87f19759a1d3",
            "abbreviatedText": "Cu",
            "expandedText": "copper",
            "instanceType": "Abbreviation"
          },
          {
            "id": "e1e7a89e-fae5-4401-8352-c4439038fb80",
            "abbreviatedText": "D",
            "expandedText": "day",
            "instanceType": "Abbreviation"
          },
          {
            "id": "003cddb5-0900-49c3-9e45-19c86e8ae011",
            "abbreviatedText": "ECG",
            "expandedText": "electrocardiogram",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f5e283fc-5924-4fae-907d-9c34055ceca3",
            "abbreviatedText": "EOS",
            "expandedText": "End of Study",
            "instanceType": "Abbreviation"
          },
          {
            "id": "7093fa47-2ccf-45c3-80d9-f1da208939e7",
            "abbreviatedText": "EOS/ET",
            "expandedText": "End of Study or Early Termination",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9d91ea06-a2fc-4011-a172-c6cdec7d7ceb",
            "abbreviatedText": "FDA",
            "expandedText": "Food and Drug Administration",
            "instanceType": "Abbreviation"
          },
          {
            "id": "6930d44b-65e6-48a1-bfce-585fa2896316",
            "abbreviatedText": "HIV",
            "expandedText": "human immunodeficiency virus",
            "instanceType": "Abbreviation"
          },
          {
            "id": "d1998d5e-cd6c-419c-9740-f9c55ed8e2da",
            "abbreviatedText": "HR",
            "expandedText": "heart rate",
            "instanceType": "Abbreviation"
          },
          {
            "id": "beaf0140-023a-4a6d-8833-0c5b60284329",
            "abbreviatedText": "I/O",
            "expandedText": "input/output",
            "instanceType": "Abbreviation"
          },
          {
            "id": "29f2294a-b545-43a0-9129-4551986e277f",
            "abbreviatedText": "IB",
            "expandedText": "Investigators Brochure",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b354929b-e734-4570-8538-fb91d3664854",
            "abbreviatedText": "IECs",
            "expandedText": "Independent Ethics Committees",
            "instanceType": "Abbreviation"
          },
          {
            "id": "fe96d8a6-805e-451f-b3ad-3bc850e79f54",
            "abbreviatedText": "IRBs",
            "expandedText": "Institutional Review Boards",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f67a147a-c6d7-4789-8955-ffc3b9ffbae0",
            "abbreviatedText": "LBC",
            "expandedText": "labile bound copper",
            "instanceType": "Abbreviation"
          },
          {
            "id": "6148940d-38e0-4c52-9316-5aa68f9922cc",
            "abbreviatedText": "Mo",
            "expandedText": "molybdenum",
            "instanceType": "Abbreviation"
          },
          {
            "id": "fbea3c42-7de7-49c4-83a6-21ef63cc5646",
            "abbreviatedText": "NCC",
            "expandedText": "non-ceruloplasmin-bound copper",
            "instanceType": "Abbreviation"
          },
          {
            "id": "4add799b-c2ba-48cc-b8b0-192ab27fd79e",
            "abbreviatedText": "NCCcorrected",
            "expandedText": "non-ceruloplasmin corrected copper concentrations corrected for TPC",
            "instanceType": "Abbreviation"
          },
          {
            "id": "83d55886-07fa-408d-8b95-fc370e35f2dc",
            "abbreviatedText": "OP",
            "expandedText": "outpatient",
            "instanceType": "Abbreviation"
          },
          {
            "id": "fbfd7bff-8666-41eb-b165-9e5d7d94e4bf",
            "abbreviatedText": "PD",
            "expandedText": "pharmacodynamic",
            "instanceType": "Abbreviation"
          },
          {
            "id": "61548319-c64f-4180-8c22-2dc5a1273331",
            "abbreviatedText": "PK",
            "expandedText": "pharmacokinetic",
            "instanceType": "Abbreviation"
          },
          {
            "id": "10946d26-eb49-448a-8594-bddba5ca123c",
            "abbreviatedText": "PUF",
            "expandedText": "plasma ultrafiltrate",
            "instanceType": "Abbreviation"
          },
          {
            "id": "82d19b21-288a-4300-9563-d8de5275e50e",
            "abbreviatedText": "PUF-Cu",
            "expandedText": "plasma ultrafiltrate copper",
            "instanceType": "Abbreviation"
          },
          {
            "id": "d8464b50-e87f-44ef-a652-9df95937c5e5",
            "abbreviatedText": "PUF-Mo",
            "expandedText": "plasma ultrafiltrate molybdenum",
            "instanceType": "Abbreviation"
          },
          {
            "id": "31fa09d8-569a-491d-a4f7-46c135fb2a9e",
            "abbreviatedText": "SAE",
            "expandedText": "serious adverse event",
            "instanceType": "Abbreviation"
          },
          {
            "id": "92f4e64b-57b3-4106-a249-636f4072d487",
            "abbreviatedText": "SMS",
            "expandedText": "Short Message Service",
            "instanceType": "Abbreviation"
          },
          {
            "id": "eaa0fd95-bc6c-4efb-8414-cefa590432c1",
            "abbreviatedText": "SoA",
            "expandedText": "Schedule of Activities",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0ac24c41-b4a1-43bc-be7e-78ce32d8e1a4",
            "abbreviatedText": "SS",
            "expandedText": "steady state",
            "instanceType": "Abbreviation"
          },
          {
            "id": "c0335c25-b1cf-4d59-a967-609204ec1d01",
            "abbreviatedText": "TPC",
            "expandedText": "tetrathiomolybdate- copper -albumin tripartite complex",
            "instanceType": "Abbreviation"
          },
          {
            "id": "7ba428f6-7eb1-4d2d-ab9b-65dc7e740882",
            "abbreviatedText": "UNS",
            "expandedText": "unscheduled",
            "instanceType": "Abbreviation"
          },
          {
            "id": "dc519dfe-2150-46f9-ba00-0490d87d56cb",
            "abbreviatedText": "WD",
            "expandedText": "Wilson disease",
            "instanceType": "Abbreviation"
          }
        ],
        "amendments": [
          {
            "id": "644979d5-a983-4fe6-ad1e-8e0bcde0f2dd",
            "number": "1",
            "name": "Amendment 1",
            "scope": {
              "id": "a5b0101b-ffdd-43de-b226-f68101c34f45",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "e28d7cc5-d1a3-478f-9c47-9d4a30bcfc4b",
              "code": {
                "id": "ef296cda-6d90-447e-8f33-800f83673e57",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "54389b72-320f-430e-a475-bd5369c57af3",
                "type": {
                  "id": "08116a8d-bf1c-4fcb-ad05-5e4bd8dd4a5c",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The main reason for preparation of this amendment was to update procedures outlined in the Schedule of Activities, remove contradictory text on the reporting of serious adverse events, and add details of an interim analysis.",
            "effectiveDate": "2020-08-18",
            "reasonIds": [
              "6aeac087-6567-4266-a3d3-383470b08518",
              "6ee6f4e4-e76d-497d-927f-f11c5907770f",
              "1a8deeb6-a82f-4fc5-87cb-9b40f9352fbf"
            ],
            "previousVersion": "Original Protocol",
            "newVersion": "1"
          },
          {
            "id": "ed1248a4-b0ac-4b5a-a750-8500ed338643",
            "number": "2",
            "name": "Amendment 2",
            "scope": {
              "id": "c89443aa-0d0b-47d4-a12b-4d3bb61f06d6",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "92da2a33-0157-4559-8967-e27d3171a272",
              "code": {
                "id": "a8b1aea2-5be3-40f0-a334-6de5192368cc",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "c4a322aa-6192-484e-9929-0c93d3b33cc8",
                "type": {
                  "id": "6d43af21-052e-4d8e-8591-84be16e320a2",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The main reason for preparation of this amendment was to revise the exclusion criterion for a urine drug screen. Changes implemented via Administrative Letter 1 and Administrative Letter 2, as well as COVID vaccination guidance, have also been incorporated.",
            "effectiveDate": "2021-03-19",
            "reasonIds": [
              "b6273bf7-f9d1-42ef-adf0-52464e9a4ec0",
              "0d1cc287-371c-4ac4-a0ed-774ece632aad",
              "bbd6cf60-402a-45f9-bd40-8fe47cfa9b7d"
            ],
            "previousVersion": "1",
            "newVersion": "2"
          },
          {
            "id": "832a54b1-519b-41ea-87f8-71b0ecf2e2bc",
            "number": "3",
            "name": "Amendment 3",
            "scope": {
              "id": "7a96c4eb-a597-4b72-8dac-ffc2f940891d",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "be81018f-ec7b-4525-ad2c-7f35f600aba7",
              "code": {
                "id": "8c6826ed-7c32-48ca-9792-a72814a92b28",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "727817a1-8970-4172-a6c2-47518a18425f",
                "type": {
                  "id": "f6630865-bb5c-4101-baf8-1d95107d142a",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The main reason for preparation of this amendment was to update the washout period for zinc.",
            "effectiveDate": "2021-08-31",
            "reasonIds": [
              "fee83dc9-71ba-47da-8539-598b16a8bde0",
              "9a507739-4cba-441f-bc25-04e2177a5d72"
            ],
            "previousVersion": "2",
            "newVersion": "3"
          },
          {
            "id": "13a6f4ef-e8f0-411c-a5d4-2faaa69bcb71",
            "number": "3.1 (US)",
            "name": "Amendment 3.1 (US)",
            "scope": {
              "id": "d854e405-b6cf-4bc4-828d-03713fc91091",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "bf81aa14-3fd3-423f-96d8-ff19dbec8cb8",
              "code": {
                "id": "e0e20c70-abef-4889-b9a3-03b9ba78553e",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "a3f5cd17-5e11-454f-b2dd-06e843ff16fd",
                "type": {
                  "id": "7a48bf92-f93a-45bd-93cd-ec793b185492",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The main reason for preparation of this amendment was to clarify study procedures occurring across different sites in the US, so as to facilitate participant recruitment across different regions of the US, and to lessen inconvenience for participants without compromising the quality of the study.",
            "effectiveDate": "2022-03-18",
            "reasonIds": [
              "5ea3357b-b5bb-4d7f-a05d-a538d27077a0",
              "c7313b80-95f1-4f12-a776-3642da4c2f17"
            ],
            "previousVersion": "3",
            "newVersion": "3.1 (US)"
          }
        ],
        "conditions": [
          {
            "id": "b33676a4-1a54-4da6-adae-4effc5dfe5ef",
            "name": "Safety Review Committee Approval",
            "instanceType": "Condition",
            "description": "SRC must review safety data before titration",
            "text": "SRC will review available safety data through Day 23 for each participant before titration to 30 mg/day."
          },
          {
            "id": "a5038977-851e-4bb5-8c5b-85a4ccaa0662",
            "name": "Liver Injury Criteria",
            "instanceType": "Condition",
            "description": "Bilirubin and ALT elevation",
            "text": "Bilirubin > 2 x ULN accompanied by ALT > 3 x ULN"
          },
          {
            "id": "adcd43f7-afe0-45db-bb22-4013a1c5146f",
            "name": "Renal Failure Exclusion",
            "instanceType": "Condition",
            "description": "Creatinine clearance threshold",
            "text": "Creatinine clearance < 30 mL/min or CKD stage 5"
          }
        ],
        "administrations": [
          {
            "id": "bd275760-17eb-4fac-ba45-8dfd969de0c5",
            "name": "Administration of ALXN1840",
            "description": "RouteOfAdministration.ORAL DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "31e05146-9606-4168-b3a9-e9ee08baae57",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          },
          {
            "id": "0e0d8df9-ab5d-489c-ace3-0d432fd83aa0",
            "name": "Administration of Zinc",
            "description": "RouteOfAdministration.ORAL DosingFrequency.THREE_TIMES_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "a44a0e7e-ce8b-4ed0-88e6-8c699b0fb4b3",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          }
        ],
        "rationale": "Protocol version"
      }
    ],
    "name": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840"
  },
  "administrations": [
    {
      "id": "1663fa73-c0e0-410a-a237-5f4fa2144b8d",
      "name": "ALXN1840 15 mg daily",
      "instanceType": "Administration",
      "dose": "15 mg",
      "doseFrequency": "once daily",
      "route": {
        "id": "6420b2b7-f767-4e89-ba34-8cfd520d3abf",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Approximately 28 days (Day 1 through Day 28)"
    },
    {
      "id": "ce9662c8-e1fe-45fd-948a-7f93676cd0aa",
      "name": "ALXN1840 30 mg daily",
      "instanceType": "Administration",
      "dose": "30 mg",
      "doseFrequency": "once daily",
      "route": {
        "id": "4f6b1d03-abd8-43f6-b9f9-ac9faa62d26e",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Day 29 through Day 39"
    },
    {
      "id": "dedc9f58-95a0-416b-8e6a-18eb5518f6a4",
      "name": "ALXN1840 15 mg QOD",
      "instanceType": "Administration",
      "dose": "15 mg",
      "doseFrequency": "every other day",
      "route": {
        "id": "f1b0126c-e5a4-415e-bb28-9727a68d34fc",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Used for dose modification/rechallenge if safety criteria are met"
    }
  ],
  "substances": [
    {
      "id": "7f5f03ed-f471-4968-8723-c5cb0451c4b3",
      "name": "bis-choline tetrathiomolybdate",
      "instanceType": "Substance",
      "description": "Active drug moiety; contains tetrathiomolybdic acid."
    }
  ],
  "studyDefinitionDocument": {
    "id": "1c60adcf-0587-461b-8840-52cb209fd471",
    "name": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
    "documentType": "Protocol",
    "language": "en",
    "instanceType": "StudyDefinitionDocument",
    "version": "3.1 (US)",
    "versionDate": "18 Mar 2022",
    "contentIds": [
      "10c28485-8959-4182-a90f-6d0a8ec64ddf",
      "5e56e3b2-60e2-4b77-8cb9-91be15273c4a",
      "ea76e56b-fa8b-4b4d-a9a7-d60f34373375",
      "e3259edd-d568-4e84-a447-2931be5632c8",
      "e34b37e7-7a94-4bae-9e1d-c443387244a8",
      "ef90f005-c9d4-4cff-ae50-d290abb50883",
      "65b0fbfd-9ad5-491f-a508-b235efac8840",
      "083251dc-a75b-4612-b020-ebb21f19c739",
      "ce00b6b0-a041-4ced-bf80-57388837db1a",
      "844e2af1-98ff-47c4-a6b3-cdfa8c21fd6f",
      "9475750c-7161-439e-b260-1fc1043b8450",
      "39b8dd11-4643-413a-a3e5-e582317d9417",
      "8a26e71c-a067-4108-abef-8d3e8ee325a3",
      "97c67439-693e-4926-a2d4-3994c2c0da3f",
      "3b4bf151-7d88-46a7-9f7e-21c1727154e6"
    ]
  },
  "geographicScope": {
    "id": "a4e917b8-78f3-4520-85e5-68efe148ecbf",
    "name": "Study Geographic Scope",
    "scopeType": "Global",
    "instanceType": "GeographicScope",
    "countryIds": [
      "78ec4c76-6690-45bc-a5a3-312fe53626b8"
    ],
    "regions": [
      "North America",
      "European Union"
    ]
  },
  "countries": [
    {
      "id": "78ec4c76-6690-45bc-a5a3-312fe53626b8",
      "name": "United States",
      "instanceType": "Country",
      "code": "US"
    }
  ],
  "_temp_ingredients": [
    {
      "id": "696b20f5-9338-42ba-af10-c985b0646f28",
      "name": "ALXN1840",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "ALXN1840"
    },
    {
      "id": "ad53e36c-f78c-4cfb-bdc1-8216b9a3167f",
      "name": "Bis-choline tetrathiomolybdate",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "a159c246-d034-453b-8701-fbc25fdb3dcb"
    },
    {
      "id": "dbcb414f-2236-46b7-aa62-e6da1a5cc704",
      "name": "Ammonium tetrathiomolybdate",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "Ammonium tetrathiomolybdate"
    }
  ],
  "_temp_strengths": [
    {
      "id": "2bf4a643-03de-4c82-b4b1-64c54d487592",
      "instanceType": "Strength",
      "value": 15,
      "unit": "mg",
      "numerator": {
        "value": 15,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "tablet"
      }
    },
    {
      "id": "716effa8-3e82-487f-aa73-44eb895b9787",
      "instanceType": "Strength",
      "value": 30,
      "unit": "mg",
      "numerator": {
        "value": 30,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "tablet"
      }
    }
  ],
  "transitionRules": [
    {
      "id": "5ce0baca-dc92-464b-9f1d-edc225b8de0b",
      "name": "Dose Titration",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "fromElementId": "00653982-4d00-440f-a641-398baf19e940",
      "toElementId": "8e348144-4a19-4ab6-a86f-5f95c50f40f1",
      "text": "Increase to 30 mg on Day 29 unless safety concerns exist."
    },
    {
      "id": "1ae7f58c-9163-49aa-8bbf-97c2dd371776",
      "name": "Dose Reduction for Neutrophils",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "text": "If Neutrophils > 30% decrease from baseline, reduce dose to previous level or 15 mg QOD."
    },
    {
      "id": "cee147ce-eba4-486f-b1a8-f21854a001ce",
      "name": "Temporary Interruption for Liver Injury",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "text": "Temporary interruption of dosing if Bilirubin > 2x ULN and ALT > 3x ULN."
    }
  ],
  "documentContentReferences": [
    {
      "id": "a0366062-e099-40ec-b0fe-53fea1676921",
      "name": "Schedule of Activities Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "1.3",
      "sectionTitle": "Schedule of Activities (SoA)",
      "description": "Reference for data collection at time of discontinuation"
    },
    {
      "id": "2297870b-1c50-4e9d-95a0-40d25abcac19",
      "name": "Dose Modification Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "6.6",
      "sectionTitle": "Dose Modification",
      "description": "Reference for liver function abnormality conditions and risk mitigation"
    },
    {
      "id": "b19f0dc5-2c1a-464a-bf01-74b0b138d44d",
      "name": "Pregnancy Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.2.6",
      "sectionTitle": "Pregnancy",
      "description": "Reference for discontinuation due to pregnancy"
    },
    {
      "id": "f29d0a82-8a25-4d98-8278-262b811277d4",
      "name": "Clinical Laboratory Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.2",
      "sectionTitle": "Clinical Laboratory Tests",
      "description": "Reference for the list of required clinical laboratory tests"
    },
    {
      "id": "25fddc16-995f-4d2a-96dd-5fd17cc9195f",
      "name": "AE/SAE Procedures Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.3",
      "sectionTitle": "Adverse Events: Definitions and Procedures",
      "description": "Reference for recording and reporting adverse events"
    },
    {
      "id": "c2b32a55-a886-4a0d-ac35-7b4cf24a0b95",
      "name": "Contraceptive Guidance Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.4",
      "sectionTitle": "Contraceptive Guidance and Collection of Pregnancy Information",
      "description": "Reference for appropriate contraceptive methods"
    },
    {
      "id": "ec3cfdde-e8f4-4cf9-9a31-498287604acd",
      "name": "COVID-19 Risk Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.5",
      "sectionTitle": "COVID-19 Vaccine Risk Assessment",
      "description": "Reference for specific risks and mitigation due to COVID-19 vaccine"
    },
    {
      "id": "61d3116d-7a9e-45c2-8825-6f086413e225",
      "name": "Genetic Testing Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.7",
      "sectionTitle": "Genetics",
      "description": "Reference clarifying that samples will not be used for genetic testing"
    }
  ],
  "commentAnnotations": [
    {
      "id": "aef242e8-28f1-4828-b408-1a07c06bc64d",
      "text": "Procedures specific to screening sites (only in the US) detailed in Section 8",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "1.3 Schedule of Activities (SoA), Table 1",
      "pageNumber": 3
    },
    {
      "id": "fc500379-1fb6-4ad7-bdfd-970fa44c2dc9",
      "text": "The physiologic turnover of human gastrointestinal epithelial cells is 3 - 5 days (Darwich, 2014)",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "4.2 Scientific Rationale for Study Design",
      "pageNumber": 3
    },
    {
      "id": "10439ddf-7f52-4dd8-98b8-1a23856903e6",
      "text": "Acetaminophen should be limited to 1000 mg/day.",
      "annotationType": "Clarification",
      "instanceType": "CommentAnnotation",
      "sourceSection": "5.3 Lifestyle Considerations",
      "pageNumber": 35
    },
    {
      "id": "5490c142-d8fb-4f89-a23b-5b89ece83a6d",
      "text": "Total molybdenum and PUF-molybdenum concentration-time profiles on Day 28 after the last 15 mg ALXN1840 dose will be extrapolated to Day 29 and subtracted from the observed Day 29 concentration-time profiles.",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "9.4.4 Pharmacokinetic Analyses",
      "pageNumber": 53
    }
  ],
  "studyDefinitionDocumentVersions": [
    {
      "id": "364ba11b-5708-4e16-aa46-8673896032ae",
      "versionNumber": "3.1 (US)",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2022-03-18",
      "description": "Substantial amendment to clarify US screening site procedures and facilitate recruitment.",
      "amendmentNumber": "3.1"
    },
    {
      "id": "086399ae-7c33-47bc-b29b-6f0105bf1d26",
      "versionNumber": "3.0",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2021-08-31",
      "description": "Amendment 3",
      "amendmentNumber": "3"
    },
    {
      "id": "7be2a36b-0a05-469b-a970-f84a7244de7b",
      "versionNumber": "2.0",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2021-03-19",
      "description": "Amendment 2",
      "amendmentNumber": "2"
    },
    {
      "id": "5d7840a2-50a8-4ae4-a604-69dd610392d3",
      "versionNumber": "1.0",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2020-08-18",
      "description": "Amendment 1",
      "amendmentNumber": "1"
    },
    {
      "id": "9fc7d884-f37b-46eb-9625-a4536310afce",
      "versionNumber": "Original",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2020-05-12",
      "description": "Original Protocol",
      "amendmentNumber": "N/A"
    }
  ],
  "studyAmendmentImpacts": [
    {
      "id": "842fc472-457c-4568-a1ee-49c5821da088",
      "amendmentId": "57133b45-e5fd-4f27-a268-f64d68720979",
      "affectedSection": "Section 1.3 Schedule of Activities (SoA), Table 1",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Added footnote regarding procedures specific to US screening sites."
    },
    {
      "id": "3aea6c65-0722-44c9-ae24-9129ef42f86d",
      "amendmentId": "57133b45-e5fd-4f27-a268-f64d68720979",
      "affectedSection": "Section 4.2 Scientific Rationale for Study Design",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Updated the duration of zinc inhibitory effects on intestinal copper absorption."
    },
    {
      "id": "ff723eee-c0e8-461b-9eef-e1de1d7c1c54",
      "amendmentId": "57133b45-e5fd-4f27-a268-f64d68720979",
      "affectedSection": "Section 8 Study Assessments and Procedures",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Introduced US-specific provision allowing sites to perform only screening procedures without subsequent study procedures."
    }
  ],
  "studyAmendmentReasons": [
    {
      "id": "a5b39403-fc08-4802-9c1e-3ad954b72926",
      "amendmentId": "57133b45-e5fd-4f27-a268-f64d68720979",
      "reasonText": "To facilitate participant recruitment across different regions of the US and lessen inconvenience for participants without compromising study quality.",
      "category": "Operational",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "cfd13210-9883-4324-9ba5-29e13d4f82e4",
      "amendmentId": "57133b45-e5fd-4f27-a268-f64d68720979",
      "reasonText": "To align the number of days for zinc discontinuation effects with mentions elsewhere in the protocol.",
      "category": "Administrative",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    }
  ],
  "studyChanges": [
    {
      "id": "111466b5-4c43-4573-b3c0-6b051699075d",
      "amendmentId": "57133b45-e5fd-4f27-a268-f64d68720979",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "1.3",
      "afterText": "Procedures specific to screening sites (only in the US) detailed in Section 8",
      "summary": "Added footnote to SoA Table 1 regarding US screening sites."
    },
    {
      "id": "b560a300-e872-4075-afe5-1dda7bd41d8f",
      "amendmentId": "57133b45-e5fd-4f27-a268-f64d68720979",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "4.2",
      "beforeText": "minimal 30 days after discontinuation of zinc",
      "afterText": "minimal 21 days after discontinuation of zinc",
      "summary": "Reduced the expected duration of zinc's inhibitory effect from 30 to 21 days."
    },
    {
      "id": "681f9847-4158-4c36-bf2e-629fc3440da9",
      "amendmentId": "57133b45-e5fd-4f27-a268-f64d68720979",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "8",
      "afterText": "Addition of text applicable only to the US that details the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures.",
      "summary": "Added provision for US-based screening-only sites."
    }
  ],
  "computationalExecution": {
    "ready": true,
    "supportedSystems": [
      "EDC",
      "ePRO",
      "CTMS",
      "RTSM"
    ],
    "validationStatus": "complete"
  }
}